filename
large_stringlengths 31
34
| dataset_variant
large_stringclasses 4
values | marker_table
large_stringlengths 163
6.14k
| gt_table
large_stringlengths 198
6.01k
| gemini_table
large_stringclasses 1
value | marker_score
float64 0.16
1
| image
imagewidth (px) 186
512
|
|---|---|---|---|---|---|---|
image_116545_1634653909.099775.png | fintabnet | <thead><tr><td></td><td>Exhibit Description</td><td>Deferred</td><td>Operating profit</td><td>Quantitative and Qualitative Disclosures About Market Risk</td><td>Property, plant and equipment</td><td>China</td><td colspan="2">XBRL Taxonomy Extension Label Linkbase Document</td><td>Price</td><td colspan="2">Operating Income</td><td>Level 2</td></tr></thead><tbody><tr><td>Treasury Stock</td><td>211154</td><td>309537</td><td>31386</td><td>128375</td><td>586733</td><td></td><td>198364</td><td>953402</td><td>425047</td><td></td><td>739323</td><td>466257</td></tr><tr><td>Exhibit No.</td><td>259595</td><td>731979</td><td></td><td>505072</td><td>369781</td><td>84164</td><td>511505</td><td>851893</td><td>333940</td><td>766142</td><td>971792</td><td>895439</td></tr><tr><td>Time deposits</td><td>699424</td><td>985137</td><td>307884</td><td>759329</td><td></td><td></td><td>439007</td><td>620729</td><td>63456</td><td>619699</td><td>585581</td><td>691584</td></tr><tr><td>Net deferred tax assets</td><td>43041</td><td>278376</td><td>623355</td><td>862510</td><td>167298</td><td>162312</td><td>57188</td><td>544086</td><td>749989</td><td>864483</td><td></td><td>724177</td></tr><tr><td>Amount</td><td>109358</td><td>734739</td><td>640341</td><td>137034</td><td>389569</td><td>957244</td><td>691120</td><td></td><td>719988</td><td>326837</td><td>915340</td><td>461045</td></tr></tbody> | <thead><tr><td></td><td>Exhibit Description</td><td>Deferred</td><td>Operating profit</td><td>Quantitative and Qualitative Disclosures About Market Risk</td><td>Property, plant and equipment</td><td>China</td><td colspan="2">XBRL Taxonomy Extension Label Linkbase Document</td><td>Price</td><td colspan="2">Operating Income</td><td>Level 2</td></tr></thead><tbody><tr><td>Treasury Stock</td><td>211154</td><td>309537</td><td>31386</td><td>128375</td><td>586733</td><td></td><td>198364</td><td>953402</td><td>425047</td><td></td><td>739323</td><td>466257</td></tr><tr><td> Exhibit No.</td><td>259595</td><td>731979</td><td></td><td>505072</td><td>369781</td><td>84164</td><td>511505</td><td>851893</td><td>333940</td><td>766142</td><td>971792</td><td>895439</td></tr><tr><td>Time deposits</td><td>699424</td><td>985137</td><td>307884</td><td>759329</td><td></td><td></td><td>439007</td><td>620729</td><td>63456</td><td>619699</td><td>585581</td><td>691584</td></tr><tr><td>Net deferred tax assets</td><td>43041</td><td>278376</td><td>623355</td><td>862510</td><td>167298</td><td>162312</td><td>57188</td><td>544086</td><td>749989</td><td>864483</td><td></td><td>724177</td></tr><tr><td>Amount</td><td>109358</td><td>734739</td><td>640341</td><td>137034</td><td>389569</td><td>957244</td><td>691120</td><td></td><td>719988</td><td>326837</td><td>915340</td><td>461045</td></tr></tbody> | 0.999008 | ||
image_141683_1634649688.652737.png | pubtabnet | <thead><tr><td>Odds ratio</td><td>Mean Β± SD</td><td>Odds ratio</td><td>Percent</td><td></td><td></td><td></td><td>Men</td><td>Factor</td><td>Model</td><td>SE</td></tr></thead><tbody><tr><td>SD</td><td>43</td><td>82</td><td>54</td><td>31</td><td>44</td><td>45</td><td>4</td><td>62</td><td>5</td><td>41</td></tr><tr><td></td><td>96</td><td>99</td><td>7</td><td>78</td><td>20</td><td>84</td><td>22</td><td>65</td><td>4</td><td>86</td></tr><tr><td>References</td><td>67</td><td>17</td><td>76</td><td>39</td><td>47</td><td>18</td><td>59</td><td>41</td><td>10</td><td>62</td></tr><tr><td>P</td><td></td><td>72</td><td>0</td><td>21</td><td>70</td><td>0</td><td>80</td><td>48</td><td>11</td><td>16</td></tr><tr><td>Item</td><td></td><td>9</td><td>71</td><td>79</td><td>26</td><td>88</td><td>75</td><td></td><td>34</td><td>92</td></tr><tr><td>Study</td><td>53</td><td>70</td><td>64</td><td></td><td>78</td><td>67</td><td></td><td>78</td><td>18</td><td>30</td></tr><tr><td>Value</td><td>25</td><td>97</td><td>83</td><td>1</td><td>14</td><td>49</td><td></td><td>43</td><td></td><td>0</td></tr><tr><td></td><td>52</td><td>95</td><td>85</td><td>91</td><td>24</td><td>69</td><td>50</td><td>24</td><td>83</td><td>20</td></tr><tr><td>p-Value</td><td>86</td><td>96</td><td>21</td><td>84</td><td>80</td><td>70</td><td>49</td><td>16</td><td>25</td><td>16</td></tr><tr><td>Study</td><td>75</td><td>50</td><td></td><td>14</td><td>64</td><td>58</td><td>85</td><td>10</td><td>16</td><td>75</td></tr><tr><td>References</td><td>85</td><td>32</td><td>69</td><td></td><td>36</td><td>98</td><td>68</td><td>75</td><td>89</td><td>83</td></tr><tr><td>P</td><td>20</td><td>25</td><td>63</td><td>90</td><td>66</td><td>11</td><td>54</td><td>36</td><td>20</td><td>6</td></tr></tbody> | <thead><tr><td>Odds ratio</td><td>Mean Β± SD</td><td>Odds ratio</td><td>Percent</td><td colspan="3"></td><td>Men</td><td>Factor</td><td>Model</td><td>SE</td></tr></thead><tbody><tr><td>SD</td><td>43</td><td>82</td><td>54</td><td>31</td><td>44</td><td>45</td><td>4</td><td>62</td><td>5</td><td>41</td></tr><tr><td></td><td>96</td><td>99</td><td>7</td><td>78</td><td>20</td><td>84</td><td>22</td><td>65</td><td>4</td><td>86</td></tr><tr><td>References</td><td>67</td><td>17</td><td>76</td><td>39</td><td>47</td><td>18</td><td>59</td><td>41</td><td>10</td><td>62</td></tr><tr><td>P</td><td></td><td>72</td><td>0</td><td>21</td><td>70</td><td>0</td><td>80</td><td>48</td><td>11</td><td>16</td></tr><tr><td>Item</td><td></td><td>9</td><td>71</td><td>79</td><td>26</td><td>88</td><td>75</td><td></td><td>34</td><td>92</td></tr><tr><td>Study</td><td>53</td><td>70</td><td>64</td><td></td><td>78</td><td>67</td><td></td><td>78</td><td>18</td><td>30</td></tr><tr><td>Value</td><td>25</td><td>97</td><td>83</td><td>1</td><td>14</td><td>49</td><td></td><td>43</td><td></td><td>0</td></tr><tr><td></td><td>52</td><td>95</td><td>85</td><td>91</td><td>24</td><td>69</td><td>50</td><td>24</td><td>83</td><td>20</td></tr><tr><td>p-Value</td><td>86</td><td>96</td><td>21</td><td>84</td><td>80</td><td>70</td><td>49</td><td>16</td><td>25</td><td>16</td></tr><tr><td>Study</td><td>75</td><td>50</td><td></td><td>14</td><td>64</td><td>58</td><td>85</td><td>10</td><td>16</td><td>75</td></tr><tr><td>References</td><td>85</td><td>32</td><td>69</td><td></td><td>36</td><td>98</td><td>68</td><td>75</td><td>89</td><td>83</td></tr><tr><td>P</td><td>20</td><td>25</td><td>63</td><td>90</td><td>66</td><td>11</td><td>54</td><td>36</td><td>20</td><td>6</td></tr></tbody> | 0.981013 | ||
image_106177_1634644558.305029.png | pubtabnet | <thead><tr><td>Baseline</td><td>SE</td><td>t</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>Patient</td><td>C</td><td>Percentage</td><td>Specificity</td><td>Number</td></tr></thead><tbody><tr><td>Female</td><td>17.72%</td><td></td><td></td><td>49.80%</td><td></td><td></td><td>8.51%</td><td>61.54%</td><td>92.25%</td><td>99.4%</td><td>33.79%</td><td>20.99%</td><td>98.92%</td><td>39.85%</td></tr><tr><td>p value</td><td>65.56%</td><td>74.86%</td><td>96.46%</td><td>64.12%</td><td>96.1%</td><td>30.64%</td><td>44.72%</td><td></td><td>88.48%</td><td>41.15%</td><td>62.41%</td><td>47.46%</td><td>91.79%</td><td>3.41%</td></tr><tr><td></td><td>16.55%</td><td>42.81%</td><td>84.48%</td><td>52.51%</td><td>43.1%</td><td>71.16%</td><td>42.51%</td><td>21.87%</td><td>36.28%</td><td>30.15%</td><td>98.49%</td><td>83.15%</td><td>93.13%</td><td>46.88%</td></tr><tr><td></td><td>69.28%</td><td></td><td>95.52%</td><td></td><td>98.21%</td><td>6.92%</td><td>84.63%</td><td>2.98%</td><td>97.87%</td><td>16.62%</td><td>48.20%</td><td>58.76%</td><td>31.19%</td><td>30.38%</td></tr><tr><td>Controls</td><td>85.10%</td><td>29.68%</td><td>39.82%</td><td>40.57%</td><td>71.50%</td><td>73.71%</td><td>54.14%</td><td>66.15%</td><td>4.43%</td><td>55.24%</td><td>58.52%</td><td>52.78%</td><td>5.48%</td><td>6.14%</td></tr><tr><td>p-Value</td><td>58.34%</td><td>64.75%</td><td>54.22%</td><td>54.95%</td><td>43.51%</td><td>6.66%</td><td></td><td>54.44%</td><td></td><td>80.97%</td><td></td><td>8.50%</td><td>74.3%</td><td>35.12%</td></tr><tr><td>Value</td><td>52.67%</td><td>76.69%</td><td>13.76%</td><td>0.67%</td><td>62.21%</td><td>6.28%</td><td></td><td>91.86%</td><td>89.33%</td><td>5.67%</td><td>63.72%</td><td>20.63%</td><td>90.77%</td><td>71.70%</td></tr><tr><td>Frequency</td><td>99.86%</td><td>75.49%</td><td>63.28%</td><td>98.28%</td><td>51.92%</td><td>58.95%</td><td>73.66%</td><td>83.70%</td><td>44.62%</td><td>81.35%</td><td>85.94%</td><td>74.47%</td><td>89.83%</td><td>9.84%</td></tr><tr><td>n</td><td>63.12%</td><td>10.82%</td><td>0.83%</td><td>97.45%</td><td>78.85%</td><td>87.90%</td><td>21.92%</td><td>67.27%</td><td>6.89%</td><td>41.87%</td><td>72.64%</td><td>84.96%</td><td>16.36%</td><td></td></tr><tr><td>Female</td><td>30.67%</td><td>88.88%</td><td>3.23%</td><td>54.61%</td><td>82.85%</td><td>93.1%</td><td></td><td>18.43%</td><td>3.51%</td><td>92.31%</td><td>65.2%</td><td>11.32%</td><td></td><td>87.2%</td></tr><tr><td>Sequence</td><td>69.58%</td><td>93.1%</td><td>53.60%</td><td>58.89%</td><td>38.48%</td><td>62.39%</td><td>53.83%</td><td>48.66%</td><td>65.76%</td><td>82.31%</td><td>2.4%</td><td>36.95%</td><td>18.53%</td><td></td></tr><tr><td>n</td><td></td><td>90.46%</td><td></td><td>55.5%</td><td>41.71%</td><td></td><td>22.22%</td><td>93.92%</td><td>7.49%</td><td>27.6%</td><td>64.20%</td><td></td><td>16.53%</td><td>52.39%</td></tr><tr><td>Control</td><td>43.61%</td><td>19.67%</td><td></td><td>78.41%</td><td>6.48%</td><td>94.66%</td><td>18.43%</td><td></td><td>83.65%</td><td>44.14%</td><td>76.57%</td><td>26.92%</td><td>29.46%</td><td>53.4%</td></tr></tbody> | <thead><tr><td>Baseline</td><td>SE</td><td colspan="8">t</td><td>Patient</td><td>C</td><td>Percentage</td><td>Specificity</td><td>Number</td></tr></thead><tbody><tr><td>Female</td><td>17.72%</td><td></td><td></td><td>49.80%</td><td></td><td></td><td>8.51%</td><td>61.54%</td><td>92.25%</td><td>99.4%</td><td>33.79%</td><td>20.99%</td><td>98.92%</td><td>39.85%</td></tr><tr><td>p value</td><td>65.56%</td><td>74.86%</td><td>96.46%</td><td>64.12%</td><td>96.1%</td><td>30.64%</td><td>44.72%</td><td></td><td>88.48%</td><td>41.15%</td><td>62.41%</td><td>47.46%</td><td>91.79%</td><td>3.41%</td></tr><tr><td></td><td>16.55%</td><td>42.81%</td><td>84.48%</td><td>52.51%</td><td>43.1%</td><td>71.16%</td><td>42.51%</td><td>21.87%</td><td>36.28%</td><td>30.15%</td><td>98.49%</td><td>83.15%</td><td>93.13%</td><td>46.88%</td></tr><tr><td></td><td>69.28%</td><td></td><td>95.52%</td><td></td><td>98.21%</td><td>6.92%</td><td>84.63%</td><td>2.98%</td><td>97.87%</td><td>16.62%</td><td>48.20%</td><td>58.76%</td><td>31.19%</td><td>30.38%</td></tr><tr><td>Controls</td><td>85.10%</td><td>29.68%</td><td>39.82%</td><td>40.57%</td><td>71.50%</td><td>73.71%</td><td>54.14%</td><td>66.15%</td><td>4.43%</td><td>55.24%</td><td>58.52%</td><td>52.78%</td><td>5.48%</td><td>6.14%</td></tr><tr><td>p-Value</td><td>58.34%</td><td>64.75%</td><td>54.22%</td><td>54.95%</td><td>43.51%</td><td>6.66%</td><td></td><td>54.44%</td><td></td><td>80.97%</td><td></td><td>8.50%</td><td>74.3%</td><td>35.12%</td></tr><tr><td>Value</td><td>52.67%</td><td>76.69%</td><td>13.76%</td><td>0.67%</td><td>62.21%</td><td>6.28%</td><td></td><td>91.86%</td><td>89.33%</td><td>5.67%</td><td>63.72%</td><td>20.63%</td><td>90.77%</td><td>71.70%</td></tr><tr><td>Frequency</td><td>99.86%</td><td>75.49%</td><td>63.28%</td><td>98.28%</td><td>51.92%</td><td>58.95%</td><td>73.66%</td><td>83.70%</td><td>44.62%</td><td>81.35%</td><td>85.94%</td><td>74.47%</td><td>89.83%</td><td>9.84%</td></tr><tr><td>n</td><td>63.12%</td><td>10.82%</td><td>0.83%</td><td>97.45%</td><td>78.85%</td><td>87.90%</td><td>21.92%</td><td>67.27%</td><td>6.89%</td><td>41.87%</td><td>72.64%</td><td>84.96%</td><td>16.36%</td><td></td></tr><tr><td>Female</td><td>30.67%</td><td>88.88%</td><td>3.23%</td><td>54.61%</td><td>82.85%</td><td>93.1%</td><td></td><td>18.43%</td><td>3.51%</td><td>92.31%</td><td>65.2%</td><td>11.32%</td><td></td><td>87.2%</td></tr><tr><td>Sequence</td><td>69.58%</td><td>93.1%</td><td>53.60%</td><td>58.89%</td><td>38.48%</td><td>62.39%</td><td>53.83%</td><td>48.66%</td><td>65.76%</td><td>82.31%</td><td>2.4%</td><td>36.95%</td><td>18.53%</td><td></td></tr><tr><td>n</td><td></td><td>90.46%</td><td></td><td>55.5%</td><td>41.71%</td><td></td><td>22.22%</td><td>93.92%</td><td>7.49%</td><td>27.6%</td><td>64.20%</td><td></td><td>16.53%</td><td>52.39%</td></tr><tr><td>Control</td><td>43.61%</td><td>19.67%</td><td></td><td>78.41%</td><td>6.48%</td><td>94.66%</td><td>18.43%</td><td></td><td>83.65%</td><td>44.14%</td><td>76.57%</td><td>26.92%</td><td>29.46%</td><td>53.4%</td></tr></tbody> | 0.964602 | ||
image_020349_1634633631.576039.png | fintabnet | <thead><tr><td>Net interest income</td><td></td><td>Total minimum lease payments</td><td>Distribution</td><td></td><td>Level 1</td><td>Beginning balance</td><td>Exhibit Description</td><td>December 31, 2007</td><td>Baa1</td><td>Asset Category</td><td>Sales</td><td>Diluted earnings per share</td></tr></thead><tbody><tr><td></td><td>Balance at end of year</td><td>Consolidated</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>December 31, 2015</td><td>Foreign exchange</td></tr><tr><td>Fair Value</td><td>Asset Management</td><td></td><td>Cost</td><td>December 31, 2009</td><td></td><td>Goodwill</td><td>For the Years Ended December 31,</td><td>High</td><td>Certain Relationships and Related Transactions, and Director Independence</td><td>Item 13.</td><td>Non-U.S.</td><td>Exhibit Number</td></tr><tr><td>Gross profit</td><td>Commercial real estate</td><td>Total debt</td><td>Amortized Cost</td><td>Southeast</td><td>Other accrued liabilities</td><td>Total current</td><td>December 31</td><td>Accumulated other comprehensive income loss</td><td>Total loans</td><td>Operating profit</td><td>Loss on extinguishment of debt</td><td>76.64%</td></tr><tr><td>Description</td><td></td><td>In millions, except per share data</td><td>ExhibitNumber</td><td>Foreign currency translation</td><td>O&R</td><td>B</td><td>Corporate and other</td><td>Net interest revenue</td><td></td><td>Rate of compensation increase</td><td>Dollars in millions</td><td>F-5</td></tr><tr><td>West</td><td>Minority interest</td><td>961.54</td><td>$ in millions</td><td>Net amount recognized</td><td>Net Income</td><td></td><td>Interest rate swaps</td><td>Amortization of prior service cost</td><td>In thousands of dollars</td><td>Other income</td><td>O&R</td><td>Year Ended December 31</td></tr><tr><td>Year Ended December</td><td>Florida</td><td>Accrued interest</td><td></td><td>December 31, 2018</td><td>Total capital</td><td>Currency</td><td>Volatility</td><td>Other intangible assets, net</td><td>Research and development</td><td>Millions of Dollars</td><td>Interest expense, net</td><td>Expired</td></tr><tr><td>Notes payable</td><td></td><td>Fair value</td><td></td><td>Assets</td><td>Fair value</td><td>PART I</td><td>Other long-term assets</td><td>F-7</td><td>Accumulated depreciation</td><td>Other expense, net</td><td>TX</td><td>Description</td></tr><tr><td>Accumulated other comprehensive income loss</td><td>Total liabilities</td><td>Dollars in millions</td><td>Second quarter</td><td>AA</td><td>Premiums</td><td>Fourth Quarter</td><td>dollar amounts in thousands</td><td>Revenues</td><td>Loans held for sale</td><td>Net interest revenue</td><td>$ Change</td><td></td></tr><tr><td>X</td><td>Total net revenue</td><td>Balance at beginning of year</td><td>Total capital</td><td>South Central</td><td>Weighted average common shares outstanding</td><td>Ameren Missouri</td><td>Net Sales</td><td>Year ended December 31,</td><td>December 31, 2015</td><td>Years ended December 31</td><td>Current liabilities:</td><td>Commercial and industrial</td></tr><tr><td>Revenue</td><td>Cash and cash equivalents at end of year</td><td>Reports of Independent Registered Public Accounting Firm</td><td>Properties</td><td>High</td><td>$ in millions</td><td>millions of dollars</td><td>Balance at end of period</td><td>Depreciation</td><td>Other</td><td>β%</td><td>Second quarter</td><td>December 31, 2012</td></tr><tr><td></td><td>Dividends paid</td><td>Revenues</td><td>High</td><td>All other</td><td>Filed herewith</td><td></td><td>Other comprehensive income loss</td><td>Entergy New Orleans</td><td>Years ended December 31,</td><td>In-process research and development</td><td>Purchases</td><td>millions of dollars</td></tr><tr><td>Insurance</td><td>December 31, 2011</td><td><sup>2</sup></td><td>Interest income</td><td>Current:</td><td>Subtotal</td><td>North America</td><td>Years Ended December 31,</td><td>Revisions of previous estimates</td><td>Rate</td><td>Exhibit No.</td><td>Trademarks</td><td>Exhibit</td></tr><tr><td>Net deferred tax liability</td><td>Leasehold improvements</td><td>Discontinued operations</td><td></td><td>Actuarial gain loss</td><td>Due after ten years</td><td>U.S.</td><td>Entergy Mississippi</td><td>AccumulatedAmortization</td><td>Midwest</td><td>Investments</td><td>Property, plant and equipment</td><td>Net cash provided by financing activities</td></tr><tr><td>Income taxes payable</td><td></td><td>Entergy Texas</td><td>AA-</td><td>Capital lease obligations</td><td>$ Change</td><td>n/a</td><td></td><td>Short-term debt</td><td>Net earnings</td><td>Weighted average common shares outstanding</td><td>Electric</td><td>Manufacturing</td></tr><tr><td>Item 3.</td><td></td><td>Property, plant and equipment, net</td><td>Amount</td><td>Item 1A.</td><td>Total stockholders' equity</td><td>March 31,</td><td>North America</td><td>Years ended December 31,</td><td>*</td><td>Cash and cash equivalents at end of period</td><td>December 31, 2014</td><td>Actual return on plan assets</td></tr></tbody> | <thead><tr><td>Net interest income</td><td></td><td>Total minimum lease payments</td><td>Distribution</td><td></td><td>Level 1</td><td>Beginning balance</td><td>Exhibit Description</td><td>December 31, 2007</td><td>Baa1</td><td>Asset Category</td><td>Sales</td><td>Diluted earnings per share</td></tr><tr><td></td><td>Balance at end of year</td><td colspan="9">Consolidated</td><td>December 31, 2015</td><td>Foreign exchange</td></tr></thead><tbody><tr><td> Fair Value</td><td>Asset Management</td><td></td><td> Cost</td><td>December 31, 2009</td><td></td><td>Goodwill</td><td>For the Years Ended December 31,</td><td>High</td><td>Certain Relationships and Related Transactions, and Director Independence</td><td>Item 13.</td><td>Non-U.S.</td><td> Exhibit Number</td></tr><tr><td>Gross profit</td><td>Commercial real estate</td><td>Total debt</td><td>Amortized Cost</td><td>Southeast</td><td>Other accrued liabilities</td><td>Total current</td><td>December 31</td><td>Accumulated other comprehensive income loss</td><td>Total loans</td><td>Operating profit</td><td>Loss on extinguishment of debt</td><td>76.64%</td></tr><tr><td>Description</td><td></td><td>In millions, except per share data</td><td>ExhibitNumber</td><td>Foreign currency translation</td><td>O&R</td><td>B</td><td>Corporate and other</td><td>Net interest revenue</td><td></td><td>Rate of compensation increase</td><td> Dollars in millions</td><td>F-5</td></tr><tr><td>West</td><td>Minority interest</td><td>961.54</td><td> $ in millions</td><td>Net amount recognized</td><td> Net Income</td><td></td><td>Interest rate swaps</td><td>Amortization of prior service cost</td><td> In thousands of dollars</td><td>Other income</td><td>O&R</td><td>Year Ended December 31</td></tr><tr><td>Year Ended December</td><td>Florida</td><td>Accrued interest</td><td></td><td>December 31, 2018</td><td>Total capital</td><td>Currency</td><td>Volatility</td><td>Other intangible assets, net</td><td>Research and development</td><td>Millions of Dollars</td><td>Interest expense, net</td><td>Expired</td></tr><tr><td>Notes payable</td><td></td><td>Fair value</td><td></td><td>Assets</td><td>Fair value</td><td>PART I</td><td>Other long-term assets</td><td>F-7</td><td>Accumulated depreciation</td><td>Other expense, net</td><td>TX</td><td>Description</td></tr><tr><td>Accumulated other comprehensive income loss</td><td>Total liabilities</td><td>Dollars in millions</td><td>Second quarter</td><td>AA</td><td>Premiums</td><td> Fourth Quarter</td><td>dollar amounts in thousands</td><td>Revenues</td><td>Loans held for sale</td><td>Net interest revenue</td><td>$ Change</td><td></td></tr><tr><td>X</td><td>Total net revenue</td><td>Balance at beginning of year</td><td>Total capital</td><td>South Central</td><td>Weighted average common shares outstanding</td><td>Ameren Missouri</td><td>Net Sales</td><td> Year ended December 31,</td><td>December 31, 2015</td><td>Years ended December 31</td><td>Current liabilities:</td><td>Commercial and industrial</td></tr><tr><td>Revenue</td><td>Cash and cash equivalents at end of year</td><td>Reports of Independent Registered Public Accounting Firm</td><td>Properties</td><td>High</td><td> $ in millions</td><td>millions of dollars</td><td>Balance at end of period</td><td>Depreciation</td><td>Other</td><td>β%</td><td>Second quarter</td><td>December 31, 2012</td></tr><tr><td></td><td>Dividends paid</td><td>Revenues</td><td> High</td><td>All other</td><td>Filed herewith</td><td></td><td>Other comprehensive income loss</td><td>Entergy New Orleans</td><td> Years ended December 31,</td><td>In-process research and development</td><td>Purchases</td><td>millions of dollars</td></tr><tr><td>Insurance</td><td>December 31, 2011</td><td><sup>2</sup></td><td>Interest income</td><td>Current:</td><td>Subtotal</td><td>North America</td><td>Years Ended December 31,</td><td>Revisions of previous estimates</td><td>Rate</td><td>Exhibit No.</td><td>Trademarks</td><td> Exhibit</td></tr><tr><td>Net deferred tax liability</td><td>Leasehold improvements</td><td>Discontinued operations</td><td></td><td>Actuarial gain loss</td><td>Due after ten years</td><td>U.S.</td><td>Entergy Mississippi</td><td>AccumulatedAmortization</td><td>Midwest</td><td>Investments</td><td>Property, plant and equipment</td><td>Net cash provided by financing activities</td></tr><tr><td>Income taxes payable</td><td></td><td>Entergy Texas</td><td>AA-</td><td>Capital lease obligations</td><td>$ Change</td><td>n/a</td><td></td><td>Short-term debt</td><td>Net earnings</td><td>Weighted average common shares outstanding</td><td>Electric</td><td>Manufacturing</td></tr><tr><td>Item 3.</td><td></td><td>Property, plant and equipment, net</td><td>Amount</td><td>Item 1A.</td><td>Total stockholdersβ equity</td><td>March 31,</td><td>North America</td><td> Years ended December 31,</td><td>*</td><td>Cash and cash equivalents at end of period</td><td>December 31, 2014</td><td>Actual return on plan assets</td></tr></tbody> | 0.937292 | ||
image_092747_1634640521.495164.png | sparse | <thead><tr><td>Item</td><td colspan="3">References</td><td>Univariate analysis</td><td></td><td>Age years</td></tr></thead><tbody><tr><td>P</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td>92</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>SNP</td><td>43</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Patient</td><td></td><td></td><td></td><td></td><td></td><td>33</td></tr><tr><td>Specificity</td><td></td><td>79</td><td>2</td><td></td><td></td><td>84</td></tr><tr><td>Name</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Location</td><td></td><td></td><td></td><td>53</td><td>9</td><td>5</td></tr><tr><td>Sensitivity</td><td></td><td></td><td></td><td>36</td><td>13</td><td></td></tr></tbody> | <thead><tr><td>Item</td><td colspan="3">References</td><td>Univariate analysis</td><td></td><td>Age years</td></tr></thead><tbody><tr><td>P</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td>92</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>SNP</td><td>43</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Patient</td><td></td><td></td><td></td><td></td><td></td><td>33</td></tr><tr><td>Specificity</td><td></td><td>79</td><td>2</td><td></td><td></td><td>84</td></tr><tr><td>Name</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Location</td><td></td><td></td><td></td><td>53</td><td>9</td><td>5</td></tr><tr><td>Sensitivity</td><td></td><td></td><td></td><td>36</td><td>13</td><td></td></tr></tbody> | 1 | ||
image_099081_1634650328.096903.png | fintabnet | <thead><tr><td>Other liabilities</td><td>Amount</td><td>$β</td><td>Owned</td><td>Net cash provided by operating activities</td><td>United States</td><td>Second Quarter</td><td></td><td>Amount</td></tr></thead><tbody><tr><td></td><td></td><td></td><td></td><td>X</td><td>$β</td><td></td><td>Accounts payable</td><td></td></tr><tr><td>Net sales</td><td>Amount</td><td></td><td>Gross profit</td><td>β</td><td>10-Q</td><td>32.39</td><td></td><td></td></tr><tr><td>10-Q</td><td>Amount</td><td>Dollars in millions</td><td>Long-term debt</td><td>Interest income</td><td>Third Quarter</td><td>State</td><td>In millions</td><td>Europe</td></tr><tr><td>Interest cost</td><td>Vested</td><td>In millions</td><td>Total</td><td>Other</td><td>Depreciation and amortization</td><td></td><td>Net cash provided by operating activities</td><td>Net sales</td></tr><tr><td>Net income loss</td><td>Long-term debt</td><td>$ in millions</td><td>Operating income</td><td></td><td>$β</td><td></td><td>December 31,</td><td>Cash and cash equivalents</td></tr><tr><td>β%</td><td>Accounts payable</td><td>Third Quarter</td><td>Net income loss</td><td>Inventories</td><td>in millions</td><td>Shares</td><td>Description</td><td></td></tr><tr><td>Discount rate</td><td>Fourth Quarter</td><td>β%</td><td>December 31,</td><td></td><td>Net income</td><td></td><td></td><td>in millions</td></tr><tr><td>Other assets</td><td></td><td>Deferred income taxes</td><td>Net cash provided by operating activities</td><td>In thousands</td><td></td><td>December 31,</td><td></td><td>Operating income</td></tr><tr><td></td><td>Third Quarter</td><td>Other, net</td><td>NA</td><td>n/a</td><td>Europe</td><td>U.S.</td><td>Year Ended December 31,</td><td>Interest cost</td></tr><tr><td></td><td>NM</td><td>Net earnings</td><td>Other, net</td><td></td><td>Low</td><td>Low</td><td>8-K</td><td>in thousands</td></tr><tr><td>Other, net</td><td>Operating income</td><td>Interest cost</td><td>Dollars in millions</td><td></td><td>Interest income</td><td>$β</td><td>Cash and cash equivalents</td><td>Diluted</td></tr><tr><td>Total assets</td><td>40387.9$</td><td></td><td>Other, net</td><td>Total</td><td>$β</td><td>Canada</td><td>Net income loss</td><td>$-</td></tr><tr><td>Federal</td><td>42.72%</td><td>Depreciation and amortization</td><td>Net income</td><td>10-Q</td><td>Year Ended December 31,</td><td>Other assets</td><td>10-Q</td><td>State</td></tr><tr><td></td><td>State</td><td>Total liabilities</td><td></td><td>496522</td><td></td><td></td><td>In thousands</td><td>In millions</td></tr><tr><td>$-</td><td>Forfeited</td><td>Income from continuing operations</td><td>U.S.</td><td>Equity securities</td><td></td><td>International</td><td>In millions</td><td>β</td></tr><tr><td>Discount rate</td><td>Net income</td><td>96.30</td><td>Cash and cash equivalents</td><td>*</td><td></td><td></td><td>Other</td><td>$β</td></tr><tr><td>β</td><td></td><td>8-K</td><td>$-</td><td>Europe</td><td>Goodwill</td><td>Net income</td><td>In thousands</td><td>Third Quarter</td></tr><tr><td>Interest cost</td><td>Total revenues</td><td>in thousands</td><td>Third Quarter</td><td></td><td>Net income</td><td>In millions</td><td>Other liabilities</td><td>Other, net</td></tr></tbody> | <thead><tr><td>Other liabilities</td><td>Amount</td><td rowspan="3">$β</td><td>Owned</td><td>Net cash provided by operating activities</td><td>United States</td><td>Second Quarter</td><td></td><td>Amount</td></tr><tr><td> </td><td></td><td></td><td>X</td><td>$β</td><td></td><td>Accounts payable</td><td></td></tr><tr><td>Net sales</td><td>Amount</td><td>Gross profit</td><td>β</td><td>10-Q</td><td colspan="3">32.39</td></tr></thead><tbody><tr><td>10-Q</td><td>Amount</td><td>Dollars in millions</td><td>Long-term debt</td><td>Interest income</td><td>Third Quarter</td><td>State</td><td>In millions</td><td>Europe</td></tr><tr><td>Interest cost</td><td>Vested</td><td> In millions</td><td>Total</td><td>Other</td><td>Depreciation and amortization</td><td></td><td>Net cash provided by operating activities</td><td>Net sales</td></tr><tr><td>Net income loss</td><td>Long-term debt</td><td>$ in millions</td><td>Operating income</td><td></td><td>$β</td><td></td><td>December 31,</td><td>Cash and cash equivalents</td></tr><tr><td>β%</td><td>Accounts payable</td><td>Third Quarter</td><td>Net income loss</td><td>Inventories</td><td>in millions</td><td>Shares</td><td>Description</td><td></td></tr><tr><td>Discount rate</td><td>Fourth Quarter</td><td>β%</td><td> December 31,</td><td></td><td>Net income</td><td></td><td></td><td>in millions</td></tr><tr><td>Other assets</td><td></td><td>Deferred income taxes</td><td>Net cash provided by operating activities</td><td>In thousands</td><td></td><td>December 31,</td><td></td><td>Operating income</td></tr><tr><td></td><td>Third Quarter</td><td>Other, net</td><td>NA</td><td>n/a</td><td>Europe</td><td>U.S.</td><td> Year Ended December 31,</td><td>Interest cost</td></tr><tr><td></td><td>NM</td><td>Net earnings</td><td>Other, net</td><td></td><td>Low</td><td>Low</td><td>8-K</td><td>in thousands</td></tr><tr><td>Other, net</td><td>Operating income</td><td>Interest cost</td><td>Dollars in millions</td><td></td><td>Interest income</td><td>$β</td><td>Cash and cash equivalents</td><td>Diluted</td></tr><tr><td>Total assets</td><td>40387.9$</td><td></td><td>Other, net</td><td> Total</td><td>$β</td><td>Canada</td><td>Net income loss</td><td>$-</td></tr><tr><td>Federal</td><td>42.72%</td><td>Depreciation and amortization</td><td>Net income</td><td>10-Q</td><td> Year Ended December 31,</td><td>Other assets</td><td>10-Q</td><td>State</td></tr><tr><td></td><td>State</td><td>Total liabilities</td><td></td><td>496522</td><td></td><td></td><td> In thousands</td><td> In millions</td></tr><tr><td>$-</td><td>Forfeited</td><td>Income from continuing operations</td><td>U.S.</td><td>Equity securities</td><td></td><td>International</td><td> In millions</td><td> β</td></tr><tr><td>Discount rate</td><td>Net income</td><td>96.30</td><td>Cash and cash equivalents</td><td>*</td><td></td><td></td><td>Other</td><td>$β</td></tr><tr><td>β</td><td></td><td>8-K</td><td>$-</td><td>Europe</td><td>Goodwill</td><td>Net income</td><td>In thousands</td><td>Third Quarter</td></tr><tr><td>Interest cost</td><td>Total revenues</td><td>in thousands</td><td>Third Quarter</td><td></td><td>Net income</td><td>In millions</td><td>Other liabilities</td><td>Other, net</td></tr></tbody> | 0.936699 | ||
image_110211_1634642629.465945.png | sparse | <thead><tr><td>Percentage</td><td>61.9%</td><td>Gender</td><td>Source</td><td>Cases</td><td>Category</td><td>Women</td><td>Age years</td><td>Genotype</td></tr></thead><tbody><tr><td>Male</td><td></td><td>469.38</td><td>Value</td><td>Model</td><td></td><td></td><td></td><td>Year</td></tr><tr><td>p Value</td><td>16</td><td></td><td></td><td></td><td></td><td>28</td><td></td><td></td></tr><tr><td>Male</td><td></td><td></td><td>65</td><td></td><td></td><td></td><td>30</td><td></td></tr><tr><td>SE</td><td></td><td></td><td></td><td></td><td></td><td></td><td>33</td><td>56</td></tr><tr><td>Description</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Year</td><td></td><td></td><td></td><td></td><td></td><td></td><td>59</td><td></td></tr><tr><td>Women</td><td>72</td><td></td><td>87</td><td></td><td></td><td>78</td><td></td><td></td></tr><tr><td>Parameters</td><td>44</td><td></td><td>64</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Outcome</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>6</td></tr><tr><td>Groups</td><td>69</td><td>77</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>P-value</td><td></td><td></td><td>89</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Study</td><td></td><td>81</td><td>49</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>26</td><td></td><td>23</td><td></td><td>64</td><td></td><td></td><td></td></tr><tr><td>Gender</td><td></td><td></td><td></td><td>7</td><td></td><td></td><td></td><td></td></tr><tr><td>N %</td><td></td><td></td><td></td><td></td><td></td><td>70</td><td></td><td></td></tr><tr><td>Male</td><td></td><td></td><td></td><td></td><td>31</td><td></td><td></td><td></td></tr><tr><td>Country</td><td></td><td></td><td></td><td></td><td></td><td>50</td><td></td><td>88</td></tr><tr><td>Mean Β± SD</td><td></td><td>34</td><td>20</td><td>8</td><td></td><td></td><td></td><td></td></tr><tr><td>Variable</td><td></td><td>53</td><td></td><td>58</td><td></td><td></td><td></td><td></td></tr><tr><td>Patient</td><td></td><td></td><td>28</td><td></td><td></td><td></td><td></td><td></td></tr></tbody> | <thead><tr><td>Percentage</td><td>61.9%</td><td>Gender</td><td>Source</td><td>Cases</td><td>Category</td><td>Women</td><td>Age years</td><td>Genotype</td></tr><tr><td>Male</td><td></td><td>469.38</td><td>Value</td><td colspan="4">Model</td><td>Year</td></tr></thead><tbody><tr><td>p Value</td><td>16</td><td></td><td></td><td></td><td></td><td>28</td><td></td><td></td></tr><tr><td>Male</td><td></td><td></td><td>65</td><td></td><td></td><td></td><td>30</td><td></td></tr><tr><td>SE</td><td></td><td></td><td></td><td></td><td></td><td></td><td>33</td><td>56</td></tr><tr><td>Description</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Year</td><td></td><td></td><td></td><td></td><td></td><td></td><td>59</td><td></td></tr><tr><td>Women</td><td>72</td><td></td><td>87</td><td></td><td></td><td>78</td><td></td><td></td></tr><tr><td>Parameters</td><td>44</td><td></td><td>64</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Outcome</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>6</td></tr><tr><td>Groups</td><td>69</td><td>77</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>P-value</td><td></td><td></td><td>89</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Study</td><td></td><td>81</td><td>49</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>26</td><td></td><td>23</td><td></td><td>64</td><td></td><td></td><td></td></tr><tr><td>Gender</td><td></td><td></td><td></td><td>7</td><td></td><td></td><td></td><td></td></tr><tr><td>N %</td><td></td><td></td><td></td><td></td><td></td><td>70</td><td></td><td></td></tr><tr><td>Male</td><td></td><td></td><td></td><td></td><td>31</td><td></td><td></td><td></td></tr><tr><td>Country</td><td></td><td></td><td></td><td></td><td></td><td>50</td><td></td><td>88</td></tr><tr><td>Mean Β± SD</td><td></td><td>34</td><td>20</td><td>8</td><td></td><td></td><td></td><td></td></tr><tr><td>Variable</td><td></td><td>53</td><td></td><td>58</td><td></td><td></td><td></td><td></td></tr><tr><td>Patient</td><td></td><td></td><td>28</td><td></td><td></td><td></td><td></td><td></td></tr></tbody> | 0.962264 | ||
image_102275_1634643991.778837.png | pubtabnet | <thead><tr><td>Source</td><td>Gene name</td><td>65.34%</td><td>95% CI</td><td>95% CI</td><td>Method</td><td>Groups</td><td>Species</td><td>Factor</td><td></td><td></td><td colspan="2">Percentage</td></tr></thead><tbody><tr><td>Genotype</td><td></td><td>48.15%</td><td>28.6%</td><td>13.42%</td><td>40.70%</td><td>12.62%</td><td>13.71%</td><td>87.72%</td><td>97.48%</td><td>94.52%</td><td>98.20%</td><td>43.25%</td></tr><tr><td>Value</td><td>81.38%</td><td>64.32%</td><td></td><td>53.57%</td><td>75.77%</td><td>6.17%</td><td>20.27%</td><td>98.64%</td><td>56.17%</td><td>48.33%</td><td>42.29%</td><td>58.24%</td></tr><tr><td>C</td><td>85.68%</td><td>97.65%</td><td>21.75%</td><td>91.65%</td><td></td><td>57.91%</td><td>71.39%</td><td>64.12%</td><td>45.98%</td><td>24.68%</td><td>65.46%</td><td>72.62%</td></tr><tr><td></td><td>9.17%</td><td>3.87%</td><td>73.39%</td><td>64.33%</td><td>60.52%</td><td></td><td></td><td>37.3%</td><td>89.22%</td><td>38.26%</td><td>84.85%</td><td>38.23%</td></tr><tr><td>Mean SD</td><td>37.19%</td><td>45.50%</td><td>41.45%</td><td>40.60%</td><td></td><td></td><td>4.13%</td><td></td><td>37.12%</td><td>48.50%</td><td>63.44%</td><td>71.92%</td></tr></tbody> | <thead><tr><td>Source</td><td>Gene name</td><td>65.34%</td><td>95% CI</td><td>95% CI</td><td>Method</td><td>Groups</td><td>Species</td><td colspan="3">Factor</td><td colspan="2">Percentage</td></tr></thead><tbody><tr><td>Genotype</td><td></td><td>48.15%</td><td>28.6%</td><td>13.42%</td><td>40.70%</td><td>12.62%</td><td>13.71%</td><td>87.72%</td><td>97.48%</td><td>94.52%</td><td>98.20%</td><td>43.25%</td></tr><tr><td>Value</td><td>81.38%</td><td>64.32%</td><td></td><td>53.57%</td><td>75.77%</td><td>6.17%</td><td>20.27%</td><td>98.64%</td><td>56.17%</td><td>48.33%</td><td>42.29%</td><td>58.24%</td></tr><tr><td>C</td><td>85.68%</td><td>97.65%</td><td>21.75%</td><td>91.65%</td><td></td><td>57.91%</td><td>71.39%</td><td>64.12%</td><td>45.98%</td><td>24.68%</td><td>65.46%</td><td>72.62%</td></tr><tr><td></td><td>9.17%</td><td>3.87%</td><td>73.39%</td><td>64.33%</td><td>60.52%</td><td></td><td></td><td>37.3%</td><td>89.22%</td><td>38.26%</td><td>84.85%</td><td>38.23%</td></tr><tr><td>Mean SD</td><td>37.19%</td><td>45.50%</td><td>41.45%</td><td>40.60%</td><td></td><td></td><td>4.13%</td><td></td><td>37.12%</td><td>48.50%</td><td>63.44%</td><td>71.92%</td></tr></tbody> | 0.964706 | ||
image_136655_1634645848.072452.png | sparse | <thead><tr><td>Mean</td><td>Age</td><td>No</td><td colspan="2">Category</td><td>Controls</td><td colspan="2">Outcome</td></tr><tr><td>Total</td><td>Genotype</td><td>Baseline</td><td>Mean</td><td>SNP</td><td>OR 95% CI</td><td>Number</td><td>p</td></tr></thead><tbody><tr><td>Control</td><td></td><td>74</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Name</td><td>60</td><td></td><td></td><td></td><td></td><td></td><td>86</td></tr><tr><td>Gene</td><td></td><td></td><td></td><td></td><td></td><td>30</td><td></td></tr><tr><td>Factor</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Type</td><td></td><td></td><td></td><td></td><td>75</td><td></td><td></td></tr><tr><td>Author</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Region</td><td></td><td></td><td>91</td><td></td><td></td><td></td><td></td></tr><tr><td>Model</td><td></td><td></td><td></td><td></td><td>93</td><td></td><td></td></tr><tr><td>Study</td><td></td><td>90</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cases</td><td></td><td>77</td><td></td><td></td><td>14</td><td>19</td><td></td></tr><tr><td>Characteristics</td><td></td><td></td><td>1</td><td>47</td><td></td><td>96</td><td>19</td></tr></tbody> | <thead><tr><td>Mean</td><td>Age</td><td>No</td><td colspan="2">Category</td><td>Controls</td><td colspan="2">Outcome</td></tr><tr><td>Total</td><td>Genotype</td><td>Baseline</td><td>Mean</td><td>SNP</td><td>OR 95% CI</td><td>Number</td><td>p</td></tr></thead><tbody><tr><td>Control</td><td></td><td>74</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Name</td><td>60</td><td></td><td></td><td></td><td></td><td></td><td>86</td></tr><tr><td>Gene</td><td></td><td></td><td></td><td></td><td></td><td>30</td><td></td></tr><tr><td>Factor</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Type</td><td></td><td></td><td></td><td></td><td>75</td><td></td><td></td></tr><tr><td>Author</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Region</td><td></td><td></td><td>91</td><td></td><td></td><td></td><td></td></tr><tr><td>Model</td><td></td><td></td><td></td><td></td><td>93</td><td></td><td></td></tr><tr><td>Study</td><td></td><td>90</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cases</td><td></td><td>77</td><td></td><td></td><td>14</td><td>19</td><td></td></tr><tr><td>Characteristics</td><td></td><td></td><td>1</td><td>47</td><td></td><td>96</td><td>19</td></tr></tbody> | 1 | ||
image_010549_1634631557.997032.png | fintabnet | <thead><tr><td>Dividends paid</td><td></td><td>Cash dividends declared</td></tr></thead><tbody><tr><td>Mortgage-backed securities</td><td>December 31, 2017</td><td>Other operating expenses</td></tr><tr><td>Average interest rate</td><td>Accrued expenses</td><td>Subtotal</td></tr><tr><td></td><td>Liabilities:</td><td>Common stock</td></tr><tr><td>Change</td><td>Asset Category</td><td>Third Quarter</td></tr><tr><td>Services</td><td>Share-based compensation</td><td>December 31, 2015</td></tr><tr><td>Marketing</td><td>Accrued liabilities</td><td>State and local</td></tr><tr><td>Net income available to common shareholders</td><td>Vested</td><td>Gross deferred tax assets</td></tr><tr><td>Australia</td><td>Distribution</td><td>Money market funds</td></tr><tr><td>Cost</td><td>IBRF</td><td></td></tr><tr><td>O&R</td><td>Noninterest expense</td><td></td></tr><tr><td>Total expenses</td><td>Automobile</td><td>Net loss income</td></tr><tr><td>Foreign exchange contracts</td><td>Net</td><td>Net Income</td></tr><tr><td>Provision for income taxes</td><td>Year ended December 31,</td><td>PART IV</td></tr></tbody> | <thead><tr><td colspan="2">Dividends paid</td><td>Cash dividends declared</td></tr></thead><tbody><tr><td>Mortgage-backed securities</td><td>December 31, 2017</td><td>Other operating expenses</td></tr><tr><td>Average interest rate</td><td>Accrued expenses</td><td>Subtotal</td></tr><tr><td></td><td>Liabilities:</td><td>Common stock</td></tr><tr><td>Change</td><td>Asset Category</td><td>Third Quarter</td></tr><tr><td>Services</td><td>Share-based compensation</td><td>December 31, 2015</td></tr><tr><td>Marketing</td><td>Accrued liabilities</td><td>State and local</td></tr><tr><td>Net income available to common shareholders</td><td>Vested</td><td>Gross deferred tax assets</td></tr><tr><td>Australia</td><td>Distribution</td><td>Money market funds</td></tr><tr><td>Cost</td><td>IBRF</td><td><sup> </sup></td></tr><tr><td>O&R</td><td>Noninterest expense</td><td></td></tr><tr><td>Total expenses</td><td>Automobile</td><td>Net loss income</td></tr><tr><td>Foreign exchange contracts</td><td> Net</td><td>Net Income</td></tr><tr><td>Provision for income taxes</td><td>Year ended December 31,</td><td> PART IV</td></tr></tbody> | 0.94181 | ||
image_121299_1634643982.768223.png | sparse | <thead><tr><td>Ξ²</td><td>Range</td><td></td><td>References</td><td>Author</td><td>Sensitivity</td><td>Treatment</td><td>Women</td><td>Female</td><td>Male</td></tr></thead><tbody><tr><td></td><td></td><td></td><td>P-value</td><td>Reference</td><td>No.</td><td>p-Value</td><td>p value</td><td>A</td><td>Year</td></tr><tr><td>N</td><td>Female</td><td>Female</td><td>p</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>All</td><td></td><td></td><td></td><td>2</td><td></td><td></td><td></td><td>17</td><td></td></tr><tr><td>Percentage</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>43</td><td></td></tr><tr><td>SNP</td><td></td><td></td><td>75</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>N</td><td></td><td>59</td><td></td><td></td><td></td><td>76</td><td>16</td><td>80</td><td>94</td></tr><tr><td>n</td><td></td><td></td><td></td><td>73</td><td></td><td></td><td></td><td></td><td>36</td></tr><tr><td>OR</td><td></td><td></td><td></td><td>6</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>M</td><td></td><td>41</td><td></td><td></td><td></td><td></td><td></td><td>77</td><td></td></tr><tr><td>Description</td><td></td><td></td><td>49</td><td></td><td></td><td></td><td></td><td></td><td>73</td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td><td></td><td></td><td>76</td><td></td><td></td></tr><tr><td>All</td><td></td><td>70</td><td>28</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Gene</td><td></td><td></td><td>16</td><td></td><td></td><td></td><td>77</td><td>87</td><td></td></tr><tr><td>HR</td><td></td><td></td><td>68</td><td>35</td><td></td><td></td><td>92</td><td></td><td></td></tr><tr><td>Year</td><td></td><td></td><td></td><td></td><td>70</td><td></td><td></td><td></td><td></td></tr></tbody> | <thead><tr><td>Ξ²</td><td>Range</td><td></td><td>References</td><td>Author</td><td>Sensitivity</td><td>Treatment</td><td>Women</td><td>Female</td><td>Male</td></tr><tr><td></td><td></td><td></td><td>P-value</td><td>Reference</td><td>No.</td><td>p-Value</td><td>p value</td><td>A</td><td>Year</td></tr><tr><td>N</td><td>Female</td><td>Female</td><td colspan="7">p</td></tr></thead><tbody><tr><td>All</td><td></td><td></td><td></td><td>2</td><td></td><td></td><td></td><td>17</td><td></td></tr><tr><td>Percentage</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>43</td><td></td></tr><tr><td>SNP</td><td></td><td></td><td>75</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>N</td><td></td><td>59</td><td></td><td></td><td></td><td>76</td><td>16</td><td>80</td><td>94</td></tr><tr><td>n</td><td></td><td></td><td></td><td>73</td><td></td><td></td><td></td><td></td><td>36</td></tr><tr><td>OR</td><td></td><td></td><td></td><td>6</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>M</td><td></td><td>41</td><td></td><td></td><td></td><td></td><td></td><td>77</td><td></td></tr><tr><td>Description</td><td></td><td></td><td>49</td><td></td><td></td><td></td><td></td><td></td><td>73</td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td><td></td><td></td><td>76</td><td></td><td></td></tr><tr><td>All</td><td></td><td>70</td><td>28</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Gene</td><td></td><td></td><td>16</td><td></td><td></td><td></td><td>77</td><td>87</td><td></td></tr><tr><td>HR</td><td></td><td></td><td>68</td><td>35</td><td></td><td></td><td>92</td><td></td><td></td></tr><tr><td>Year</td><td></td><td></td><td></td><td></td><td>70</td><td></td><td></td><td></td><td></td></tr></tbody> | 0.938202 | ||
image_048161_1634636089.693369.png | pubtabnet | <thead><tr><td rowspan="2">Source</td><td>SD</td><td>SE</td></tr><tr><td>95% CI</td><td>Age years</td></tr><tr><td>Country</td><td>P-value</td><td>Factor</td></tr></thead><tbody><tr><td>Factor</td><td>77</td><td>30</td></tr><tr><td></td><td>1</td><td>40</td></tr><tr><td>M</td><td>45</td><td>63</td></tr><tr><td></td><td>33</td><td>51</td></tr><tr><td>Strain</td><td>15</td><td>57</td></tr><tr><td>df</td><td>48</td><td>50</td></tr><tr><td>Strain</td><td></td><td>51</td></tr></tbody> | <thead><tr><td rowspan="2">Source</td><td>SD</td><td>SE</td></tr><tr><td>95% CI</td><td>Age years</td></tr><tr><td>Country</td><td>P-value</td><td>Factor</td></tr></thead><tbody><tr><td>Factor</td><td>77</td><td>30</td></tr><tr><td></td><td>1</td><td>40</td></tr><tr><td>M</td><td>45</td><td>63</td></tr><tr><td></td><td>33</td><td>51</td></tr><tr><td>Strain</td><td>15</td><td>57</td></tr><tr><td>df</td><td>48</td><td>50</td></tr><tr><td>Strain</td><td></td><td>51</td></tr></tbody> | 1 | ||
image_138322_1634649221.956292.png | pubtabnet | <thead><tr><td></td><td>A</td><td>No.</td><td>Source</td><td>No</td><td></td><td>Item</td></tr><tr><td>Controls</td><td>A</td><td rowspan="2">Groups</td><td></td><td>524.31</td><td></td><td>Item</td></tr><tr><td>Characteristics</td><td></td><td>Sample</td><td>Strain</td><td></td><td>Range</td></tr></thead><tbody><tr><td>Baseline</td><td></td><td>Yes</td><td>Gender</td><td>13001.65$</td><td>Negative</td><td>Yes</td></tr><tr><td>References</td><td>I</td><td>Mean</td><td>**</td><td>This study</td><td>n.d.</td><td>< 0.001</td></tr><tr><td>Strain</td><td>--</td><td>β</td><td></td><td></td><td>Male</td><td>Education</td></tr><tr><td></td><td>78.16%</td><td>95% CI</td><td>Gender</td><td>Ref</td><td>P value</td><td>Male</td></tr><tr><td></td><td>F</td><td>x</td><td>n.d.</td><td>Mean</td><td>na</td><td></td></tr><tr><td>Number</td><td>p</td><td></td><td>n.d.</td><td>L</td><td>Positive</td><td>Total</td></tr><tr><td>Total</td><td>309.14</td><td>β</td><td>yes</td><td>Negative</td><td>T</td><td><.0001</td></tr><tr><td>Genotype</td><td>Male</td><td>Age</td><td></td><td>L</td><td>C</td><td></td></tr><tr><td>Frequency</td><td>No</td><td>P-value</td><td>95% CI</td><td>132452</td><td>Total</td><td>504111</td></tr><tr><td>df</td><td></td><td>X</td><td>M</td><td>n.a.</td><td>β</td><td>Education</td></tr><tr><td>M</td><td>C</td><td>Normal</td><td>Female</td><td>/</td><td>%</td><td>n.a.</td></tr><tr><td>Frequency</td><td>< 0.001</td><td>β</td><td><0.05</td><td>-</td><td></td><td>36486.10$</td></tr><tr><td>Item</td><td>β</td><td>53.41%</td><td>No</td><td>L</td><td>Male</td><td>E</td></tr><tr><td>Model</td><td></td><td>No</td><td>β</td><td></td><td>N/A</td><td></td></tr><tr><td>Sample</td><td>T</td><td><.0001</td><td>II</td><td>Reference</td><td>Total</td><td></td></tr><tr><td></td><td>β</td><td>nd</td><td>n.s.</td><td>n.a.</td><td>***</td><td>Ref</td></tr><tr><td></td><td>II</td><td>D</td><td>Negative</td><td>I</td><td>P-value</td><td>Age years</td></tr><tr><td>Year</td><td>Age</td><td>n.s.</td><td>Low</td><td>Yes</td><td><.0001</td><td>T</td></tr></tbody> | <thead><tr><td></td><td>A</td><td>No.</td><td>Source</td><td>No</td><td rowspan="3"></td><td>Item</td></tr><tr><td>Controls</td><td>A</td><td rowspan="2">Groups</td><td></td><td>524.31</td><td>Item</td></tr><tr><td>Characteristics</td><td></td><td>Sample</td><td>Strain</td><td>Range</td></tr></thead><tbody><tr><td>Baseline</td><td></td><td>Yes</td><td>Gender</td><td>13001.65$</td><td>Negative</td><td> Yes</td></tr><tr><td>References</td><td>I</td><td>Mean</td><td>**</td><td>This study</td><td>n.d.</td><td>< 0.001</td></tr><tr><td>Strain</td><td>--</td><td>β</td><td></td><td></td><td> Male</td><td>Education</td></tr><tr><td></td><td>78.16%</td><td>95% CI</td><td>Gender</td><td>Ref</td><td>P value</td><td> Male</td></tr><tr><td></td><td>F</td><td>x</td><td>n.d.</td><td>Mean</td><td>na</td><td></td></tr><tr><td>Number</td><td>p</td><td></td><td>n.d.</td><td>L</td><td>Positive</td><td>Total</td></tr><tr><td>Total</td><td>309.14</td><td>β</td><td>yes</td><td>Negative</td><td>T</td><td><.0001</td></tr><tr><td>Genotype</td><td> Male</td><td>Age</td><td>.</td><td>L</td><td>C</td><td></td></tr><tr><td>Frequency</td><td> No</td><td>P-value</td><td>95% CI</td><td>132452</td><td>Total</td><td>504111</td></tr><tr><td>df</td><td></td><td>X</td><td>M</td><td>n.a.</td><td>β</td><td>Education</td></tr><tr><td>M</td><td>C</td><td>Normal</td><td>Female</td><td>/</td><td>%</td><td>n.a.</td></tr><tr><td>Frequency</td><td>< 0.001</td><td>β</td><td><0.05</td><td>-</td><td></td><td>36486.10$</td></tr><tr><td>Item</td><td>β</td><td>53.41%</td><td> No</td><td>L</td><td> Male</td><td>E</td></tr><tr><td>Model</td><td></td><td>No</td><td>β</td><td></td><td>N/A</td><td>.</td></tr><tr><td>Sample</td><td>T</td><td><.0001</td><td>II</td><td>Reference</td><td>Total</td><td> </td></tr><tr><td></td><td>β</td><td>nd</td><td>n.s.</td><td>n.a.</td><td>***</td><td>Ref</td></tr><tr><td></td><td>II</td><td>D</td><td>Negative</td><td>I</td><td>P-value</td><td>Age years</td></tr><tr><td>Year</td><td>Age</td><td>n.s.</td><td>Low</td><td> Yes</td><td><.0001</td><td>T</td></tr></tbody> | 0.95286 | ||
image_040821_1634635031.700416.png | pubtabnet | <thead><tr><td>Median</td><td>Women</td><td>Strain</td><td></td></tr></thead><tbody><tr><td>Model</td><td>Control</td><td></td><td>Sensitivity</td></tr><tr><td>Factor</td><td>SD</td><td></td><td>Groups</td></tr><tr><td>Species</td><td>75</td><td>87</td><td>19</td></tr><tr><td>B</td><td>45</td><td>87</td><td>89</td></tr><tr><td></td><td>90</td><td>78</td><td>53</td></tr><tr><td>P value</td><td>31</td><td>47</td><td>55</td></tr><tr><td>Controls</td><td>59</td><td></td><td>12</td></tr><tr><td>Description</td><td>16</td><td>61</td><td>25</td></tr><tr><td>Value</td><td>4</td><td>62</td><td></td></tr><tr><td></td><td>3</td><td>38</td><td>51</td></tr></tbody> | <thead><tr><td>Median</td><td>Women</td><td colspan="2">Strain</td></tr><tr><td>Model</td><td>Control</td><td rowspan="2"></td><td>Sensitivity</td></tr><tr><td>Factor</td><td>SD</td><td>Groups</td></tr></thead><tbody><tr><td>Species</td><td>75</td><td>87</td><td>19</td></tr><tr><td>B</td><td>45</td><td>87</td><td>89</td></tr><tr><td></td><td>90</td><td>78</td><td>53</td></tr><tr><td>P value</td><td>31</td><td>47</td><td>55</td></tr><tr><td>Controls</td><td>59</td><td></td><td>12</td></tr><tr><td>Description</td><td>16</td><td>61</td><td>25</td></tr><tr><td>Value</td><td>4</td><td>62</td><td></td></tr><tr><td></td><td>3</td><td>38</td><td>51</td></tr></tbody> | 0.859649 | ||
image_025799_1634634803.901102.png | fintabnet | <thead><tr><td></td><td>Capital lease obligations</td><td>Expired</td></tr></thead><tbody><tr><td>Stockholders' equity:</td><td></td><td></td></tr><tr><td>General</td><td>5.84%</td><td>67.10%</td></tr><tr><td>Income loss from continuing operations</td><td>83.74%</td><td></td></tr><tr><td>Item 15.</td><td></td><td>5.84%</td></tr><tr><td>Benefits paid</td><td>57.8%</td><td>65.83%</td></tr><tr><td>pts</td><td>99.24%</td><td></td></tr><tr><td>*</td><td></td><td>93.1%</td></tr><tr><td>Additional paid-in capital</td><td>78.61%</td><td>92.37%</td></tr><tr><td>Other long-term assets</td><td>3.58%</td><td>17.8%</td></tr><tr><td>Costs and expenses:</td><td>99.57%</td><td>10.58%</td></tr><tr><td>Cancelled</td><td>48.32%</td><td>93.89%</td></tr><tr><td>Description</td><td>99.17%</td><td>95.80%</td></tr><tr><td>Oil</td><td>76.24%</td><td>54.48%</td></tr><tr><td>Item 8.</td><td>31.43%</td><td>77.52%</td></tr><tr><td>Assets:</td><td></td><td>13.85%</td></tr><tr><td>Retail</td><td>83.28%</td><td>31.84%</td></tr><tr><td>Diluted earnings per share</td><td>38.2%</td><td></td></tr><tr><td>10-K</td><td>70.12%</td><td></td></tr><tr><td>Fourth Quarter</td><td></td><td>36.41%</td></tr><tr><td></td><td>27.39%</td><td>75.1%</td></tr><tr><td>TX</td><td></td><td></td></tr><tr><td>XBRL Instance Document</td><td>45.19%</td><td>14.91%</td></tr><tr><td>New York</td><td>3.87%</td><td></td></tr><tr><td>Deferred revenue</td><td>29.9%</td><td>51.77%</td></tr></tbody> | <thead><tr><td></td><td>Capital lease obligations</td><td>Expired</td></tr><tr><td>Stockholdersβ equity:</td><td colspan="2"></td></tr></thead><tbody><tr><td>General</td><td>5.84%</td><td>67.10%</td></tr><tr><td>Income loss from continuing operations</td><td>83.74%</td><td></td></tr><tr><td>Item 15.</td><td></td><td>5.84%</td></tr><tr><td>Benefits paid</td><td>57.8%</td><td>65.83%</td></tr><tr><td>pts</td><td>99.24%</td><td></td></tr><tr><td>*</td><td></td><td>93.1%</td></tr><tr><td>Additional paid-in capital</td><td>78.61%</td><td>92.37%</td></tr><tr><td>Other long-term assets</td><td>3.58%</td><td>17.8%</td></tr><tr><td>Costs and expenses:</td><td>99.57%</td><td>10.58%</td></tr><tr><td>Cancelled</td><td>48.32%</td><td>93.89%</td></tr><tr><td>Description</td><td>99.17%</td><td>95.80%</td></tr><tr><td>Oil</td><td>76.24%</td><td>54.48%</td></tr><tr><td>Item 8.</td><td>31.43%</td><td>77.52%</td></tr><tr><td>Assets:</td><td></td><td>13.85%</td></tr><tr><td>Retail</td><td>83.28%</td><td>31.84%</td></tr><tr><td>Diluted earnings per share</td><td>38.2%</td><td></td></tr><tr><td>10-K</td><td>70.12%</td><td></td></tr><tr><td> Fourth Quarter</td><td></td><td>36.41%</td></tr><tr><td></td><td>27.39%</td><td>75.1%</td></tr><tr><td>TX</td><td></td><td></td></tr><tr><td>XBRL Instance Document</td><td>45.19%</td><td>14.91%</td></tr><tr><td>New York</td><td>3.87%</td><td></td></tr><tr><td>Deferred revenue</td><td>29.9%</td><td>51.77%</td></tr></tbody> | 0.940056 | ||
image_072408_1634638086.851754.png | sparse | <thead><tr><td>Groups</td><td>SD</td><td>OR</td><td></td><td></td><td>Variables</td><td></td><td>A</td><td colspan="4">Parameters</td><td>P value</td><td>Gene name</td></tr></thead><tbody><tr><td>Method</td><td></td><td></td><td></td><td></td><td>32</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>92</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>38</td><td></td></tr><tr><td>Cases</td><td></td><td></td><td></td><td>33</td><td></td><td>33</td><td></td><td></td><td>82</td><td></td><td>89</td><td></td><td></td></tr><tr><td>Sequence</td><td></td><td>98</td><td></td><td></td><td>76</td><td>21</td><td></td><td>4</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>B</td><td></td><td></td><td></td><td>82</td><td></td><td></td><td></td><td></td><td></td><td></td><td>7</td><td>4</td><td></td></tr><tr><td>Men</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>17</td><td></td><td></td></tr><tr><td>OR</td><td></td><td></td><td></td><td></td><td></td><td>22</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Name</td><td>0</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>23</td></tr><tr><td>Characteristics</td><td></td><td>40</td><td>47</td><td></td><td></td><td></td><td>36</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Gender</td><td></td><td></td><td>81</td><td></td><td></td><td></td><td></td><td></td><td>17</td><td></td><td>44</td><td></td><td></td></tr><tr><td>P value</td><td></td><td>30</td><td></td><td></td><td></td><td></td><td></td><td></td><td>36</td><td></td><td></td><td></td><td></td></tr></tbody> | <thead><tr><td>Groups</td><td>SD</td><td>OR</td><td></td><td></td><td>Variables</td><td></td><td>A</td><td colspan="4">Parameters</td><td>P value</td><td>Gene name</td></tr></thead><tbody><tr><td>Method</td><td></td><td></td><td></td><td></td><td>32</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>92</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>38</td><td></td></tr><tr><td>Cases</td><td></td><td></td><td></td><td>33</td><td></td><td>33</td><td></td><td></td><td>82</td><td></td><td>89</td><td></td><td></td></tr><tr><td>Sequence</td><td></td><td>98</td><td></td><td></td><td>76</td><td>21</td><td></td><td>4</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>B</td><td></td><td></td><td></td><td>82</td><td></td><td></td><td></td><td></td><td></td><td></td><td>7</td><td>4</td><td></td></tr><tr><td>Men</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>17</td><td></td><td></td></tr><tr><td>OR</td><td></td><td></td><td></td><td></td><td></td><td>22</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Name</td><td>0</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>23</td></tr><tr><td>Characteristics</td><td></td><td>40</td><td>47</td><td></td><td></td><td></td><td>36</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Gender</td><td></td><td></td><td>81</td><td></td><td></td><td></td><td></td><td></td><td>17</td><td></td><td>44</td><td></td><td></td></tr><tr><td>P value</td><td></td><td>30</td><td></td><td></td><td></td><td></td><td></td><td></td><td>36</td><td></td><td></td><td></td><td></td></tr></tbody> | 1 | ||
image_012461_1634630893.487754.png | pubtabnet | <thead><tr><td>CG</td><td>Characteristics</td><td>Standard Deviation</td><td>CR</td><td>Risk factor</td><td>Intervention</td><td>Mn</td><td>Forward primer</td><td>Moderate</td><td>Fold Change</td><td>Inclusion criteria</td><td>Day</td><td>Upper</td><td>Annealing temperature Β°C</td></tr></thead><tbody><tr><td>t-value</td><td>Accession</td><td>ANOVA</td><td>P*</td><td>Height cm</td><td>Comparison</td><td>Company</td><td>CV %</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Number</td><td></td><td><0.01</td><td>-1</td><td>β </td><td>Stage</td><td>NO</td><td>+/+</td><td>Adult</td><td></td><td>Education years</td><td>Ns</td><td>/</td><td>β24</td></tr><tr><td>Absent</td><td>/</td><td>Males</td><td>total</td><td>IL-6</td><td>Smoking</td><td>Age</td><td>Stomach</td><td>n.a.</td><td>Liver</td><td>Control</td><td>Intergenic</td><td></td><td>C4</td></tr><tr><td></td><td>Difference</td><td>β0.30</td><td>Secondary</td><td>Forward</td><td>Staphylococcus aureus</td><td></td><td>IA</td><td>β0.17</td><td>0/6</td><td>Private</td><td>Neg</td><td>Temperature</td><td>Hypertension %</td></tr><tr><td></td><td>β0.004</td><td>N0</td><td></td><td>Minimum</td><td>IV</td><td>Median</td><td>PA</td><td>IL-6</td><td>1.0 ref</td><td>SNP</td><td>985.91</td><td>[36]</td><td>Median range</td></tr><tr><td>Assay</td><td>Dead</td><td></td><td></td><td>Negative</td><td>G/A</td><td></td><td></td><td>Urban</td><td>Count</td><td>Escherichia coli</td><td>1.00 ref.</td><td>Age y</td><td>P Value</td></tr></tbody> | <thead><tr><td>CG</td><td>Characteristics</td><td>Standard Deviation</td><td>CR</td><td>Risk factor</td><td>Intervention</td><td>Mn</td><td>Forward primer</td><td>Moderate</td><td>Fold Change</td><td>Inclusion criteria</td><td>Day</td><td>Upper</td><td>Annealing temperature Β°C</td></tr><tr><td>t-value</td><td>Accession</td><td>ANOVA</td><td>P*</td><td>Height cm</td><td>Comparison</td><td>Company</td><td colspan="7">CV %</td></tr></thead><tbody><tr><td>Number</td><td></td><td><0.01</td><td>-1</td><td>β </td><td>Stage</td><td>NO</td><td>+/+</td><td>Adult</td><td>.</td><td>Education years</td><td>Ns</td><td>/</td><td>β24</td></tr><tr><td>Absent</td><td>/</td><td>Males</td><td>total</td><td>IL-6</td><td>Smoking</td><td>Age</td><td>Stomach</td><td>n.a.</td><td>Liver</td><td> Control</td><td>Intergenic</td><td></td><td>C4</td></tr><tr><td></td><td>Difference</td><td>β0.30</td><td> Secondary</td><td>Forward</td><td>Staphylococcus aureus</td><td></td><td>IA</td><td>β0.17</td><td>0/6</td><td>Private</td><td>Neg</td><td>Temperature</td><td>Hypertension %</td></tr><tr><td></td><td>β0.004</td><td> N0</td><td>.</td><td>Minimum</td><td>IV</td><td>Median</td><td>PA</td><td>IL-6</td><td>1.0 ref</td><td>SNP</td><td>985.91</td><td>[36]</td><td> Median range</td></tr><tr><td>Assay</td><td>Dead</td><td></td><td></td><td>Negative</td><td>G/A</td><td></td><td></td><td>Urban</td><td>Count</td><td>Escherichia coli</td><td>1.00 ref.</td><td>Age y</td><td>P Value</td></tr></tbody> | 0.872568 | ||
image_041486_1634635117.647402.png | pubtabnet | <thead><tr><td>Men</td><td>Patient</td><td colspan="2">Species</td><td colspan="3">Median</td></tr><tr><td>Strain</td><td>Median</td><td>Outcome</td><td>p-Value</td><td>Mean</td><td></td><td>Species</td></tr><tr><td>SD</td><td>P value</td><td>P</td><td></td><td>Sample</td><td>No.</td><td>M</td></tr></thead><tbody><tr><td>n</td><td>50</td><td>92</td><td>47</td><td>21</td><td>29</td><td>82</td></tr><tr><td>HR</td><td>12</td><td>5</td><td>11</td><td>59</td><td>4</td><td>5</td></tr></tbody> | <thead><tr><td>Men</td><td>Patient</td><td>Species</td><td rowspan="3">p-Value</td><td colspan="3">Median</td></tr><tr><td>Strain</td><td>Median</td><td>Outcome</td><td>Mean</td><td></td><td>Species</td></tr><tr><td>SD</td><td>P value</td><td>P</td><td>Sample</td><td>No.</td><td>M</td></tr></thead><tbody><tr><td>n</td><td>50</td><td>92</td><td>47</td><td>21</td><td>29</td><td>82</td></tr><tr><td>HR</td><td>12</td><td>5</td><td>11</td><td>59</td><td>4</td><td>5</td></tr></tbody> | 0.897436 | ||
image_092573_1634648982.529119.png | fintabnet | <thead><tr><td>Amounts in thousands</td><td>Amortization of intangibles</td><td>Income taxes</td><td>For the years ended December 31,</td><td>Form</td><td>Total investments</td><td></td></tr></thead><tbody><tr><td>Interest paid</td><td></td><td></td><td></td><td></td><td>Participant contributions</td><td>Prepaid expenses</td></tr><tr><td></td><td></td><td></td><td>Industrial</td><td>Valuation allowance</td><td></td><td>Revenues</td></tr><tr><td>Units</td><td>77.93%</td><td>88.5%</td><td>25.26%</td><td>82.98%</td><td>25.4%</td><td></td></tr></tbody> | <thead><tr><td>Amounts in thousands</td><td>Amortization of intangibles</td><td>Income taxes</td><td>For the years ended December 31,</td><td rowspan="2">Form</td><td>Total investments</td><td></td></tr><tr><td>Interest paid</td><td rowspan="2" colspan="2"></td><td></td><td>Participant contributions</td><td>Prepaid expenses</td></tr><tr><td></td><td>Industrial</td><td>Valuation allowance</td><td></td><td> Revenues</td></tr></thead><tbody><tr><td>Units</td><td>77.93%</td><td>88.5%</td><td>25.26%</td><td>82.98%</td><td>25.4%</td><td></td></tr></tbody> | 0.702614 | ||
image_073230_1634642980.573112.png | marketing | <thead><tr><td>β</td><td>Net income</td><td></td><td></td><td>10-K</td><td>in millions</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Total assets</td><td colspan="4">Exercised</td><td>Cash and cash equivalents</td><td></td><td></td><td></td><td></td><td></td></tr></thead><tbody><tr><td>N/A</td><td>Dollars in millions</td><td>Interest income</td><td>% Change</td><td>β</td><td></td><td></td><td>in thousands</td><td>Goodwill</td><td>Inventories</td><td>Other assets</td></tr><tr><td>*</td><td>Year Ended December 31,</td><td>First Quarter</td><td></td><td>Thereafter</td><td>In thousands</td><td rowspan="3">Deferred income taxes</td><td>Leased</td><td colspan="2" rowspan="2">Second Quarter<br/>-</td><td></td></tr><tr><td></td><td>Inventories</td><td>Forfeited</td><td>8-K</td><td>Depreciation and amortization</td><td></td><td>26678.36$</td><td></td></tr><tr><td rowspan="6"></td><td>Deferred income taxes</td><td>Deferred income taxes</td><td>Foreign</td><td>Federal</td><td>NA</td><td rowspan="3">n/a</td><td colspan="3" rowspan="2"></td></tr><tr><td>In thousands</td><td>*</td><td>Interest cost</td><td>Shares</td><td>December 31,</td><td></td></tr><tr><td>NA</td><td>8-K</td><td>-</td><td>United States</td><td></td><td></td><td>10-K</td><td>in millions</td><td></td></tr><tr><td>Federal</td><td>Owned</td><td>Low</td><td>10-K</td><td>NA</td><td>Thereafter</td><td>International</td><td>U.S.</td><td>Long-term debt</td><td></td></tr><tr><td>X</td><td>β</td><td>β</td><td>In millions</td><td></td><td>β</td><td>Leased</td><td>Second Quarter</td><td>Diluted</td><td>In thousands</td></tr><tr><td>Granted</td><td>Goodwill</td><td>β</td><td>Interest cost</td><td>Discount rate</td><td>Years Ended December 31,</td><td>Gross profit</td><td>Interest expense</td><td>Owned</td><td>Net income loss</td></tr></tbody> | <thead><tr><td>β</td><td>Net income</td><td></td><td> </td><td>10-K</td><td>in millions</td><td rowspan="2" colspan="5"></td></tr><tr><td>Total assets</td><td colspan="4">Exercised</td><td>Cash and cash equivalents</td></tr></thead><tbody><tr><td>N/A</td><td>Dollars in millions</td><td>Interest income</td><td>% Change</td><td>β</td><td></td><td></td><td>in thousands</td><td>Goodwill</td><td>Inventories</td><td>Other assets</td></tr><tr><td>*</td><td> Year Ended December 31,</td><td>First Quarter</td><td></td><td>Thereafter</td><td>In thousands</td><td rowspan="5">Deferred income taxes</td><td>Leased</td><td rowspan="4" colspan="2">Second Quarter</td><td rowspan="4">-</td></tr><tr><td></td><td>Inventories</td><td>Forfeited</td><td>8-K</td><td>Depreciation and amortization</td><td></td><td>26678.36$</td></tr><tr><td rowspan="6"></td><td>Deferred income taxes</td><td>Deferred income taxes</td><td>Foreign</td><td>Federal</td><td>NA</td><td rowspan="3">n/a</td></tr><tr><td> In thousands</td><td>*</td><td>Interest cost</td><td>Shares</td><td> December 31,</td></tr><tr><td>NA</td><td>8-K</td><td>-</td><td>United States</td><td></td><td>10-K</td><td colspan="2">in millions</td></tr><tr><td>Federal</td><td>Owned</td><td>Low</td><td>10-K</td><td>NA</td><td>Thereafter</td><td>International</td><td>U.S.</td><td>Long-term debt</td><td></td></tr><tr><td>X</td><td> β</td><td>β</td><td> In millions</td><td></td><td>β</td><td>Leased</td><td>Second Quarter</td><td>Diluted</td><td> In thousands</td></tr><tr><td>Granted</td><td>Goodwill</td><td>β</td><td>Interest cost</td><td>Discount rate</td><td>Years Ended December 31,</td><td>Gross profit</td><td>Interest expense</td><td>Owned</td><td>Net income loss</td></tr></tbody> | 0.818645 | ||
image_012070_1634630836.930008.png | pubtabnet | <thead><tr><td>Number</td><td>Type</td><td>n</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr></thead><tbody><tr><td>Outcome</td><td></td><td>92.19%</td><td>61.42%</td><td>73.8%</td><td>11.92%</td><td>57.9%</td><td>79.27%</td><td>85.95%</td><td></td></tr><tr><td>Parameter</td><td>48.21%</td><td>28.74%</td><td>17.52%</td><td></td><td>27.59%</td><td>77.51%</td><td>74.48%</td><td>72.83%</td><td>9.21%</td></tr><tr><td>n</td><td>80.95%</td><td>63.86%</td><td>7.19%</td><td>88.37%</td><td>19.12%</td><td>36.98%</td><td>68.44%</td><td>2.11%</td><td>20.19%</td></tr><tr><td>df</td><td>0.56%</td><td>45.55%</td><td></td><td>73.42%</td><td></td><td>93.95%</td><td>19.14%</td><td>73.18%</td><td></td></tr><tr><td>Factor</td><td>66.53%</td><td>94.40%</td><td>16.81%</td><td>33.9%</td><td>38.45%</td><td>13.88%</td><td>98.57%</td><td>6.97%</td><td>0.6%</td></tr><tr><td>Variable</td><td>48.20%</td><td>90.75%</td><td>72.54%</td><td>83.92%</td><td>52.70%</td><td>9.43%</td><td>52.88%</td><td>65.70%</td><td>35.25%</td></tr><tr><td>F</td><td>53.15%</td><td>43.73%</td><td>2.29%</td><td>6.23%</td><td>9.51%</td><td></td><td>47.30%</td><td>71.5%</td><td>0.2%</td></tr><tr><td>Women</td><td>9.28%</td><td>82.54%</td><td>10.90%</td><td>51.12%</td><td>71.13%</td><td>22.75%</td><td>39.39%</td><td>68.41%</td><td>21.44%</td></tr><tr><td>Gene name</td><td>22.19%</td><td>55.20%</td><td>65.46%</td><td>31.81%</td><td>38.40%</td><td>31.96%</td><td>72.35%</td><td>71.44%</td><td>82.23%</td></tr><tr><td></td><td>79.68%</td><td>38.12%</td><td>52.61%</td><td>3.10%</td><td>1.88%</td><td>29.88%</td><td>69.93%</td><td>98.59%</td><td>16.20%</td></tr></tbody> | <thead><tr><td>Number</td><td>Type</td><td colspan="7">n</td><td></td></tr></thead><tbody><tr><td>Outcome</td><td></td><td>92.19%</td><td>61.42%</td><td>73.8%</td><td>11.92%</td><td>57.9%</td><td>79.27%</td><td>85.95%</td><td></td></tr><tr><td>Parameter</td><td>48.21%</td><td>28.74%</td><td>17.52%</td><td></td><td>27.59%</td><td>77.51%</td><td>74.48%</td><td>72.83%</td><td>9.21%</td></tr><tr><td>n</td><td>80.95%</td><td>63.86%</td><td>7.19%</td><td>88.37%</td><td>19.12%</td><td>36.98%</td><td>68.44%</td><td>2.11%</td><td>20.19%</td></tr><tr><td>df</td><td>0.56%</td><td>45.55%</td><td></td><td>73.42%</td><td></td><td>93.95%</td><td>19.14%</td><td>73.18%</td><td></td></tr><tr><td>Factor</td><td>66.53%</td><td>94.40%</td><td>16.81%</td><td>33.9%</td><td>38.45%</td><td>13.88%</td><td>98.57%</td><td>6.97%</td><td>0.6%</td></tr><tr><td>Variable</td><td>48.20%</td><td>90.75%</td><td>72.54%</td><td>83.92%</td><td>52.70%</td><td>9.43%</td><td>52.88%</td><td>65.70%</td><td>35.25%</td></tr><tr><td>F</td><td>53.15%</td><td>43.73%</td><td>2.29%</td><td>6.23%</td><td>9.51%</td><td></td><td>47.30%</td><td>71.5%</td><td>0.2%</td></tr><tr><td>Women</td><td>9.28%</td><td>82.54%</td><td>10.90%</td><td>51.12%</td><td>71.13%</td><td>22.75%</td><td>39.39%</td><td>68.41%</td><td>21.44%</td></tr><tr><td>Gene name</td><td>22.19%</td><td>55.20%</td><td>65.46%</td><td>31.81%</td><td>38.40%</td><td>31.96%</td><td>72.35%</td><td>71.44%</td><td>82.23%</td></tr><tr><td></td><td>79.68%</td><td>38.12%</td><td>52.61%</td><td>3.10%</td><td>1.88%</td><td>29.88%</td><td>69.93%</td><td>98.59%</td><td>16.20%</td></tr></tbody> | 0.943089 | ||
image_139541_1634658563.927423.png | fintabnet | <thead><tr><td>Compensation and benefits</td><td>December 31, in millions</td><td>December 31, 2009</td><td>Total deferred tax liabilities</td><td>Other income expense, net</td><td>PART II</td><td>Total stockholders' equity</td><td>Level 2</td><td>Total debt</td></tr></thead><tbody><tr><td>West</td><td colspan="2">A-</td><td></td><td>Baa1</td><td colspan="2">Gross Profit</td><td>Owned</td><td></td></tr><tr><td>Baa1</td><td>AccumulatedAmortization</td><td></td><td>Operating margin</td><td>Participant contributions</td><td>% of Total</td><td>Cost of sales</td><td>Ending balance</td><td>As of December</td></tr><tr><td>Operating Profit</td><td>72.22%</td><td>11.2%</td><td>45.41%</td><td>81.99%</td><td>20.60%</td><td></td><td>40.43%</td><td>83.37%</td></tr><tr><td>Actuarial gain loss</td><td>6.20%</td><td>66.49%</td><td>84.86%</td><td>2.20%</td><td>16.93%</td><td>87.27%</td><td>76.71%</td><td>56.24%</td></tr><tr><td>December 31, 2014</td><td>47.49%</td><td>45.72%</td><td>68.98%</td><td>52.26%</td><td>11.33%</td><td>52.96%</td><td>72.99%</td><td>54.52%</td></tr><tr><td>Service cost</td><td>56.31%</td><td>89.21%</td><td>64.78%</td><td>5.4%</td><td></td><td></td><td>31.15%</td><td>2.84%</td></tr><tr><td>Services</td><td>4.13%</td><td>23.81%</td><td>83.8%</td><td>42.96%</td><td></td><td></td><td>71.18%</td><td>43.59%</td></tr><tr><td>December 31, 2010</td><td>8.88%</td><td></td><td>65.89%</td><td>53.4%</td><td></td><td>43.13%</td><td>73.76%</td><td>75.93%</td></tr><tr><td>Sales</td><td>3.39%</td><td>48.10%</td><td>66.82%</td><td>83.89%</td><td>91.53%</td><td>66.35%</td><td>76.5%</td><td>17.28%</td></tr><tr><td>Adjustments to reconcile net income to net cash provided by operating activities:</td><td>13.23%</td><td>4.36%</td><td></td><td>3.45%</td><td>31.28%</td><td>56.93%</td><td>87.42%</td><td>73.58%</td></tr><tr><td>S-8</td><td>22.64%</td><td></td><td>62.21%</td><td>22.14%</td><td>20.58%</td><td>55.68%</td><td>30.10%</td><td>95.30%</td></tr><tr><td>Sales and marketing</td><td>60.5%</td><td>50.22%</td><td>46.14%</td><td>47.46%</td><td>3.83%</td><td>79.90%</td><td></td><td>80.52%</td></tr><tr><td></td><td>16.94%</td><td>74.24%</td><td>65.46%</td><td>53.58%</td><td>33.66%</td><td>45.93%</td><td>74.79%</td><td></td></tr><tr><td>Percentage</td><td>77.94%</td><td>92.80%</td><td>70.71%</td><td>69.89%</td><td>16.33%</td><td>65.1%</td><td>71.8%</td><td>46.43%</td></tr></tbody> | <thead><tr><td>Compensation and benefits</td><td>December 31, in millions</td><td> December 31, 2009</td><td>Total deferred tax liabilities</td><td>Other income expense, net</td><td>PART II</td><td>Total stockholdersβ equity</td><td> Level 2</td><td>Total debt</td></tr><tr><td>West</td><td colspan="3">A-</td><td>Baa1</td><td colspan="2">Gross Profit</td><td>Owned</td><td rowspan="2">As of December</td></tr><tr><td>Baa1</td><td>AccumulatedAmortization</td><td></td><td>Operating margin</td><td>Participant contributions</td><td>% of Total</td><td>Cost of sales</td><td>Ending balance</td></tr></thead><tbody><tr><td>Operating Profit</td><td>72.22%</td><td>11.2%</td><td>45.41%</td><td>81.99%</td><td>20.60%</td><td></td><td>40.43%</td><td>83.37%</td></tr><tr><td>Actuarial gain loss</td><td>6.20%</td><td>66.49%</td><td>84.86%</td><td>2.20%</td><td>16.93%</td><td>87.27%</td><td>76.71%</td><td>56.24%</td></tr><tr><td>December 31, 2014</td><td>47.49%</td><td>45.72%</td><td>68.98%</td><td>52.26%</td><td>11.33%</td><td>52.96%</td><td>72.99%</td><td>54.52%</td></tr><tr><td>Service cost</td><td>56.31%</td><td>89.21%</td><td>64.78%</td><td>5.4%</td><td></td><td></td><td>31.15%</td><td>2.84%</td></tr><tr><td>Services</td><td>4.13%</td><td>23.81%</td><td>83.8%</td><td>42.96%</td><td></td><td></td><td>71.18%</td><td>43.59%</td></tr><tr><td> December 31, 2010</td><td>8.88%</td><td></td><td>65.89%</td><td>53.4%</td><td></td><td>43.13%</td><td>73.76%</td><td>75.93%</td></tr><tr><td>Sales</td><td>3.39%</td><td>48.10%</td><td>66.82%</td><td>83.89%</td><td>91.53%</td><td>66.35%</td><td>76.5%</td><td>17.28%</td></tr><tr><td>Adjustments to reconcile net income to net cash provided by operating activities:</td><td>13.23%</td><td>4.36%</td><td></td><td>3.45%</td><td>31.28%</td><td>56.93%</td><td>87.42%</td><td>73.58%</td></tr><tr><td>S-8</td><td>22.64%</td><td></td><td>62.21%</td><td>22.14%</td><td>20.58%</td><td>55.68%</td><td>30.10%</td><td>95.30%</td></tr><tr><td>Sales and marketing</td><td>60.5%</td><td>50.22%</td><td>46.14%</td><td>47.46%</td><td>3.83%</td><td>79.90%</td><td></td><td>80.52%</td></tr><tr><td></td><td>16.94%</td><td>74.24%</td><td>65.46%</td><td>53.58%</td><td>33.66%</td><td>45.93%</td><td>74.79%</td><td></td></tr><tr><td>Percentage</td><td>77.94%</td><td>92.80%</td><td>70.71%</td><td>69.89%</td><td>16.33%</td><td>65.1%</td><td>71.8%</td><td>46.43%</td></tr></tbody> | 0.944836 | ||
image_149904_1634650872.963819.png | pubtabnet | <thead><tr><td>HR</td><td>Gene</td><td>Total</td><td></td><td>Group</td></tr><tr><td>Author</td><td>Odds ratio</td><td colspan="2"></td><td></td></tr><tr><td>All</td><td></td><td>Total</td><td></td><td></td></tr></thead><tbody><tr><td>Gene name</td><td>Gender</td><td></td><td></td><td>C</td></tr><tr><td>Mean Β± SD</td><td></td><td>Ref</td><td></td><td>High</td></tr><tr><td>Group</td><td>SD</td><td>Ref</td><td>p</td><td>Female</td></tr><tr><td>Age</td><td></td><td>Normal</td><td>II</td><td>G</td></tr><tr><td>Total</td><td>D</td><td>III</td><td>No</td><td></td></tr><tr><td>Region</td><td>G</td><td>Ref</td><td>High</td><td>X</td></tr><tr><td>Sample</td><td>Yes</td><td>Total</td><td>Normal</td><td>%</td></tr><tr><td>Patient</td><td>**</td><td>%</td><td>95% CI</td><td>N</td></tr><tr><td>References</td><td>no</td><td>A</td><td>D</td><td><0.001</td></tr><tr><td>Year</td><td></td><td>NA</td><td>***</td><td><0.001</td></tr><tr><td>Cases</td><td>Ref</td><td><0.0001</td><td>Gender</td><td>G</td></tr><tr><td></td><td>x</td><td>Female</td><td>G</td><td>n.s.</td></tr><tr><td></td><td>P</td><td></td><td>Yes</td><td>12.7%</td></tr><tr><td>Percentage</td><td>na</td><td>B</td><td>++</td><td>Sex</td></tr><tr><td>Frequency</td><td>Male</td><td><0.01</td><td>n.s.</td><td></td></tr><tr><td>p-Value</td><td>Negative</td><td><0.01</td><td>P-value</td><td>None</td></tr><tr><td>p-Value</td><td>β</td><td>Female</td><td>B</td><td>Total</td></tr><tr><td>Sample</td><td>Yes</td><td>ns</td><td>This study</td><td>Age</td></tr><tr><td>Odds ratio</td><td>< 0.001</td><td>Age</td><td>ns</td><td>no</td></tr></tbody> | <thead><tr><td>HR</td><td>Gene</td><td>Total</td><td></td><td>Group</td></tr><tr><td>Author</td><td>Odds ratio</td><td rowspan="2" colspan="3">Total</td></tr><tr><td>All</td><td></td></tr></thead><tbody><tr><td>Gene name</td><td>Gender</td><td></td><td></td><td>C</td></tr><tr><td>Mean Β± SD</td><td></td><td>Ref</td><td></td><td>High</td></tr><tr><td>Group</td><td>SD</td><td>Ref</td><td>p</td><td>Female</td></tr><tr><td>Age</td><td></td><td>Normal</td><td>II</td><td>G</td></tr><tr><td>Total</td><td>D</td><td>III</td><td> No</td><td></td></tr><tr><td>Region</td><td>G</td><td>Ref</td><td>High</td><td>X</td></tr><tr><td>Sample</td><td>Yes</td><td>Total</td><td>Normal</td><td>%</td></tr><tr><td>Patient</td><td>**</td><td>%</td><td>95% CI</td><td>N</td></tr><tr><td>References</td><td>no</td><td>A</td><td>D</td><td><0.001</td></tr><tr><td>Year</td><td></td><td>NA</td><td>***</td><td><0.001</td></tr><tr><td>Cases</td><td>Ref</td><td><0.0001</td><td>Gender</td><td>G</td></tr><tr><td></td><td>x</td><td> Female</td><td>G</td><td>n.s.</td></tr><tr><td> </td><td>P</td><td></td><td>Yes</td><td>12.7%</td></tr><tr><td>Percentage</td><td>na</td><td>B</td><td>++</td><td>Sex</td></tr><tr><td>Frequency</td><td> Male</td><td><0.01</td><td>n.s.</td><td> </td></tr><tr><td>p-Value</td><td>Negative</td><td><0.01</td><td>P-value</td><td>None</td></tr><tr><td>p-Value</td><td>β</td><td> Female</td><td>B</td><td>Total</td></tr><tr><td>Sample</td><td>Yes</td><td>ns</td><td>This study</td><td>Age</td></tr><tr><td>Odds ratio</td><td>< 0.001</td><td>Age</td><td>ns</td><td>no</td></tr></tbody> | 0.94121 | ||
image_026815_1634632987.602361.png | pubtabnet | <thead><tr><td>Controls</td><td>95% CI</td><td>p value</td><td>p Value</td><td>Gene</td><td>C</td><td colspan="3">Mean</td></tr></thead><tbody><tr><td>All</td><td></td><td>67</td><td>63</td><td></td><td>83</td><td>24</td><td>53</td><td>93</td></tr><tr><td></td><td>27</td><td></td><td>84</td><td>27</td><td>67</td><td>20</td><td>3</td><td>64</td></tr><tr><td>No.</td><td>80</td><td>19</td><td>82</td><td>45</td><td>89</td><td>99</td><td>21</td><td>98</td></tr><tr><td>p Value</td><td>88</td><td>62</td><td>59</td><td>76</td><td>12</td><td></td><td>11</td><td>14</td></tr><tr><td>HR</td><td>3</td><td>55</td><td>5</td><td>82</td><td>67</td><td>8</td><td></td><td></td></tr><tr><td>Mean SD</td><td>3</td><td>76</td><td>88</td><td>70</td><td>9</td><td>53</td><td>0</td><td>11</td></tr><tr><td>p-Value</td><td></td><td>80</td><td>1</td><td>88</td><td>48</td><td>68</td><td>5</td><td></td></tr><tr><td>Gene name</td><td>74</td><td>61</td><td>15</td><td>14</td><td>71</td><td>71</td><td>1</td><td>78</td></tr><tr><td>Type</td><td>15</td><td>0</td><td>40</td><td>40</td><td></td><td></td><td>91</td><td>73</td></tr><tr><td>Patient</td><td>94</td><td>36</td><td>57</td><td>3</td><td>78</td><td>45</td><td>38</td><td>23</td></tr><tr><td>Category</td><td>26</td><td>9</td><td>34</td><td>43</td><td>29</td><td>38</td><td>99</td><td>16</td></tr><tr><td></td><td>3</td><td>15</td><td>17</td><td>35</td><td>79</td><td></td><td>93</td><td>1</td></tr><tr><td>p-Value</td><td></td><td>35</td><td>81</td><td>64</td><td>68</td><td>83</td><td></td><td>8</td></tr><tr><td>Odds ratio</td><td>92</td><td>12</td><td>0</td><td></td><td>74</td><td>62</td><td>47</td><td>9</td></tr><tr><td>Gender</td><td>51</td><td>86</td><td></td><td>98</td><td>66</td><td></td><td>49</td><td>36</td></tr><tr><td></td><td>98</td><td>39</td><td>22</td><td>25</td><td>67</td><td>42</td><td>33</td><td>70</td></tr></tbody> | <thead><tr><td>Controls</td><td>95% CI</td><td>p value</td><td>p Value</td><td>Gene</td><td>C</td><td colspan="3">Mean</td></tr></thead><tbody><tr><td>All</td><td></td><td>67</td><td>63</td><td></td><td>83</td><td>24</td><td>53</td><td>93</td></tr><tr><td></td><td>27</td><td></td><td>84</td><td>27</td><td>67</td><td>20</td><td>3</td><td>64</td></tr><tr><td>No.</td><td>80</td><td>19</td><td>82</td><td>45</td><td>89</td><td>99</td><td>21</td><td>98</td></tr><tr><td>p Value</td><td>88</td><td>62</td><td>59</td><td>76</td><td>12</td><td></td><td>11</td><td>14</td></tr><tr><td>HR</td><td>3</td><td>55</td><td>5</td><td>82</td><td>67</td><td>8</td><td></td><td></td></tr><tr><td>Mean SD</td><td>3</td><td>76</td><td>88</td><td>70</td><td>9</td><td>53</td><td>0</td><td>11</td></tr><tr><td>p-Value</td><td></td><td>80</td><td>1</td><td>88</td><td>48</td><td>68</td><td>5</td><td></td></tr><tr><td>Gene name</td><td>74</td><td>61</td><td>15</td><td>14</td><td>71</td><td>71</td><td>1</td><td>78</td></tr><tr><td>Type</td><td>15</td><td>0</td><td>40</td><td>40</td><td></td><td></td><td>91</td><td>73</td></tr><tr><td>Patient</td><td>94</td><td>36</td><td>57</td><td>3</td><td>78</td><td>45</td><td>38</td><td>23</td></tr><tr><td>Category</td><td>26</td><td>9</td><td>34</td><td>43</td><td>29</td><td>38</td><td>99</td><td>16</td></tr><tr><td></td><td>3</td><td>15</td><td>17</td><td>35</td><td>79</td><td></td><td>93</td><td>1</td></tr><tr><td>p-Value</td><td></td><td>35</td><td>81</td><td>64</td><td>68</td><td>83</td><td></td><td>8</td></tr><tr><td>Odds ratio</td><td>92</td><td>12</td><td>0</td><td></td><td>74</td><td>62</td><td>47</td><td>9</td></tr><tr><td>Gender</td><td>51</td><td>86</td><td></td><td>98</td><td>66</td><td></td><td>49</td><td>36</td></tr><tr><td></td><td>98</td><td>39</td><td>22</td><td>25</td><td>67</td><td>42</td><td>33</td><td>70</td></tr></tbody> | 1 | ||
image_048617_1634639655.341794.png | fintabnet | <thead><tr><td>Liabilities:</td><td></td><td>Investments</td><td></td><td>Total assets</td><td>Provision for loan losses</td><td>Credit card</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></thead><tbody><tr><td>in billions</td><td>Principal Accounting Fees and Services</td><td>Amortization of prior service cost</td><td></td><td>Net cash provided by used in operating activities</td><td></td><td>% Change</td><td></td><td>Baa1</td><td>Total equity</td><td>Operating earnings</td><td></td><td>Capital lease obligations</td></tr><tr><td>000-21184</td><td>Retail</td><td>Other long-term liabilities</td><td>Item 3.</td><td>As of December 31,</td><td>Non-U.S.</td><td>Other</td><td>Numerator:</td><td>September 30</td><td>Net periodic benefit cost</td><td>Stockholders' equity</td><td>Change</td><td>c</td></tr><tr><td>Item 3.</td><td>Income tax benefit</td><td>IBRF</td><td>First quarter</td><td>Total net sales</td><td></td><td></td><td>Leasehold improvements</td><td>Less:</td><td>Exhibit No.</td><td></td><td>Argentina</td><td></td></tr></tbody> | <thead><tr><td>Liabilities:</td><td><sup> </sup></td><td>Investments</td><td></td><td>Total assets</td><td>Provision for loan losses</td><td colspan="7">Credit card</td></tr></thead><tbody><tr><td>in billions</td><td>Principal Accounting Fees and Services</td><td>Amortization of prior service cost</td><td></td><td>Net cash provided by used in operating activities</td><td></td><td> % Change</td><td></td><td>Baa1</td><td>Total equity</td><td>Operating earnings</td><td></td><td>Capital lease obligations</td></tr><tr><td>000-21184</td><td>Retail</td><td>Other long-term liabilities</td><td>Item 3.</td><td> As of December 31,</td><td>Non-U.S.</td><td>Other</td><td>Numerator:</td><td>September 30</td><td>Net periodic benefit cost</td><td>Stockholdersβ equity</td><td> Change</td><td>c</td></tr><tr><td>Item 3.</td><td>Income tax benefit</td><td>IBRF</td><td>First quarter</td><td>Total net sales</td><td></td><td></td><td>Leasehold improvements</td><td>Less:</td><td>Exhibit No.</td><td></td><td>Argentina</td><td></td></tr></tbody> | 0.855921 | ||
image_007507_1634630279.267811.png | sparse | <thead><tr><td>No</td><td>No.</td><td>p value</td><td>Name</td><td>Category</td><td>Gender</td><td>Strain</td><td>Variable</td><td></td></tr></thead><tbody><tr><td>HR</td><td>Female</td><td>p-Value</td><td>Characteristics</td><td>Female</td><td>df</td><td>Gender</td><td>Case</td><td>Mean Β± SD</td></tr><tr><td></td><td></td><td>Source</td><td></td><td></td><td>All</td><td>Variable</td><td>Genotype</td><td></td></tr><tr><td>p-value</td><td></td><td>71</td><td>88</td><td></td><td>22</td><td></td><td>41</td><td></td></tr><tr><td>Controls</td><td>39</td><td></td><td>94</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Group</td><td>76</td><td></td><td></td><td>75</td><td></td><td></td><td></td><td>37</td></tr><tr><td>Mean Β± SD</td><td></td><td>18</td><td></td><td></td><td></td><td>93</td><td></td><td></td></tr><tr><td>Frequency</td><td>79</td><td></td><td></td><td></td><td></td><td>51</td><td>99</td><td></td></tr><tr><td>Characteristics</td><td>13</td><td></td><td>43</td><td>38</td><td>11</td><td>71</td><td></td><td></td></tr><tr><td>Location</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>OR</td><td></td><td></td><td>23</td><td></td><td></td><td>7</td><td></td><td></td></tr><tr><td>Variable</td><td></td><td></td><td></td><td>44</td><td></td><td></td><td></td><td></td></tr><tr><td>Number</td><td></td><td></td><td>53</td><td></td><td>70</td><td></td><td></td><td></td></tr><tr><td>Baseline</td><td>4</td><td></td><td></td><td></td><td>47</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td>16</td><td></td><td></td></tr><tr><td>Factor</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td>92</td><td></td><td></td></tr><tr><td>Gene name</td><td>50</td><td></td><td></td><td></td><td></td><td></td><td></td><td>80</td></tr><tr><td>Ξ²</td><td></td><td>92</td><td></td><td></td><td>56</td><td></td><td></td><td>76</td></tr><tr><td>Median</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody> | <thead><tr><td>No</td><td>No.</td><td>p value</td><td>Name</td><td>Category</td><td>Gender</td><td>Strain</td><td>Variable</td><td rowspan="3">Mean Β± SD</td></tr><tr><td>HR</td><td rowspan="2">Female</td><td>p-Value</td><td>Characteristics</td><td>Female</td><td>df</td><td>Gender</td><td>Case</td></tr><tr><td></td><td colspan="3">Source</td><td>All</td><td>Variable</td><td>Genotype</td></tr></thead><tbody><tr><td>p-value</td><td></td><td>71</td><td>88</td><td></td><td>22</td><td></td><td>41</td><td></td></tr><tr><td>Controls</td><td>39</td><td></td><td>94</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Group</td><td>76</td><td></td><td></td><td>75</td><td></td><td></td><td></td><td>37</td></tr><tr><td>Mean Β± SD</td><td></td><td>18</td><td></td><td></td><td></td><td>93</td><td></td><td></td></tr><tr><td>Frequency</td><td>79</td><td></td><td></td><td></td><td></td><td>51</td><td>99</td><td></td></tr><tr><td>Characteristics</td><td>13</td><td></td><td>43</td><td>38</td><td>11</td><td>71</td><td></td><td></td></tr><tr><td>Location</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>OR</td><td></td><td></td><td>23</td><td></td><td></td><td>7</td><td></td><td></td></tr><tr><td>Variable</td><td></td><td></td><td></td><td>44</td><td></td><td></td><td></td><td></td></tr><tr><td>Number</td><td></td><td></td><td>53</td><td></td><td>70</td><td></td><td></td><td></td></tr><tr><td>Baseline</td><td>4</td><td></td><td></td><td></td><td>47</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td>16</td><td></td><td></td></tr><tr><td>Factor</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td>92</td><td></td><td></td></tr><tr><td>Gene name</td><td>50</td><td></td><td></td><td></td><td></td><td></td><td></td><td>80</td></tr><tr><td>Ξ²</td><td></td><td>92</td><td></td><td></td><td>56</td><td></td><td></td><td>76</td></tr><tr><td>Median</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody> | 0.940594 | ||
image_137611_1634654809.701358.png | marketing | <thead><tr><td>SNP</td><td>Sample</td><td></td><td>n</td><td>Univariate analysis</td><td></td><td>P value</td><td>SD</td><td>Total</td><td>All</td><td>Gene</td><td>Gene name</td><td>Frequency</td></tr></thead><tbody><tr><td>No</td><td>N</td><td>Variables</td><td></td><td>M</td><td>Strain</td><td>Location</td><td>Male</td><td>Mean Β± SD</td><td>HR</td><td>A</td><td>N %</td><td>F</td></tr><tr><td>Controls</td><td>No</td><td>Reference</td><td>Number</td><td>Reference</td><td>Sensitivity</td><td>C</td><td>Female</td><td>Gene</td><td>Univariate analysis</td><td></td><td>Age</td><td>Type</td></tr><tr><td>Author</td><td>N/A</td><td colspan="10">F</td><td>Male</td></tr><tr><td>p value</td><td>Unknown</td><td>< 0.0001</td><td>G</td><td></td><td>β</td><td colspan="6"></td><td></td></tr><tr><td>A</td><td>P-value</td><td>NS</td><td></td><td>Other</td><td>-</td><td></td><td></td><td>n.a.</td><td>Education</td><td>Normal</td><td>L</td><td></td></tr><tr><td>N</td><td>-</td><td>< 0.001</td><td>Control</td><td>nd</td><td rowspan="6">n<br/>Education</td><td>Normal</td><td>X</td><td><0.05</td><td>Control</td><td></td><td>D</td><td>NR</td></tr><tr><td>Total</td><td>β</td><td>Total</td><td></td><td>**</td><td>L</td><td>A</td><td>p-value</td><td>***</td><td>6313.99$</td><td>III</td><td>N/A</td></tr><tr><td>Study</td><td>II</td><td>G</td><td></td><td>Control</td><td rowspan="4"></td><td>M</td><td>Positive</td><td>P value</td><td>NS</td><td colspan="2">Age</td></tr><tr><td>F</td><td>P-value</td><td>Mean</td><td>S</td><td>S</td><td>SD</td><td>x</td><td>G</td><td></td><td>II</td><td>None</td></tr><tr><td>Name</td><td>Age years</td><td>A</td><td>n.a.</td><td>Male</td><td>D</td><td rowspan="2"></td><td>n/a</td><td>Total</td><td>This study</td><td>++</td></tr><tr><td>Controls</td><td>R</td><td></td><td>nd</td><td>High</td><td>T</td><td>II</td><td>P</td><td>E</td><td>III</td></tr><tr><td>Range</td><td colspan="4">Unknown</td><td>/</td><td>n.s.</td><td>ns</td><td></td><td>C</td><td>Yes</td><td>Y</td><td>Education</td></tr><tr><td>Patient</td><td colspan="2" rowspan="2">NA</td><td>Age years</td><td>86.35%</td><td>+</td><td></td><td>625.11</td><td rowspan="2">/</td><td>No</td><td>Female</td><td>Female</td><td></td></tr><tr><td></td><td>na</td><td></td><td>P-value</td><td></td><td>SD</td><td>x</td><td><0.0001</td><td></td><td></td></tr><tr><td>Sensitivity</td><td colspan="4">II<br/>nd</td><td></td><td></td><td>**</td><td></td><td>Yes</td><td>782.95</td><td>E</td><td>T</td></tr><tr><td>t</td><td colspan="9"></td><td><0.01</td><td>G</td></tr><tr><td>Percent</td><td colspan="4">n.s.</td><td></td><td></td><td colspan="3"></td><td></td><td>Unknown</td><td>Yes</td></tr><tr><td>A</td><td colspan="2" rowspan="2">--</td><td>G</td><td>p</td><td>N/A</td><td colspan="2">p-value<br/>84.42%<br/>n.d.<br/>III</td><td></td><td colspan="2"></td></tr><tr><td>Item</td><td>**</td><td>Positive</td><td><0.0001</td><td></td><td>Gender</td><td>Total</td><td>n.d.</td><td>< 0.0001</td><td>Control</td><td></td></tr><tr><td>Number</td><td colspan="5">Ref.<br/>β</td><td></td><td>999209</td><td>64.75%</td><td>nd</td><td>NR</td><td>Normal</td><td><.001</td></tr></tbody> | <thead><tr><td>SNP</td><td>Sample</td><td></td><td>n</td><td>Univariate analysis</td><td> </td><td>P value</td><td>SD</td><td>Total</td><td>All</td><td>Gene</td><td>Gene name</td><td>Frequency</td></tr><tr><td>No</td><td>N</td><td>Variables</td><td></td><td>M</td><td>Strain</td><td>Location</td><td>Male</td><td>Mean Β± SD</td><td>HR</td><td>A</td><td>N %</td><td>F</td></tr><tr><td>Controls</td><td>No</td><td>Reference</td><td>Number</td><td>Reference</td><td>Sensitivity</td><td>C</td><td>Female</td><td>Gene</td><td>Univariate analysis</td><td></td><td>Age</td><td>Type</td></tr></thead><tbody><tr><td>Author</td><td>N/A</td><td colspan="9">F</td><td></td><td>Male</td></tr><tr><td>p value</td><td>Unknown</td><td>< 0.0001</td><td>G</td><td></td><td colspan="7">β</td><td></td></tr><tr><td>A</td><td>P-value</td><td>NS</td><td></td><td>Other</td><td>-</td><td>.</td><td></td><td>n.a.</td><td>Education</td><td>Normal</td><td>L</td><td>.</td></tr><tr><td>N</td><td>-</td><td>< 0.001</td><td>Control</td><td>nd</td><td rowspan="5">n</td><td>Normal</td><td>X</td><td><0.05</td><td>Control</td><td></td><td>D</td><td>NR</td></tr><tr><td>Total</td><td>β</td><td>Total</td><td></td><td>**</td><td>L</td><td>A</td><td>p-value</td><td>***</td><td>6313.99$</td><td>III</td><td>N/A</td></tr><tr><td>Study</td><td>II</td><td>G</td><td>.</td><td>Control</td><td rowspan="8">n.s.</td><td>M</td><td>Positive</td><td>P value</td><td>NS</td><td colspan="2">Age</td></tr><tr><td>F</td><td>P-value</td><td>Mean</td><td>S</td><td>S</td><td>SD</td><td>x</td><td>G</td><td> </td><td>II</td><td>None</td></tr><tr><td>Name</td><td>Age years</td><td>A</td><td>n.a.</td><td> Male</td><td>D</td><td rowspan="6">/</td><td>n/a</td><td>Total</td><td>This study</td><td>++</td></tr><tr><td>Controls</td><td>R</td><td></td><td>nd</td><td>High</td><td>Education</td><td>T</td><td>II</td><td>P</td><td>E</td><td>III</td></tr><tr><td>Range</td><td colspan="4">Unknown</td><td>/</td><td>ns</td><td>C</td><td> Yes</td><td>Y</td><td>Education</td></tr><tr><td>Patient</td><td rowspan="2" colspan="2">NA</td><td>Age years</td><td>86.35%</td><td>+</td><td>625.11</td><td>No</td><td>Female</td><td>Female</td><td></td></tr><tr><td></td><td>na</td><td></td><td>P-value</td><td>SD</td><td>x</td><td><0.0001</td><td></td><td></td></tr><tr><td>Sensitivity</td><td>II</td><td colspan="4">nd</td><td>**</td><td>Yes</td><td>782.95</td><td>E</td><td>T</td></tr><tr><td>t</td><td rowspan="2" colspan="10">n.s.</td><td><0.01</td><td>G</td></tr><tr><td>Percent</td><td>Unknown</td><td>Yes</td></tr><tr><td>A</td><td rowspan="2" colspan="2">--</td><td>G</td><td>p</td><td>N/A</td><td>p-value</td><td>84.42%</td><td>n.d.</td><td>III</td><td></td><td rowspan="2" colspan="2">Control</td></tr><tr><td>Item</td><td>**</td><td>Positive</td><td><0.0001</td><td></td><td>Gender</td><td>Total</td><td>n.d.</td><td>< 0.0001</td></tr><tr><td>Number</td><td>Ref.</td><td colspan="5">β</td><td>999209</td><td>64.75%</td><td>nd</td><td>NR</td><td>Normal</td><td><.001</td></tr></tbody> | 0.829424 | ||
image_089121_1634642051.814309.png | pubtabnet | <thead><tr><td>Value</td><td colspan="6"></td><td>Model</td><td>Ξ²</td></tr></thead><tbody><tr><td>HR</td><td colspan="8">t<br/>Year<br/>Method</td></tr><tr><td>Group</td><td>Sample</td><td>Region</td><td colspan="4">250.62</td><td>Species</td><td>OR</td></tr><tr><td></td><td>72.71%</td><td>54.69%</td><td>92.79%</td><td>5.50%</td><td></td><td>65.58%</td><td>20.39%</td><td>15.57%</td></tr><tr><td>Value</td><td>19.84%</td><td>43.22%</td><td>20.88%</td><td>59.55%</td><td>60.73%</td><td>24.59%</td><td></td><td>47.93%</td></tr><tr><td>No.</td><td>73.37%</td><td>19.92%</td><td>52.69%</td><td>21.22%</td><td>63.47%</td><td>25.67%</td><td>78.45%</td><td>33.19%</td></tr><tr><td></td><td>47.34%</td><td>18.83%</td><td>91.3%</td><td>19.1%</td><td>78.8%</td><td>11.18%</td><td>89.19%</td><td>65.95%</td></tr><tr><td>Characteristics</td><td>91.13%</td><td>30.86%</td><td>31.25%</td><td></td><td>97.97%</td><td></td><td>95.47%</td><td>92.81%</td></tr><tr><td>Case</td><td>46.57%</td><td>47.67%</td><td>46.21%</td><td>43.29%</td><td>81.6%</td><td>40.54%</td><td>40.91%</td><td>2.7%</td></tr><tr><td>Median</td><td>94.7%</td><td></td><td></td><td>80.3%</td><td>35.3%</td><td>84.26%</td><td>84.84%</td><td>73.30%</td></tr><tr><td>Mean SD</td><td>98.33%</td><td>73.1%</td><td>21.60%</td><td>93.74%</td><td>52.4%</td><td>42.50%</td><td>31.55%</td><td></td></tr><tr><td>n</td><td>8.77%</td><td>93.71%</td><td>97.8%</td><td>53.2%</td><td>30.47%</td><td>84.5%</td><td>51.62%</td><td>91.21%</td></tr><tr><td>df</td><td>57.47%</td><td>97.27%</td><td>17.2%</td><td>92.54%</td><td></td><td>4.39%</td><td>82.20%</td><td>62.70%</td></tr><tr><td>Item</td><td>34.14%</td><td>2.71%</td><td></td><td>4.56%</td><td>74.84%</td><td>49.30%</td><td>99.36%</td><td>31.94%</td></tr><tr><td>Sensitivity</td><td>84.37%</td><td>61.12%</td><td>54.80%</td><td>65.49%</td><td>62.52%</td><td></td><td>93.66%</td><td>3.10%</td></tr><tr><td></td><td>3.80%</td><td>59.16%</td><td>31.12%</td><td></td><td></td><td>84.29%</td><td>90.92%</td><td>90.99%</td></tr><tr><td>M</td><td>85.64%</td><td>85.20%</td><td></td><td>0.68%</td><td>68.19%</td><td>6.88%</td><td>63.5%</td><td>81.79%</td></tr><tr><td>Year</td><td></td><td>31.47%</td><td>33.85%</td><td>94.70%</td><td></td><td>41.74%</td><td>96.25%</td><td>78.40%</td></tr><tr><td>M</td><td>19.59%</td><td>53.11%</td><td>73.33%</td><td>84.68%</td><td>16.18%</td><td>72.86%</td><td>17.94%</td><td></td></tr></tbody> | <thead><tr><td>Value</td><td rowspan="2" colspan="6">t</td><td>Model</td><td>Ξ²</td></tr><tr><td>HR</td><td>Year</td><td>Method</td></tr><tr><td>Group</td><td>Sample</td><td>Region</td><td colspan="4">250.62</td><td>Species</td><td>OR</td></tr></thead><tbody><tr><td></td><td>72.71%</td><td>54.69%</td><td>92.79%</td><td>5.50%</td><td></td><td>65.58%</td><td>20.39%</td><td>15.57%</td></tr><tr><td>Value</td><td>19.84%</td><td>43.22%</td><td>20.88%</td><td>59.55%</td><td>60.73%</td><td>24.59%</td><td></td><td>47.93%</td></tr><tr><td>No.</td><td>73.37%</td><td>19.92%</td><td>52.69%</td><td>21.22%</td><td>63.47%</td><td>25.67%</td><td>78.45%</td><td>33.19%</td></tr><tr><td></td><td>47.34%</td><td>18.83%</td><td>91.3%</td><td>19.1%</td><td>78.8%</td><td>11.18%</td><td>89.19%</td><td>65.95%</td></tr><tr><td>Characteristics</td><td>91.13%</td><td>30.86%</td><td>31.25%</td><td></td><td>97.97%</td><td></td><td>95.47%</td><td>92.81%</td></tr><tr><td>Case</td><td>46.57%</td><td>47.67%</td><td>46.21%</td><td>43.29%</td><td>81.6%</td><td>40.54%</td><td>40.91%</td><td>2.7%</td></tr><tr><td>Median</td><td>94.7%</td><td></td><td></td><td>80.3%</td><td>35.3%</td><td>84.26%</td><td>84.84%</td><td>73.30%</td></tr><tr><td>Mean SD</td><td>98.33%</td><td>73.1%</td><td>21.60%</td><td>93.74%</td><td>52.4%</td><td>42.50%</td><td>31.55%</td><td></td></tr><tr><td>n</td><td>8.77%</td><td>93.71%</td><td>97.8%</td><td>53.2%</td><td>30.47%</td><td>84.5%</td><td>51.62%</td><td>91.21%</td></tr><tr><td>df</td><td>57.47%</td><td>97.27%</td><td>17.2%</td><td>92.54%</td><td></td><td>4.39%</td><td>82.20%</td><td>62.70%</td></tr><tr><td>Item</td><td>34.14%</td><td>2.71%</td><td></td><td>4.56%</td><td>74.84%</td><td>49.30%</td><td>99.36%</td><td>31.94%</td></tr><tr><td>Sensitivity</td><td>84.37%</td><td>61.12%</td><td>54.80%</td><td>65.49%</td><td>62.52%</td><td></td><td>93.66%</td><td>3.10%</td></tr><tr><td></td><td>3.80%</td><td>59.16%</td><td>31.12%</td><td></td><td></td><td>84.29%</td><td>90.92%</td><td>90.99%</td></tr><tr><td>M</td><td>85.64%</td><td>85.20%</td><td></td><td>0.68%</td><td>68.19%</td><td>6.88%</td><td>63.5%</td><td>81.79%</td></tr><tr><td>Year</td><td></td><td>31.47%</td><td>33.85%</td><td>94.70%</td><td></td><td>41.74%</td><td>96.25%</td><td>78.40%</td></tr><tr><td>M</td><td>19.59%</td><td>53.11%</td><td>73.33%</td><td>84.68%</td><td>16.18%</td><td>72.86%</td><td>17.94%</td><td></td></tr></tbody> | 0.960894 | ||
image_101800_1634648300.306165.png | marketing | <thead><tr><td>Plan amendments</td><td>Canada</td><td>Income from continuing operations</td><td>Balance, end of period</td><td>Fixed maturity securities</td><td colspan="2">Beginning balance</td><td>Basic earnings per common share</td><td colspan="4">Second Quarter</td><td>n/m</td></tr></thead><tbody><tr><td>Consolidated Statements of Comprehensive Income</td><td>58329.18$</td><td>55286.76$</td><td>2444.68$</td><td></td><td></td><td>46560.43$</td><td></td><td></td><td></td><td>34838.34$</td><td>68363.41$</td><td>96286.8$</td></tr><tr><td>As reported</td><td>38456.30$</td><td>51245.42$</td><td>69808.87$</td><td></td><td>18842.3$</td><td>38459.98$</td><td>85561.38$</td><td>89690.8$</td><td>71691.12$</td><td>67487.63$</td><td>78964.4$</td><td></td></tr><tr><td>Time deposits</td><td>65001.42$</td><td>57567.23$</td><td>47809.18$</td><td>73945.90$</td><td></td><td>36965.16$</td><td>66100.48$</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Investment income</td><td>78377.11$</td><td></td><td>66410.97$</td><td>81973.71$</td><td></td><td>94945.93$</td><td></td><td>32638.23$</td><td>18357.87$</td><td>12306.97$</td><td>16523.21$</td><td></td></tr></tbody> | <thead><tr><td>Plan amendments</td><td>Canada</td><td>Income from continuing operations</td><td>Balance, end of period</td><td>Fixed maturity securities</td><td>Beginning balance</td><td></td><td>Basic earnings per common share</td><td colspan="3">Second Quarter</td><td></td><td>n/m</td></tr></thead><tbody><tr><td>Consolidated Statements of Comprehensive Income</td><td>58329.18$</td><td>55286.76$</td><td>2444.68$</td><td></td><td rowspan="4">18842.3$</td><td colspan="4">46560.43$</td><td>34838.34$</td><td>68363.41$</td><td>96286.8$</td></tr><tr><td>As reported</td><td>38456.30$</td><td>51245.42$</td><td>69808.87$</td><td></td><td>38459.98$</td><td>85561.38$</td><td>89690.8$</td><td>71691.12$</td><td>67487.63$</td><td colspan="2">78964.4$</td></tr><tr><td>Time deposits</td><td>65001.42$</td><td>57567.23$</td><td>47809.18$</td><td>73945.90$</td><td>36965.16$</td><td colspan="6">66100.48$</td></tr><tr><td>Investment income</td><td>78377.11$</td><td></td><td>66410.97$</td><td>81973.71$</td><td>94945.93$</td><td></td><td>32638.23$</td><td>18357.87$</td><td>12306.97$</td><td colspan="2">16523.21$</td></tr></tbody> | 0.676471 | ||
image_101967_1634641622.977975.png | sparse | <thead><tr><td>Genotype</td><td></td><td>SE</td><td>SE</td><td>Outcome</td><td>Median</td><td>Species</td></tr></thead><tbody><tr><td>Mean Β± SD</td><td>81</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Model</td><td></td><td></td><td></td><td>11</td><td>66</td><td></td></tr><tr><td>Parameter</td><td></td><td></td><td></td><td></td><td></td><td>46</td></tr><tr><td></td><td></td><td>35</td><td>28</td><td></td><td></td><td></td></tr><tr><td>Value</td><td></td><td></td><td></td><td>49</td><td></td><td></td></tr><tr><td></td><td>44</td><td></td><td></td><td></td><td>43</td><td>2</td></tr><tr><td></td><td>92</td><td></td><td>46</td><td></td><td></td><td>55</td></tr><tr><td>Median</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cases</td><td>40</td><td></td><td></td><td>34</td><td></td><td></td></tr><tr><td>Characteristics</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Odds ratio</td><td>12</td><td>84</td><td></td><td></td><td></td><td></td></tr><tr><td>p Value</td><td></td><td></td><td></td><td>21</td><td></td><td></td></tr><tr><td>Age years</td><td></td><td>5</td><td>45</td><td></td><td></td><td></td></tr><tr><td>Gene name</td><td></td><td></td><td>1</td><td></td><td></td><td></td></tr><tr><td>F</td><td></td><td></td><td></td><td></td><td></td><td>42</td></tr><tr><td>df</td><td></td><td></td><td></td><td></td><td>13</td><td></td></tr><tr><td>Mean Β± SD</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Mean</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>p-value</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody> | <thead><tr><td colspan="2">Genotype</td><td>SE</td><td>SE</td><td>Outcome</td><td>Median</td><td>Species</td></tr></thead><tbody><tr><td>Mean Β± SD</td><td>81</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Model</td><td></td><td></td><td></td><td>11</td><td>66</td><td></td></tr><tr><td>Parameter</td><td></td><td></td><td></td><td></td><td></td><td>46</td></tr><tr><td></td><td></td><td>35</td><td>28</td><td></td><td></td><td></td></tr><tr><td>Value</td><td></td><td></td><td></td><td>49</td><td></td><td></td></tr><tr><td></td><td>44</td><td></td><td></td><td></td><td>43</td><td>2</td></tr><tr><td></td><td>92</td><td></td><td>46</td><td></td><td></td><td>55</td></tr><tr><td>Median</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cases</td><td>40</td><td></td><td></td><td>34</td><td></td><td></td></tr><tr><td>Characteristics</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Odds ratio</td><td>12</td><td>84</td><td></td><td></td><td></td><td></td></tr><tr><td>p Value</td><td></td><td></td><td></td><td>21</td><td></td><td></td></tr><tr><td>Age years</td><td></td><td>5</td><td>45</td><td></td><td></td><td></td></tr><tr><td>Gene name</td><td></td><td></td><td>1</td><td></td><td></td><td></td></tr><tr><td>F</td><td></td><td></td><td></td><td></td><td></td><td>42</td></tr><tr><td>df</td><td></td><td></td><td></td><td></td><td>13</td><td></td></tr><tr><td>Mean Β± SD</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Mean</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>p-value</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody> | 0.987654 | ||
image_098873_1634647759.831758.png | marketing | <thead><tr><td>Outcome</td><td>Age</td><td>Outcome</td><td>SE</td><td>Author</td><td>Reference</td><td>Variable</td><td>p</td><td>Percentage</td><td>Outcome</td><td>95 % CI</td></tr></thead><tbody><tr><td rowspan="4">Region</td><td>20</td><td>25</td><td>47</td><td>59</td><td>58</td><td>17</td><td>62</td><td>41</td><td>35</td><td>92</td></tr><tr><td>39</td><td>93</td><td>90</td><td>74</td><td></td><td>85</td><td>12</td><td>71</td><td>40</td><td>35</td></tr><tr><td>38</td><td>91</td><td>56</td><td>10</td><td>70</td><td>0</td><td>92</td><td>89</td><td>62</td><td>88</td></tr><tr><td>39</td><td colspan="7">66</td><td>95</td><td>98</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td>71</td><td>60</td><td>47</td><td>6</td><td>58</td><td>95</td></tr><tr><td colspan="7">16</td><td></td><td>76</td><td></td><td></td></tr><tr><td colspan="5" rowspan="3">Sex</td><td>59</td><td></td><td></td><td>14</td><td>14</td><td>62</td></tr><tr><td>77</td><td>3</td><td></td><td>55</td><td>38</td><td></td></tr><tr><td>75</td><td></td><td></td><td>25</td><td>2</td><td></td></tr><tr><td></td><td></td><td>32</td><td>55</td><td>81</td><td>61</td><td colspan="2"></td><td>42</td><td>78</td><td></td></tr><tr><td>Male</td><td>14</td><td>59</td><td>84</td><td>84</td><td>82</td><td>72</td><td>21</td><td>1</td><td>46</td><td></td></tr><tr><td colspan="5">Male</td><td>23</td><td>32</td><td>83</td><td>15</td><td>14</td><td>17</td></tr><tr><td>df</td><td>58</td><td>56</td><td>37</td><td>6</td><td>71</td><td>73</td><td>16<br/>5</td><td></td><td>80</td><td>68</td></tr><tr><td>SNP</td><td>81</td><td></td><td>95</td><td>81</td><td>29</td><td>69</td><td>13</td><td></td><td></td><td>50</td></tr><tr><td>Male</td><td></td><td>3</td><td>16</td><td>63</td><td>95</td><td>0</td><td>89</td><td>72</td><td>21</td><td>15</td></tr><tr><td>Source</td><td>47</td><td>28</td><td>49</td><td>43</td><td>98</td><td>32</td><td>43</td><td>70</td><td>34</td><td>91</td></tr><tr><td>Type</td><td>86</td><td>45</td><td colspan="6" rowspan="2">79</td><td></td><td></td></tr><tr><td>Study</td><td>24</td><td>30</td><td></td><td></td></tr><tr><td>Percent</td><td>18</td><td>97</td><td>35</td><td>50</td><td></td><td></td><td>43</td><td></td><td></td><td>31</td></tr></tbody> | <thead><tr><td>Outcome</td><td>Age</td><td>Outcome</td><td>SE</td><td>Author</td><td>Reference</td><td>Variable</td><td>p</td><td>Percentage</td><td>Outcome</td><td>95 % CI</td></tr></thead><tbody><tr><td rowspan="4">Region</td><td>20</td><td>25</td><td>47</td><td>59</td><td>58</td><td>17</td><td>62</td><td>41</td><td>35</td><td>92</td></tr><tr><td>39</td><td>93</td><td>90</td><td>74</td><td></td><td>85</td><td>12</td><td>71</td><td>40</td><td>35</td></tr><tr><td>38</td><td>91</td><td>56</td><td>10</td><td>70</td><td>0</td><td>92</td><td>89</td><td>62</td><td>88</td></tr><tr><td>39</td><td colspan="7">66</td><td>95</td><td>98</td></tr><tr><td rowspan="5" colspan="5">Sex</td><td>71</td><td>60</td><td>47</td><td>6</td><td>58</td><td>95</td></tr><tr><td>16</td><td rowspan="5" colspan="2">3</td><td>76</td><td></td><td></td></tr><tr><td>59</td><td>14</td><td>14</td><td>62</td></tr><tr><td>77</td><td>55</td><td>38</td><td></td></tr><tr><td>75</td><td>25</td><td>2</td><td></td></tr><tr><td></td><td></td><td>32</td><td>55</td><td>81</td><td>61</td><td>42</td><td>78</td><td></td></tr><tr><td>Male</td><td>14</td><td>59</td><td>84</td><td>84</td><td>82</td><td>72</td><td>21</td><td>1</td><td>46</td><td></td></tr><tr><td colspan="5">Male</td><td>23</td><td>32</td><td>83</td><td>15</td><td>14</td><td>17</td></tr><tr><td>df</td><td>58</td><td>56</td><td>37</td><td>6</td><td>71</td><td>73</td><td>16</td><td rowspan="2">5</td><td>80</td><td>68</td></tr><tr><td>SNP</td><td>81</td><td></td><td>95</td><td>81</td><td>29</td><td>69</td><td>13</td><td></td><td>50</td></tr><tr><td>Male</td><td></td><td>3</td><td>16</td><td>63</td><td>95</td><td>0</td><td>89</td><td>72</td><td>21</td><td>15</td></tr><tr><td>Source</td><td>47</td><td>28</td><td>49</td><td>43</td><td>98</td><td>32</td><td>43</td><td>70</td><td>34</td><td>91</td></tr><tr><td>Type</td><td>86</td><td>45</td><td rowspan="2" colspan="8">79</td></tr><tr><td>Study</td><td>24</td><td>30</td></tr><tr><td>Percent</td><td>18</td><td>97</td><td>35</td><td>50</td><td></td><td></td><td>43</td><td></td><td></td><td>31</td></tr></tbody> | 0.885859 | ||
image_125460_1634652586.018007.png | marketing | <thead><tr><td>V</td><td>Complications</td><td>HC</td><td>Standard error</td><td>Animal</td><td>Comments</td></tr></thead><tbody><tr><td colspan="4">Gene Name</td><td></td><td></td></tr><tr><td>Univariate analysis</td><td>-0.06</td><td>AB</td><td>β0.1</td><td></td><td></td></tr><tr><td>Coef.</td><td>Employment</td><td>[29]</td><td>II</td><td>Rectum</td><td rowspan="4">R1</td></tr><tr><td>Category</td><td>Both</td><td>A</td><td>Lung</td><td>++</td></tr><tr><td>OR 95% CI</td><td>Lung cancer</td><td>Decrease</td><td>Obesity</td><td rowspan="2">US</td></tr><tr><td>Standard</td><td>+++</td><td>UD</td><td>p < 0.05</td></tr></tbody> | <thead><tr><td>V</td><td>Complications</td><td>HC</td><td>Standard error</td><td>Animal</td><td>Comments</td></tr><tr><td colspan="4">Gene Name</td><td colspan="2"></td></tr></thead><tbody><tr><td>Univariate analysis</td><td>-0.06</td><td>AB</td><td colspan="3">β0.1</td></tr><tr><td>Coef.</td><td>Employment</td><td>[29]</td><td>II</td><td>Rectum</td><td rowspan="4">R1</td></tr><tr><td>Category</td><td>Both</td><td>A</td><td>Lung</td><td>++</td></tr><tr><td>OR 95% CI</td><td>Lung cancer</td><td>Decrease</td><td>Obesity</td><td rowspan="2">US</td></tr><tr><td>Standard</td><td>+++</td><td>UD</td><td>p < 0.05</td></tr></tbody> | 0.795455 | ||
image_052900_1634640561.213287.png | fintabnet | <thead><tr><td>Item 11.</td><td>In thousands of dollars</td><td></td><td>BBB-</td><td></td></tr></thead><tbody><tr><td>Noninterest expense</td><td>87.35%</td><td>90.84%</td><td></td><td>10.29%</td></tr><tr><td>Other, net</td><td>88.32%</td><td>50.35%</td><td></td><td>49.70%</td></tr><tr><td></td><td>84.45%</td><td>82.70%</td><td>50.75%</td><td>42.31%</td></tr><tr><td>Mexico</td><td>38.37%</td><td>74.37%</td><td>54.43%</td><td>49.69%</td></tr><tr><td></td><td>16.63%</td><td>78.24%</td><td>88.75%</td><td>50.67%</td></tr><tr><td>Commercial mortgage-backed securities</td><td>73.80%</td><td>56.22%</td><td>37.3%</td><td>57.1%</td></tr><tr><td>Third quarter</td><td></td><td>37.24%</td><td>44.50%</td><td>26.68%</td></tr><tr><td>Net Income</td><td>27.82%</td><td>69.66%</td><td>3.57%</td><td>20.19%</td></tr><tr><td>Exhibit No.</td><td>66.48%</td><td>37.32%</td><td>31.19%</td><td></td></tr><tr><td>Gross Carrying Amount</td><td>0.86%</td><td>8.81%</td><td>98.30%</td><td>96.76%</td></tr><tr><td>Balance at December 31, 2014</td><td>78.49%</td><td>62.75%</td><td>29.65%</td><td>69.87%</td></tr><tr><td></td><td></td><td>44.66%</td><td>89.88%</td><td>3.72%</td></tr><tr><td>0-20322</td><td>61.17%</td><td>47.90%</td><td>55.47%</td><td>35.3%</td></tr><tr><td>unaudited</td><td>9.98%</td><td>80.3%</td><td>82.3%</td><td>90.17%</td></tr><tr><td>Revenues</td><td>69.15%</td><td></td><td>88.27%</td><td></td></tr></tbody> | <thead><tr><td>Item 11.</td><td> In thousands of dollars</td><td></td><td colspan="2">BBB-</td></tr></thead><tbody><tr><td>Noninterest expense</td><td>87.35%</td><td>90.84%</td><td></td><td>10.29%</td></tr><tr><td>Other, net</td><td>88.32%</td><td>50.35%</td><td></td><td>49.70%</td></tr><tr><td></td><td>84.45%</td><td>82.70%</td><td>50.75%</td><td>42.31%</td></tr><tr><td>Mexico</td><td>38.37%</td><td>74.37%</td><td>54.43%</td><td>49.69%</td></tr><tr><td></td><td>16.63%</td><td>78.24%</td><td>88.75%</td><td>50.67%</td></tr><tr><td>Commercial mortgage-backed securities</td><td>73.80%</td><td>56.22%</td><td>37.3%</td><td>57.1%</td></tr><tr><td>Third quarter</td><td></td><td>37.24%</td><td>44.50%</td><td>26.68%</td></tr><tr><td> Net Income</td><td>27.82%</td><td>69.66%</td><td>3.57%</td><td>20.19%</td></tr><tr><td>Exhibit No.</td><td>66.48%</td><td>37.32%</td><td>31.19%</td><td></td></tr><tr><td>Gross Carrying Amount</td><td>0.86%</td><td>8.81%</td><td>98.30%</td><td>96.76%</td></tr><tr><td>Balance at December 31, 2014</td><td>78.49%</td><td>62.75%</td><td>29.65%</td><td>69.87%</td></tr><tr><td></td><td></td><td>44.66%</td><td>89.88%</td><td>3.72%</td></tr><tr><td>0-20322</td><td>61.17%</td><td>47.90%</td><td>55.47%</td><td>35.3%</td></tr><tr><td>unaudited</td><td>9.98%</td><td>80.3%</td><td>82.3%</td><td>90.17%</td></tr><tr><td>Revenues</td><td>69.15%</td><td></td><td>88.27%</td><td></td></tr></tbody> | 0.978239 | ||
image_037474_1634636317.089365.png | marketing | <thead><tr><td></td><td>$β</td><td>Cash and cash equivalents</td><td>International</td><td colspan="7">10-Q</td><td>First Quarter</td></tr></thead><tbody><tr><td>Basic</td><td>Leased</td><td>X</td><td colspan="8">Total assets</td><td>in millions</td></tr><tr><td>December 31</td><td>Net earnings</td><td>Net sales</td><td>Equity securities</td><td></td><td>United States</td><td>First Quarter</td><td>Years Ended December 31,</td><td>Interest income</td><td>Total revenues</td><td>Cash and cash equivalents</td><td>811.70</td></tr><tr><td>Operating income</td><td>Deferred income taxes</td><td>Amount</td><td></td><td>Net income loss</td><td>Forfeited</td><td>in thousands</td><td>Diluted</td><td>Revenues</td><td>Interest cost</td><td></td><td>Thereafter</td></tr><tr><td>Year Ended December 31,</td><td>Inventories</td><td>Total revenues</td><td>n/a</td><td>Third Quarter</td><td>Total liabilities</td><td>Year Ended December 31,</td><td>in thousands</td><td></td><td>*</td><td>Granted</td><td>Total revenues</td></tr><tr><td>*</td><td></td><td>Other, net</td><td>% Change</td><td>188.12</td><td>Net earnings</td><td>Other liabilities</td><td>Year Ended December 31,</td><td></td><td>β</td><td>High</td><td></td></tr><tr><td>Inventories</td><td>Net sales</td><td>Federal</td><td>Dollars in millions</td><td>Deferred income taxes</td><td>N/A</td><td colspan="4"></td><td></td><td>Year Ended December 31,</td></tr><tr><td>Owned</td><td>December 31,</td><td>96423.83$</td><td></td><td>Basic</td><td></td><td></td><td></td><td></td><td></td><td></td><td>Exercised</td></tr><tr><td>$β</td><td>In millions</td><td></td><td>Dollars in millions</td><td>Inventories</td><td>β</td><td></td><td colspan="3"></td><td>β</td><td></td></tr><tr><td colspan="2" rowspan="2">Gross profit</td><td>Description</td><td>International</td><td>Exercised</td><td>Second Quarter</td><td>State</td><td colspan="3">Change</td><td>Dollars in millions</td><td>Change</td></tr><tr><td>Service cost</td><td>Description</td><td>Owned</td><td>Provision for income taxes</td><td>Low</td><td>Year Ended December 31,</td><td></td><td></td><td>Income from continuing operations</td><td>International</td></tr><tr><td>Vested</td><td>Gross profit</td><td></td><td>Depreciation and amortization</td><td>β</td><td>First Quarter</td><td colspan="2">$ in millions</td><td rowspan="2">Total assets</td><td rowspan="2">Thereafter</td><td>Fair Value</td></tr><tr><td></td><td>Year Ended December 31,</td><td></td><td></td><td colspan="3"></td><td>Third Quarter</td><td>Revenues</td><td>$β</td></tr><tr><td></td><td></td><td rowspan="3">Canada</td><td>Low</td><td>Owned</td><td>Second Quarter</td><td>Amount</td><td></td><td>$ in millions</td><td></td><td>Foreign</td></tr><tr><td></td><td>93422.41$</td><td>Fair Value</td><td>Equity securities</td><td>Low</td><td>Revenue</td><td></td><td colspan="2">$β</td><td>Year Ended December 31,</td><td></td></tr><tr><td>Fourth Quarter</td><td>Years Ended December 31,</td><td>Provision for income taxes</td><td colspan="8">Change<br/>β%</td></tr><tr><td>in millions</td><td>$-</td><td></td><td colspan="2">78491.68$</td><td>Income from continuing operations</td><td>Provision for income taxes</td><td></td><td>$ in millions</td><td></td><td>Net earnings</td><td>β%</td></tr><tr><td>in millions</td><td rowspan="3">Net cash provided by operating activities</td><td>Second Quarter</td><td>Dollars in millions</td><td></td><td>Forfeited</td><td>n/a</td><td rowspan="3">Cash and cash equivalents</td><td>Year Ended December 31,</td><td>Second Quarter</td><td>Granted</td><td>Net cash provided by operating activities</td></tr><tr><td>-</td><td>83.81%</td><td>Cash and cash equivalents</td><td>Thereafter</td><td>Federal</td><td>Other</td><td>Year Ended December 31,</td><td>Goodwill</td><td>N/A</td><td></td></tr><tr><td>Equity securities</td><td>Interest expense</td><td>Europe</td><td>Service cost</td><td></td><td>High</td><td>Total assets</td><td>U.S.</td><td></td><td>Net earnings</td></tr></tbody> | <thead><tr><td></td><td>$β</td><td>Cash and cash equivalents</td><td>International</td><td colspan="6">10-Q</td><td>Interest cost</td><td>First Quarter</td></tr><tr><td>Basic</td><td>Leased</td><td>X</td><td colspan="8">Total assets</td><td>in millions</td></tr></thead><tbody><tr><td>December 31</td><td>Net earnings</td><td>Net sales</td><td>Equity securities</td><td></td><td>United States</td><td>First Quarter</td><td>Years Ended December 31,</td><td>Interest income</td><td>Total revenues</td><td>Cash and cash equivalents</td><td>811.70</td></tr><tr><td>Operating income</td><td>Deferred income taxes</td><td>Amount</td><td></td><td>Net income loss</td><td>Forfeited</td><td>in thousands</td><td>Diluted</td><td>Revenues</td><td>Interest cost</td><td></td><td>Thereafter</td></tr><tr><td> Year Ended December 31,</td><td>Inventories</td><td>Total revenues</td><td>n/a</td><td>Third Quarter</td><td>Total liabilities</td><td>Year Ended December 31,</td><td>in thousands</td><td></td><td>*</td><td>Granted</td><td>Total revenues</td></tr><tr><td>*</td><td></td><td>Other, net</td><td>% Change</td><td>188.12</td><td>Net earnings</td><td>Other liabilities</td><td> Year Ended December 31,</td><td></td><td>β</td><td>High</td><td></td></tr><tr><td>Inventories</td><td>Net sales</td><td>Federal</td><td>Dollars in millions</td><td>Deferred income taxes</td><td>N/A</td><td rowspan="3" colspan="4"></td><td></td><td> Year Ended December 31,</td></tr><tr><td>Owned</td><td>December 31,</td><td>96423.83$</td><td></td><td colspan="2">Basic</td><td></td><td>Exercised</td></tr><tr><td>$β</td><td> In millions</td><td></td><td>Dollars in millions</td><td>Inventories</td><td> β</td><td>β</td><td></td></tr><tr><td rowspan="2" colspan="2">Gross profit</td><td>Description</td><td>International</td><td>Exercised</td><td>Second Quarter</td><td>State</td><td rowspan="2" colspan="2"> Year Ended December 31,</td><td>Change</td><td>Dollars in millions</td><td>Change</td></tr><tr><td>Service cost</td><td>Description</td><td>Owned</td><td>Provision for income taxes</td><td>Low</td><td rowspan="5">Total assets</td><td>Income from continuing operations</td><td>International</td></tr><tr><td>Vested</td><td>Gross profit</td><td></td><td>Depreciation and amortization</td><td>β</td><td colspan="3">First Quarter</td><td>$ in millions</td><td rowspan="3">Thereafter</td><td>Fair Value</td></tr><tr><td colspan="7"> Year Ended December 31,</td><td>Third Quarter</td><td>Revenues</td><td>$β</td></tr><tr><td></td><td></td><td rowspan="4">Canada</td><td>Low</td><td>Owned</td><td>Second Quarter</td><td>Amount</td><td></td><td>$ in millions</td><td>Foreign</td></tr><tr><td></td><td>93422.41$</td><td>Fair Value</td><td>Equity securities</td><td>Low</td><td colspan="2">Revenue</td><td>$β</td><td> Year Ended December 31,</td><td></td></tr><tr><td>Fourth Quarter</td><td>Years Ended December 31,</td><td>Provision for income taxes</td><td colspan="7">Change</td><td>β%</td></tr><tr><td>in millions</td><td>$-</td><td colspan="2">78491.68$</td><td>Income from continuing operations</td><td>Provision for income taxes</td><td rowspan="4">Cash and cash equivalents</td><td>$ in millions</td><td></td><td>Net earnings</td><td>β%</td></tr><tr><td>in millions</td><td>Net cash provided by operating activities</td><td>Second Quarter</td><td>Dollars in millions</td><td></td><td>Forfeited</td><td>n/a</td><td>Year Ended December 31,</td><td>Second Quarter</td><td>Granted</td><td>Net cash provided by operating activities</td></tr><tr><td>-</td><td rowspan="2"></td><td>83.81%</td><td>Cash and cash equivalents</td><td>Thereafter</td><td>Federal</td><td>Other</td><td> Year Ended December 31,</td><td>Goodwill</td><td>N/A</td><td></td></tr><tr><td>Equity securities</td><td>Interest expense</td><td>Europe</td><td>Service cost</td><td></td><td>High</td><td>Total assets</td><td>U.S.</td><td></td><td>Net earnings</td></tr></tbody> | 0.808295 | ||
image_002742_1634629477.062471.png | pubtabnet | <thead><tr><td>Number</td><td>Sequence</td><td rowspan="2">Group</td><td>Median</td><td>Ξ²</td><td>Controls</td><td>Range</td><td>Strain</td><td>Reference</td><td></td><td>Genotype</td><td>HR</td><td>Range</td><td></td><td></td></tr></thead><tbody><tr><td>Group</td><td>Author</td><td>Specificity</td><td>Sex</td><td>Genotype</td><td>P-value</td><td>Sequence</td><td></td><td>M</td><td>Odds ratio</td><td></td><td></td><td>References</td><td>982.6</td></tr><tr><td>Parameter</td><td>Control</td><td></td><td>Mean</td><td>Ref.</td><td>L</td><td>++</td><td>II</td><td></td><td>nd</td><td>Unknown</td><td>Low</td><td></td><td>x</td><td>Negative</td></tr><tr><td>Reference</td><td>n.d.</td><td>< 0.001</td><td></td><td>+++</td><td>Ref</td><td>Education</td><td>257453</td><td>--</td><td>Y</td><td>Female</td><td>n/a</td><td>Education</td><td></td><td>n/a</td></tr><tr><td>Percent</td><td>β</td><td>n/a</td><td>N</td><td>Sex</td><td>No</td><td>p-value</td><td>I</td><td>β</td><td>**</td><td>n.s.</td><td></td><td>++</td><td>Sex</td><td>B</td></tr><tr><td>Type</td><td>ns</td><td>< 0.001</td><td>Other</td><td>P value</td><td>Unknown</td><td>Yes</td><td></td><td>R</td><td>< 0.0001</td><td>Female</td><td>R</td><td>Other</td><td>L</td><td>Ref.</td></tr><tr><td>df</td><td>NS</td><td></td><td>Low</td><td>/</td><td></td><td>ns</td><td><.0001</td><td>79384.60$</td><td>B</td><td>Age</td><td><0.001</td><td></td><td></td><td><.0001</td></tr><tr><td>Mean SD</td><td>E</td><td>NR</td><td>x</td><td>< 0.001</td><td><.0001</td><td>T</td><td><0.05</td><td><.0001</td><td>β</td><td><.0001</td><td>Yes</td><td></td><td>+</td><td>+</td></tr><tr><td>p-Value</td><td>No</td><td>Unknown</td><td>X</td><td>n</td><td>na</td><td></td><td>N</td><td>p</td><td>no</td><td>na</td><td></td><td>< 0.001</td><td>Female</td><td><0.01</td></tr><tr><td>Item</td><td>< 0.001</td><td><0.001</td><td>N/A</td><td>High</td><td>Gender</td><td>nd</td><td>I</td><td>no</td><td>20.93%</td><td>Mean</td><td>Reference</td><td></td><td>***</td><td></td></tr><tr><td>p-value</td><td>Other</td><td></td><td>***</td><td>Other</td><td>This study</td><td>R</td><td>24.88%</td><td>-</td><td>--</td><td>no</td><td>β</td><td></td><td></td><td>Age</td></tr><tr><td></td><td>R</td><td></td><td>Low</td><td>N</td><td>Sex</td><td>II</td><td>Education</td><td>This study</td><td>I</td><td></td><td>ND</td><td>**</td><td></td><td></td></tr><tr><td>Genotype</td><td>Normal</td><td>P-value</td><td>Female</td><td>Ref.</td><td><0.01</td><td>Reference</td><td></td><td></td><td>Age years</td><td></td><td>L</td><td>II</td><td></td><td>nd</td></tr></tbody> | <thead><tr><td>Number</td><td>Sequence</td><td rowspan="2">Group</td><td>Median</td><td>Ξ²</td><td>Controls</td><td>Range</td><td>Strain</td><td>Reference</td><td></td><td>Genotype</td><td>HR</td><td colspan="3">Range</td></tr><tr><td>Group</td><td>Author</td><td>Specificity</td><td>Sex</td><td>Genotype</td><td>P-value</td><td>Sequence</td><td></td><td>M</td><td colspan="3">Odds ratio</td><td>References</td><td>982.6</td></tr></thead><tbody><tr><td>Parameter</td><td>Control</td><td></td><td>Mean</td><td>Ref.</td><td>L</td><td>++</td><td>II</td><td></td><td>nd</td><td>Unknown</td><td>Low</td><td>.</td><td>x</td><td>Negative</td></tr><tr><td>Reference</td><td>n.d.</td><td>< 0.001</td><td></td><td>+++</td><td>Ref</td><td>Education</td><td>257453</td><td>--</td><td>Y</td><td>Female</td><td>n/a</td><td>Education</td><td></td><td>n/a</td></tr><tr><td>Percent</td><td>β</td><td>n/a</td><td>N</td><td>Sex</td><td>No</td><td>p-value</td><td>I</td><td>β</td><td>**</td><td>n.s.</td><td></td><td>++</td><td>Sex</td><td>B</td></tr><tr><td>Type</td><td>ns</td><td>< 0.001</td><td>Other</td><td>P value</td><td>Unknown</td><td>Yes</td><td></td><td>R</td><td>< 0.0001</td><td> Female</td><td>R</td><td>Other</td><td>L</td><td>Ref.</td></tr><tr><td>df</td><td>NS</td><td></td><td>Low</td><td>/</td><td></td><td>ns</td><td><.0001</td><td>79384.60$</td><td>B</td><td>Age</td><td><0.001</td><td></td><td></td><td><.0001</td></tr><tr><td>Mean SD</td><td>E</td><td>NR</td><td>x</td><td>< 0.001</td><td><.0001</td><td>T</td><td><0.05</td><td><.0001</td><td>β</td><td><.0001</td><td>Yes</td><td> </td><td>+</td><td>+</td></tr><tr><td>p-Value</td><td> No</td><td>Unknown</td><td>X</td><td>n</td><td>na</td><td></td><td>N</td><td>p</td><td>no</td><td>na</td><td>.</td><td>< 0.001</td><td> Female</td><td><0.01</td></tr><tr><td>Item</td><td>< 0.001</td><td><0.001</td><td>N/A</td><td>High</td><td>Gender</td><td>nd</td><td>I</td><td>no</td><td>20.93%</td><td>Mean</td><td>Reference</td><td></td><td>***</td><td></td></tr><tr><td>p-value</td><td> Other</td><td></td><td>***</td><td> Other</td><td>This study</td><td>R</td><td>24.88%</td><td>-</td><td>--</td><td>no</td><td>β</td><td>.</td><td></td><td>Age</td></tr><tr><td></td><td>R</td><td></td><td>Low</td><td>N</td><td>Sex</td><td>II</td><td>Education</td><td>This study</td><td>I</td><td></td><td>ND</td><td>**</td><td></td><td></td></tr><tr><td>Genotype</td><td>Normal</td><td>P-value</td><td>Female</td><td>Ref.</td><td><0.01</td><td>Reference</td><td></td><td></td><td>Age years</td><td></td><td>L</td><td>II</td><td></td><td>nd</td></tr></tbody> | 0.928458 | ||
image_142589_1634659140.712994.png | fintabnet | <thead><tr><td>June 30</td><td>Earnings from operations</td><td>N/A</td><td>Income tax expense benefit</td><td>Products</td><td>Mortgage-backed securities</td><td>in millions</td><td colspan="3" rowspan="2">Prior years</td><td>Share-based compensation expense</td></tr></thead><tbody><tr><td>Level 3</td><td></td><td>Shareholders' equity</td><td>Other comprehensive income</td><td>Due in one year or less</td><td>Worldwide</td><td>Years Ended December 31,</td><td>Cancelled</td></tr><tr><td>Second</td><td>715.94$</td><td>75777.27$</td><td>54711.96$</td><td>63245.92$</td><td>5887.50$</td><td>75807.4$</td><td>29766.71$</td><td>95511.93$</td><td>48986.12$</td><td>78832.49$</td></tr><tr><td>Net revenue</td><td>70400.14$</td><td>42728.60$</td><td>38097.52$</td><td>31017.98$</td><td></td><td>74235.5$</td><td>81793.44$</td><td>85188.33$</td><td>50237.62$</td><td>62800.71$</td></tr><tr><td>Commercial lease financing</td><td>80534.18$</td><td>312.75$</td><td>84950.19$</td><td></td><td>47367.36$</td><td>7184.87$</td><td>15541.83$</td><td>34615.76$</td><td>45442.56$</td><td>70711.30$</td></tr><tr><td>PART I</td><td>62223.99$</td><td>82491.24$</td><td>30100.84$</td><td>70619.97$</td><td>62127.44$</td><td>89526.33$</td><td>3103.60$</td><td>44269.81$</td><td>20794.79$</td><td>67295.71$</td></tr><tr><td>Stock-based compensation expense</td><td>5370.57$</td><td>71336.80$</td><td>50498.44$</td><td>59014.16$</td><td>31252.61$</td><td></td><td>65010.78$</td><td>29126.71$</td><td>57312.80$</td><td>9359.29$</td></tr><tr><td></td><td>58625.64$</td><td>5037.47$</td><td>32492.14$</td><td>86932.75$</td><td>85167.15$</td><td>45092.28$</td><td>36922.53$</td><td>4755.14$</td><td>15230.51$</td><td>71743.32$</td></tr><tr><td>S-8</td><td>19847.82$</td><td>79090.13$</td><td></td><td>78459.51$</td><td>70623.1$</td><td>41101.26$</td><td>55274.27$</td><td>76252.2$</td><td>19049.55$</td><td>95856.9$</td></tr><tr><td>France</td><td>25676.78$</td><td></td><td>19421.45$</td><td>30993.96$</td><td>41905.55$</td><td>69468.41$</td><td></td><td></td><td>33943.29$</td><td>13776.49$</td></tr><tr><td></td><td>44027.83$</td><td>83565.60$</td><td>73350.18$</td><td>91703.42$</td><td>9406.22$</td><td>94909.44$</td><td>14337.60$</td><td>61631.69$</td><td>94671.91$</td><td>7058.66$</td></tr><tr><td>Wind</td><td>60332.33$</td><td></td><td>87791.90$</td><td></td><td>91607.78$</td><td>88210.80$</td><td>57540.85$</td><td>5215.1$</td><td>38559.29$</td><td>14230.49$</td></tr><tr><td>in thousands</td><td>27236.28$</td><td>70214.55$</td><td>21194.75$</td><td>19819.55$</td><td>79140.79$</td><td>57430.98$</td><td>69154.68$</td><td>77237.3$</td><td>24855.10$</td><td>93511.31$</td></tr><tr><td>Year ended December 31,</td><td>6613.88$</td><td>20848.93$</td><td>95501.26$</td><td>56835.63$</td><td>61081.15$</td><td>95340.29$</td><td>99644.35$</td><td>4408.74$</td><td>23475.8$</td><td>44208.26$</td></tr><tr><td>Commodity contracts</td><td>58269.78$</td><td>14924.61$</td><td>77213.50$</td><td>8256.89$</td><td></td><td>61192.65$</td><td>79421.66$</td><td>65360.97$</td><td>33836.75$</td><td>47451.76$</td></tr><tr><td>Expected dividend yield</td><td>94734.41$</td><td>77794.7$</td><td>63183.5$</td><td>93687.85$</td><td>66558.91$</td><td>72913.21$</td><td>74536.70$</td><td>20265.62$</td><td>34750.43$</td><td>87652.19$</td></tr><tr><td>000-06920</td><td>96404.41$</td><td>13278.69$</td><td>18832.50$</td><td>41066.83$</td><td>95273.76$</td><td>80605.11$</td><td>56600.43$</td><td>1095.57$</td><td>44342.33$</td><td>84259.53$</td></tr></tbody> | <thead><tr><td>June 30</td><td>Earnings from operations</td><td> N/A</td><td>Income tax expense benefit</td><td>Products</td><td>Mortgage-backed securities</td><td> in millions</td><td rowspan="2" colspan="3">Prior years</td><td>Share-based compensation expense</td></tr><tr><td> Level 3</td><td></td><td>Shareholdersβ equity</td><td>Other comprehensive income</td><td>Due in one year or less</td><td>Worldwide</td><td> Years Ended December 31,</td><td>Cancelled</td></tr></thead><tbody><tr><td>Second</td><td>715.94$</td><td>75777.27$</td><td>54711.96$</td><td>63245.92$</td><td>5887.50$</td><td>75807.4$</td><td>29766.71$</td><td>95511.93$</td><td>48986.12$</td><td>78832.49$</td></tr><tr><td>Net revenue</td><td>70400.14$</td><td>42728.60$</td><td>38097.52$</td><td>31017.98$</td><td></td><td>74235.5$</td><td>81793.44$</td><td>85188.33$</td><td>50237.62$</td><td>62800.71$</td></tr><tr><td>Commercial lease financing</td><td>80534.18$</td><td>312.75$</td><td>84950.19$</td><td></td><td>47367.36$</td><td>7184.87$</td><td>15541.83$</td><td>34615.76$</td><td>45442.56$</td><td>70711.30$</td></tr><tr><td>PART I</td><td>62223.99$</td><td>82491.24$</td><td>30100.84$</td><td>70619.97$</td><td>62127.44$</td><td>89526.33$</td><td>3103.60$</td><td>44269.81$</td><td>20794.79$</td><td>67295.71$</td></tr><tr><td>Stock-based compensation expense</td><td>5370.57$</td><td>71336.80$</td><td>50498.44$</td><td>59014.16$</td><td>31252.61$</td><td></td><td>65010.78$</td><td>29126.71$</td><td>57312.80$</td><td>9359.29$</td></tr><tr><td></td><td>58625.64$</td><td>5037.47$</td><td>32492.14$</td><td>86932.75$</td><td>85167.15$</td><td>45092.28$</td><td>36922.53$</td><td>4755.14$</td><td>15230.51$</td><td>71743.32$</td></tr><tr><td>S-8</td><td>19847.82$</td><td>79090.13$</td><td></td><td>78459.51$</td><td>70623.1$</td><td>41101.26$</td><td>55274.27$</td><td>76252.2$</td><td>19049.55$</td><td>95856.9$</td></tr><tr><td>France</td><td>25676.78$</td><td></td><td>19421.45$</td><td>30993.96$</td><td>41905.55$</td><td>69468.41$</td><td></td><td></td><td>33943.29$</td><td>13776.49$</td></tr><tr><td></td><td>44027.83$</td><td>83565.60$</td><td>73350.18$</td><td>91703.42$</td><td>9406.22$</td><td>94909.44$</td><td>14337.60$</td><td>61631.69$</td><td>94671.91$</td><td>7058.66$</td></tr><tr><td>Wind</td><td>60332.33$</td><td></td><td>87791.90$</td><td></td><td>91607.78$</td><td>88210.80$</td><td>57540.85$</td><td>5215.1$</td><td>38559.29$</td><td>14230.49$</td></tr><tr><td> in thousands</td><td>27236.28$</td><td>70214.55$</td><td>21194.75$</td><td>19819.55$</td><td>79140.79$</td><td>57430.98$</td><td>69154.68$</td><td>77237.3$</td><td>24855.10$</td><td>93511.31$</td></tr><tr><td>Year ended December 31,</td><td>6613.88$</td><td>20848.93$</td><td>95501.26$</td><td>56835.63$</td><td>61081.15$</td><td>95340.29$</td><td>99644.35$</td><td>4408.74$</td><td>23475.8$</td><td>44208.26$</td></tr><tr><td>Commodity contracts</td><td>58269.78$</td><td>14924.61$</td><td>77213.50$</td><td>8256.89$</td><td></td><td>61192.65$</td><td>79421.66$</td><td>65360.97$</td><td>33836.75$</td><td>47451.76$</td></tr><tr><td>Expected dividend yield</td><td>94734.41$</td><td>77794.7$</td><td>63183.5$</td><td>93687.85$</td><td>66558.91$</td><td>72913.21$</td><td>74536.70$</td><td>20265.62$</td><td>34750.43$</td><td>87652.19$</td></tr><tr><td>000-06920</td><td>96404.41$</td><td>13278.69$</td><td>18832.50$</td><td>41066.83$</td><td>95273.76$</td><td>80605.11$</td><td>56600.43$</td><td>1095.57$</td><td>44342.33$</td><td>84259.53$</td></tr></tbody> | 0.976989 | ||
image_108318_1634644895.155157.png | pubtabnet | <thead><tr><td>Crude OR</td><td>S1</td><td>Primer sequence</td><td>Protocol</td><td>Std. error</td><td>t</td><td></td><td></td><td></td><td>p value</td><td>Property</td><td>Forward</td><td>p-values</td><td></td><td>PA</td></tr></thead><tbody><tr><td>Database</td><td></td><td>Mean SD</td><td></td><td>IL-6</td><td>C/T</td><td></td><td>Model 2</td><td></td><td>T/C</td><td>T1</td><td>Gene</td><td>[19]</td><td>β0.03</td><td>Vomiting</td></tr><tr><td>Mortality</td><td>Increased</td><td></td><td>Anemia</td><td>Intermediate</td><td>NR</td><td>Body mass index</td><td>HCC</td><td>Outcome</td><td>Accuracy</td><td>Waist circumference cm</td><td>Na</td><td>0 0β0</td><td>This work</td><td>Canada</td></tr><tr><td>L</td><td>Turkey</td><td></td><td>>50</td><td></td><td></td><td>< 1</td><td></td><td>Γ</td><td>m</td><td>n.s</td><td>1 reference</td><td>NAS</td><td>+</td><td>Before</td></tr><tr><td>Adjusted OR</td><td>β0.11</td><td>Fixed</td><td>Stroke</td><td>Retrospective</td><td>-0.01</td><td>Group</td><td>Staphylococcus aureus</td><td>Histology</td><td><20</td><td>Mean</td><td>AR</td><td>Hypertension %</td><td>Urine</td><td>Zn</td></tr><tr><td>Cohort</td><td><sup>*</sup></td><td></td><td>Race</td><td></td><td><0.001</td><td></td><td>1.00 ref</td><td>Rural</td><td>N2</td><td>Mean Β± SD</td><td></td><td>Height</td><td>Intergenic</td><td>0/4</td></tr><tr><td>Cell line</td><td>Rabbit</td><td>Lung</td><td>BP</td><td>Active</td><td>CT</td><td>Na</td><td><20</td><td>F2</td><td>>5</td><td>β0.31</td><td>0.004*</td><td>Obesity</td><td>β0.34</td><td>Adult</td></tr><tr><td></td><td>---</td><td><0.001**</td><td>Estimate</td><td>0.01*</td><td></td><td>β0.003</td><td>0 0β0</td><td>positive</td><td>IDA</td><td>NC</td><td>High</td><td>SP</td><td>1.0 reference</td><td>++++</td></tr><tr><td>DF</td><td>IV</td><td>Denmark</td><td>-0.09</td><td>-</td><td>>60</td><td></td><td>1 ref</td><td><0.01</td><td>0 Β± 0</td><td>Q</td><td>Turkey</td><td>Number</td><td>N %</td><td>< 0.001</td></tr><tr><td>Dataset</td><td></td><td>β</td><td>CI</td><td>***</td><td>ND</td><td>Unemployed</td><td>Education</td><td></td><td>Primary</td><td>control</td><td></td><td>Korea</td><td>Illiterate</td><td>M2</td></tr><tr><td>I<sup>2</sup> %</td><td>β3</td><td>Tumor location</td><td>TG</td><td>t</td><td>Lower</td><td></td><td>>20</td><td>Widowed</td><td>[43]</td><td>Residence</td><td>p < 0.0001</td><td>[25]</td><td>Boys</td><td>A3</td></tr><tr><td></td><td>Median</td><td>-</td><td></td><td>β0.09</td><td>Income</td><td>-0.02</td><td>[13]</td><td></td><td>Male sex</td><td>Placebo</td><td>AA</td><td></td><td>---</td><td>Ethnicity</td></tr><tr><td>Obese</td><td>J</td><td>Healthy</td><td>China</td><td>Comorbidities</td><td>0/4</td><td>Variable</td><td></td><td></td><td>Ns</td><td>[42]</td><td>-2</td><td>Grade</td><td>Model</td><td>β</td></tr><tr><td>Risk factor</td><td>[25]</td><td>0/3</td><td>Reverse</td><td>Educational level</td><td>Diagnosis</td><td>Others</td><td>Cohort</td><td>neg</td><td>Pancreas</td><td>0.02*</td><td>Healthy</td><td></td><td>Combined</td><td>[32]</td></tr><tr><td>Factor 1</td><td>Y</td><td>β</td><td>+/-</td><td>Z</td><td>--</td><td>Negative</td><td></td><td>Unemployed</td><td>β0.18</td><td></td><td>< 0.0001</td><td></td><td></td><td>Sense</td></tr></tbody> | <thead><tr><td>Crude OR</td><td>S1</td><td>Primer sequence</td><td>Protocol</td><td>Std. error</td><td colspan="3">t</td><td></td><td>p value</td><td>Property</td><td>Forward</td><td>p-values</td><td></td><td>PA</td></tr></thead><tbody><tr><td>Database</td><td></td><td> Mean SD</td><td></td><td>IL-6</td><td>C/T</td><td></td><td>Model 2</td><td></td><td>T/C</td><td> T1</td><td>Gene</td><td>[19]</td><td>β0.03</td><td>Vomiting</td></tr><tr><td>Mortality</td><td>Increased</td><td></td><td>Anemia</td><td>Intermediate</td><td>NR</td><td>Body mass index</td><td>HCC</td><td>Outcome</td><td>Accuracy</td><td>Waist circumference cm</td><td>Na</td><td>0 0β0</td><td>This work</td><td>Canada</td></tr><tr><td>L</td><td>Turkey</td><td></td><td>>50</td><td></td><td></td><td>< 1</td><td></td><td>Γ</td><td>m</td><td>n.s</td><td>1 reference</td><td>NAS</td><td>+</td><td>Before</td></tr><tr><td>Adjusted OR</td><td>β0.11</td><td>Fixed</td><td>Stroke</td><td>Retrospective</td><td>-0.01</td><td>Group</td><td>Staphylococcus aureus</td><td>Histology</td><td><20</td><td>Mean</td><td>AR</td><td>Hypertension %</td><td>Urine</td><td>Zn</td></tr><tr><td>Cohort</td><td><sup>*</sup></td><td></td><td>Race</td><td></td><td><0.001</td><td></td><td>1.00 ref</td><td> Rural</td><td>N2</td><td>Mean Β± SD</td><td></td><td>Height</td><td>Intergenic</td><td>0/4</td></tr><tr><td>Cell line</td><td>Rabbit</td><td>Lung</td><td>BP</td><td>Active</td><td>CT</td><td>Na</td><td><20</td><td>F2</td><td>>5</td><td>β0.31</td><td>0.004*</td><td>Obesity</td><td>β0.34</td><td>Adult</td></tr><tr><td></td><td>---</td><td><0.001**</td><td>Estimate</td><td>0.01*</td><td></td><td>β0.003</td><td>0 0β0</td><td>positive</td><td>IDA</td><td>NC</td><td>High</td><td>SP</td><td>1.0 reference</td><td>++++</td></tr><tr><td>DF</td><td>IV</td><td>Denmark</td><td>-0.09</td><td> -</td><td>>60</td><td></td><td>1 ref</td><td><0.01</td><td>0 Β± 0</td><td>Q</td><td>Turkey</td><td>Number</td><td>N %</td><td>< 0.001</td></tr><tr><td>Dataset</td><td></td><td>β</td><td>CI</td><td>***</td><td>ND</td><td> Unemployed</td><td>Education</td><td></td><td> Primary</td><td>control</td><td></td><td>Korea</td><td>Illiterate</td><td>M2</td></tr><tr><td>I<sup>2</sup> %</td><td>β3</td><td>Tumor location</td><td>TG</td><td>t</td><td>Lower</td><td></td><td>>20</td><td>Widowed</td><td>[43]</td><td>Residence</td><td>p < 0.0001</td><td>[25]</td><td>Boys</td><td>A3</td></tr><tr><td></td><td> Median</td><td> -</td><td></td><td>β0.09</td><td>Income</td><td>-0.02</td><td>[13]</td><td></td><td>Male sex</td><td>Placebo</td><td>AA</td><td></td><td>---</td><td>Ethnicity</td></tr><tr><td>Obese</td><td>J</td><td>Healthy</td><td>China</td><td>Comorbidities</td><td>0/4</td><td>Variable</td><td></td><td></td><td>Ns</td><td>[42]</td><td>-2</td><td>Grade</td><td>Model</td><td>β</td></tr><tr><td>Risk factor</td><td>[25]</td><td>0/3</td><td>Reverse</td><td>Educational level</td><td>Diagnosis</td><td> Others</td><td>Cohort</td><td>neg</td><td>Pancreas</td><td>0.02*</td><td>Healthy</td><td></td><td>Combined</td><td>[32]</td></tr><tr><td>Factor 1</td><td>Y</td><td>β</td><td>+/-</td><td>Z</td><td>--</td><td>Negative</td><td></td><td> Unemployed</td><td>β0.18</td><td></td><td>< 0.0001</td><td></td><td></td><td>Sense</td></tr></tbody> | 0.978617 | ||
image_123404_1634655317.236046.png | fintabnet | <thead><tr><td>in thousands</td><td>Interest Rate</td><td>--</td><td>Income taxes</td><td>Numerator:</td><td>First quarter</td><td>Period</td><td>Other intangible assets, net</td><td rowspan="2">Exercised</td></tr></thead><tbody><tr><td>AccumulatedAmortization</td><td>Third quarter</td><td>Principal Accounting Fees and Services</td><td>Principal Accountant Fees and Services</td><td>NM</td><td>Gross Profit</td><td>Exhibit Number</td><td>Fair value of plan assets</td></tr><tr><td>Liabilities</td><td>Michigan</td><td>Total liabilities and shareholders' equity</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Loss from discontinued operations</td><td>19.42%</td><td>34.87%</td><td>41.1%</td><td>92.90%</td><td>71.8%</td><td>82.49%</td><td>53.72%</td><td>94.60%</td></tr><tr><td>Third Quarter</td><td>58.38%</td><td>6.85%</td><td>87.26%</td><td>95.27%</td><td>1.65%</td><td>75.71%</td><td>74.73%</td><td>97.91%</td></tr><tr><td>Revenue</td><td>92.1%</td><td>54.58%</td><td>54.40%</td><td>25.16%</td><td>34.39%</td><td>90.98%</td><td>41.22%</td><td>73.51%</td></tr><tr><td>Exhibit</td><td>81.16%</td><td></td><td>15.63%</td><td>47.15%</td><td>95.21%</td><td>41.72%</td><td>71.34%</td><td>29.74%</td></tr><tr><td></td><td></td><td>94.59%</td><td>18.11%</td><td>78.26%</td><td>53.90%</td><td>99.45%</td><td>33.98%</td><td>9.89%</td></tr><tr><td>Minority interest</td><td>21.16%</td><td></td><td></td><td>31.1%</td><td>93.71%</td><td>22.15%</td><td>74.74%</td><td></td></tr><tr><td>Amount</td><td>64.65%</td><td></td><td>34.47%</td><td></td><td>78.79%</td><td>90.43%</td><td>2.41%</td><td>56.47%</td></tr><tr><td>Equipment</td><td>73.27%</td><td>38.12%</td><td>29.39%</td><td></td><td>30.18%</td><td>4.72%</td><td>15.40%</td><td>43.79%</td></tr><tr><td>Fourth quarter</td><td>9.97%</td><td>65.18%</td><td>64.67%</td><td></td><td>47.63%</td><td>84.4%</td><td>91.91%</td><td>54.60%</td></tr><tr><td>Long-term debt</td><td>95.69%</td><td>70.1%</td><td>20.24%</td><td></td><td>10.83%</td><td>60.15%</td><td></td><td></td></tr><tr><td>Operating revenues</td><td>20.20%</td><td>31.49%</td><td>41.7%</td><td>23.75%</td><td>96.65%</td><td>7.84%</td><td>67.79%</td><td>97.16%</td></tr><tr><td>Less accumulated depreciation and amortization</td><td>79.39%</td><td></td><td>65.56%</td><td></td><td>56.27%</td><td>36.33%</td><td>41.77%</td><td>36.53%</td></tr><tr><td></td><td>39.83%</td><td>94.12%</td><td>24.2%</td><td>58.1%</td><td>55.42%</td><td>32.69%</td><td>32.23%</td><td>9.7%</td></tr><tr><td>Item 12.</td><td>19.35%</td><td>71.65%</td><td>48.26%</td><td></td><td>87.14%</td><td>12.99%</td><td>7.97%</td><td>1.53%</td></tr><tr><td>Thereafter</td><td></td><td>5.75%</td><td>81.81%</td><td></td><td>29.3%</td><td>7.23%</td><td>72.27%</td><td>85.78%</td></tr><tr><td></td><td>88.66%</td><td>36.41%</td><td>87.22%</td><td>69.78%</td><td>24.34%</td><td>54.15%</td><td>20.20%</td><td>29.14%</td></tr><tr><td>S-8</td><td>17.77%</td><td>57.79%</td><td>96.41%</td><td>4.94%</td><td>87.35%</td><td>84.90%</td><td>82.40%</td><td>80.52%</td></tr><tr><td>Interest rate swaps</td><td>9.76%</td><td>87.24%</td><td>18.71%</td><td>41.23%</td><td>40.34%</td><td>69.25%</td><td>36.3%</td><td>95.58%</td></tr><tr><td></td><td>41.2%</td><td>40.86%</td><td>19.56%</td><td>52.92%</td><td>18.73%</td><td>34.93%</td><td>13.91%</td><td>97.10%</td></tr><tr><td>Filed herewith</td><td>62.27%</td><td>6.23%</td><td>72.43%</td><td>98.10%</td><td>99.87%</td><td>53.43%</td><td>64.46%</td><td>30.60%</td></tr><tr><td>Dividends paid</td><td>88.76%</td><td>73.99%</td><td></td><td>51.44%</td><td>72.9%</td><td>2.42%</td><td>34.44%</td><td></td></tr><tr><td>Year</td><td>26.43%</td><td>15.28%</td><td></td><td></td><td>65.25%</td><td>46.92%</td><td>82.99%</td><td>53.9%</td></tr></tbody> | <thead><tr><td>in thousands</td><td>Interest Rate</td><td>--</td><td>Income taxes</td><td>Numerator:</td><td>First quarter</td><td>Period</td><td>Other intangible assets, net</td><td rowspan="2">Exercised</td></tr><tr><td>AccumulatedAmortization</td><td>Third quarter</td><td>Principal Accounting Fees and Services</td><td>Principal Accountant Fees and Services</td><td>NM</td><td>Gross Profit</td><td> Exhibit Number</td><td>Fair value of plan assets</td></tr><tr><td> Liabilities</td><td>Michigan</td><td>Total liabilities and shareholdersβ equity</td><td colspan="6"></td></tr></thead><tbody><tr><td>Loss from discontinued operations</td><td>19.42%</td><td>34.87%</td><td>41.1%</td><td>92.90%</td><td>71.8%</td><td>82.49%</td><td>53.72%</td><td>94.60%</td></tr><tr><td> Third Quarter</td><td>58.38%</td><td>6.85%</td><td>87.26%</td><td>95.27%</td><td>1.65%</td><td>75.71%</td><td>74.73%</td><td>97.91%</td></tr><tr><td> Revenue</td><td>92.1%</td><td>54.58%</td><td>54.40%</td><td>25.16%</td><td>34.39%</td><td>90.98%</td><td>41.22%</td><td>73.51%</td></tr><tr><td> Exhibit</td><td>81.16%</td><td></td><td>15.63%</td><td>47.15%</td><td>95.21%</td><td>41.72%</td><td>71.34%</td><td>29.74%</td></tr><tr><td></td><td></td><td>94.59%</td><td>18.11%</td><td>78.26%</td><td>53.90%</td><td>99.45%</td><td>33.98%</td><td>9.89%</td></tr><tr><td>Minority interest</td><td>21.16%</td><td></td><td></td><td>31.1%</td><td>93.71%</td><td>22.15%</td><td>74.74%</td><td></td></tr><tr><td> Amount</td><td>64.65%</td><td></td><td>34.47%</td><td></td><td>78.79%</td><td>90.43%</td><td>2.41%</td><td>56.47%</td></tr><tr><td>Equipment</td><td>73.27%</td><td>38.12%</td><td>29.39%</td><td></td><td>30.18%</td><td>4.72%</td><td>15.40%</td><td>43.79%</td></tr><tr><td>Fourth quarter</td><td>9.97%</td><td>65.18%</td><td>64.67%</td><td></td><td>47.63%</td><td>84.4%</td><td>91.91%</td><td>54.60%</td></tr><tr><td>Long-term debt</td><td>95.69%</td><td>70.1%</td><td>20.24%</td><td></td><td>10.83%</td><td>60.15%</td><td></td><td></td></tr><tr><td>Operating revenues</td><td>20.20%</td><td>31.49%</td><td>41.7%</td><td>23.75%</td><td>96.65%</td><td>7.84%</td><td>67.79%</td><td>97.16%</td></tr><tr><td>Less accumulated depreciation and amortization</td><td>79.39%</td><td></td><td>65.56%</td><td></td><td>56.27%</td><td>36.33%</td><td>41.77%</td><td>36.53%</td></tr><tr><td></td><td>39.83%</td><td>94.12%</td><td>24.2%</td><td>58.1%</td><td>55.42%</td><td>32.69%</td><td>32.23%</td><td>9.7%</td></tr><tr><td>Item 12.</td><td>19.35%</td><td>71.65%</td><td>48.26%</td><td></td><td>87.14%</td><td>12.99%</td><td>7.97%</td><td>1.53%</td></tr><tr><td>Thereafter</td><td></td><td>5.75%</td><td>81.81%</td><td></td><td>29.3%</td><td>7.23%</td><td>72.27%</td><td>85.78%</td></tr><tr><td></td><td>88.66%</td><td>36.41%</td><td>87.22%</td><td>69.78%</td><td>24.34%</td><td>54.15%</td><td>20.20%</td><td>29.14%</td></tr><tr><td>S-8</td><td>17.77%</td><td>57.79%</td><td>96.41%</td><td>4.94%</td><td>87.35%</td><td>84.90%</td><td>82.40%</td><td>80.52%</td></tr><tr><td>Interest rate swaps</td><td>9.76%</td><td>87.24%</td><td>18.71%</td><td>41.23%</td><td>40.34%</td><td>69.25%</td><td>36.3%</td><td>95.58%</td></tr><tr><td></td><td>41.2%</td><td>40.86%</td><td>19.56%</td><td>52.92%</td><td>18.73%</td><td>34.93%</td><td>13.91%</td><td>97.10%</td></tr><tr><td>Filed herewith</td><td>62.27%</td><td>6.23%</td><td>72.43%</td><td>98.10%</td><td>99.87%</td><td>53.43%</td><td>64.46%</td><td>30.60%</td></tr><tr><td>Dividends paid</td><td>88.76%</td><td>73.99%</td><td></td><td>51.44%</td><td>72.9%</td><td>2.42%</td><td>34.44%</td><td></td></tr><tr><td>Year</td><td>26.43%</td><td>15.28%</td><td></td><td></td><td>65.25%</td><td>46.92%</td><td>82.99%</td><td>53.9%</td></tr></tbody> | 0.957617 | ||
image_056255_1634641255.342525.png | fintabnet | <thead><tr><td>As of December 31,</td><td>As of December 31,</td><td>Outlook</td><td>SecondQuarter</td><td>Automobile</td><td>Low</td></tr></thead><tbody><tr><td>December 31, 2011</td><td>Short-term borrowings</td><td>Changes in operating assets and liabilities:</td><td>General and administrative expense</td><td>Total</td><td>PART IV</td></tr><tr><td>In thousands, except per share data</td><td>Software</td><td></td><td></td><td></td><td>Level 1</td></tr><tr><td>Liabilities:</td><td>Operating profit</td><td>Amount</td><td>Accumulated other comprehensive loss</td><td>Fourth</td><td>Retained earnings</td></tr><tr><td>Incorporated by Reference</td><td>Shares</td><td>Share-based compensation</td><td>Reports of Independent Registered Public Accounting Firm</td><td>Fourth Quarter</td><td>Total shareholders' equity</td></tr><tr><td>Net earnings</td><td>Income tax expense benefit</td><td>Cash flows from financing activities:</td><td>PART II</td><td>Cost of revenue</td><td>Directors, Executive Officers and Corporate Governance</td></tr><tr><td>101.PRE</td><td>Consolidated</td><td>December 31, 2011</td><td>Price</td><td>Entergy Arkansas</td><td>Foreign exchange contracts</td></tr><tr><td></td><td>Australia</td><td>All other</td><td>A</td><td>Commitments and contingencies</td><td>In millions of dollars</td></tr><tr><td>Entergy New Orleans</td><td></td><td>Commercial and industrial</td><td></td><td>Ameren Missouri</td><td>Numerator:</td></tr><tr><td>Dollars</td><td></td><td>Effective income tax rate</td><td>A</td><td>Operating</td><td>Dividends paid</td></tr><tr><td>Current portion of long-term debt</td><td>Virginia</td><td>Asset-backed securities</td><td>December 31, 2006</td><td>PART IV</td><td>101.PRE</td></tr><tr><td>Projected benefit obligation</td><td>$β</td><td>Variation</td><td></td><td>Ameren</td><td>Total Revenues</td></tr><tr><td>Own</td><td>Gross deferred tax assets</td><td>Baa1</td><td>Amortization of prior service cost</td><td>dollars in millions</td><td>101.LAB</td></tr><tr><td>Georgia</td><td>Balance at December 31, 2014</td><td>Michigan</td><td>Total current liabilities</td><td>Cash and cash equivalents at end of year</td><td>Item 7.</td></tr><tr><td>β</td><td>For the year ended December 31,</td><td>Fixed income</td><td>S-1</td><td>Level 3</td><td></td></tr><tr><td></td><td>For the years ended December 31,</td><td>June 30,</td><td></td><td>Income taxes</td><td>Accounts payable and accrued expenses</td></tr><tr><td></td><td>Year Ended October 31,</td><td>Income loss from continuing operations</td><td>High</td><td>ASSETS</td><td>Other comprehensive income</td></tr><tr><td>Ending balance</td><td>Additions for tax positions of prior years</td><td>Second</td><td>XBRL Taxonomy Extension Calculation Linkbase Document</td><td>Number</td><td>Percentage of total revenue</td></tr><tr><td>Year Ended December 31</td><td>Forfeited</td><td>Item 3.</td><td>10-Q</td><td>Value</td><td>Thereafter</td></tr><tr><td>Inventories</td><td></td><td>Home equity</td><td>DOLLARS IN THOUSANDS</td><td>Year Ended December 31</td><td></td></tr></tbody> | <thead><tr><td>As of December 31,</td><td>As of December 31,</td><td>Outlook</td><td>SecondQuarter</td><td>Automobile</td><td> Low</td></tr><tr><td> December 31, 2011</td><td>Short-term borrowings</td><td>Changes in operating assets and liabilities:</td><td>General and administrative expense</td><td> Total </td><td>PART IV</td></tr><tr><td>In thousands, except per share data</td><td colspan="4">Software</td><td>Level 1</td></tr></thead><tbody><tr><td>Liabilities:</td><td>Operating profit</td><td>Amount</td><td>Accumulated other comprehensive loss</td><td>Fourth</td><td>Retained earnings</td></tr><tr><td>Incorporated by Reference</td><td> Shares</td><td>Share-based compensation</td><td>Reports of Independent Registered Public Accounting Firm</td><td> Fourth Quarter</td><td>Total shareholdersβ equity</td></tr><tr><td>Net earnings</td><td>Income tax expense benefit</td><td>Cash flows from financing activities:</td><td> PART II</td><td>Cost of revenue</td><td>Directors, Executive Officers and Corporate Governance</td></tr><tr><td>101.PRE</td><td>Consolidated</td><td>December 31, 2011</td><td>Price</td><td>Entergy Arkansas</td><td>Foreign exchange contracts</td></tr><tr><td></td><td>Australia</td><td>All other</td><td>A</td><td>Commitments and contingencies</td><td>In millions of dollars</td></tr><tr><td>Entergy New Orleans</td><td></td><td>Commercial and industrial</td><td></td><td>Ameren Missouri</td><td>Numerator:</td></tr><tr><td>Dollars</td><td> </td><td>Effective income tax rate</td><td>A</td><td>Operating</td><td>Dividends paid</td></tr><tr><td>Current portion of long-term debt</td><td>Virginia</td><td>Asset-backed securities</td><td>December 31, 2006</td><td>PART IV</td><td>101.PRE</td></tr><tr><td>Projected benefit obligation</td><td>$β</td><td>Variation</td><td></td><td>Ameren</td><td>Total Revenues</td></tr><tr><td>Own</td><td>Gross deferred tax assets</td><td>Baa1</td><td>Amortization of prior service cost</td><td>dollars in millions</td><td>101.LAB</td></tr><tr><td>Georgia</td><td>Balance at December 31, 2014</td><td>Michigan</td><td>Total current liabilities</td><td>Cash and cash equivalents at end of year</td><td>Item 7.</td></tr><tr><td>β</td><td>For the year ended December 31,</td><td>Fixed income</td><td>S-1</td><td>Level 3</td><td> </td></tr><tr><td></td><td>For the years ended December 31,</td><td>June 30,</td><td></td><td>Income taxes</td><td>Accounts payable and accrued expenses</td></tr><tr><td></td><td>Year Ended October 31,</td><td>Income loss from continuing operations</td><td>High</td><td> ASSETS</td><td>Other comprehensive income</td></tr><tr><td>Ending balance</td><td>Additions for tax positions of prior years</td><td>Second</td><td>XBRL Taxonomy Extension Calculation Linkbase Document</td><td>Number</td><td>Percentage of total revenue</td></tr><tr><td>Year Ended December 31</td><td>Forfeited</td><td>Item 3.</td><td>10-Q</td><td> Value</td><td>Thereafter</td></tr><tr><td>Inventories</td><td></td><td>Home equity</td><td>DOLLARS IN THOUSANDS</td><td> Year Ended December 31</td><td></td></tr></tbody> | 0.920301 | ||
image_020305_1634632039.929939.png | pubtabnet | <thead><tr><td colspan="10">N</td><td>Ξ²</td><td colspan="2">Number</td><td>Gender</td></tr></thead><tbody><tr><td></td><td></td><td>70</td><td>80</td><td>81</td><td>9</td><td>79</td><td></td><td>85</td><td>69</td><td>46</td><td>91</td><td>20</td><td>77</td></tr><tr><td>P value</td><td>42</td><td>16</td><td>15</td><td>16</td><td>19</td><td>27</td><td>66</td><td>18</td><td></td><td>45</td><td>27</td><td>7</td><td>11</td></tr><tr><td>Parameter</td><td>74</td><td>16</td><td>93</td><td>13</td><td>43</td><td>41</td><td>24</td><td>84</td><td>87</td><td>53</td><td>0</td><td>7</td><td>0</td></tr><tr><td></td><td></td><td>44</td><td>38</td><td>69</td><td>33</td><td>49</td><td>90</td><td>15</td><td>10</td><td>46</td><td>5</td><td>31</td><td>84</td></tr><tr><td>Reference</td><td>13</td><td>14</td><td>3</td><td>28</td><td>46</td><td>5</td><td>18</td><td>46</td><td>52</td><td></td><td></td><td>17</td><td>19</td></tr><tr><td>Study</td><td>83</td><td></td><td>20</td><td>7</td><td>39</td><td>59</td><td>65</td><td>56</td><td>39</td><td>45</td><td>32</td><td>95</td><td>70</td></tr></tbody> | <thead><tr><td colspan="10">N</td><td>Ξ²</td><td colspan="2">Number</td><td>Gender</td></tr></thead><tbody><tr><td></td><td></td><td>70</td><td>80</td><td>81</td><td>9</td><td>79</td><td></td><td>85</td><td>69</td><td>46</td><td>91</td><td>20</td><td>77</td></tr><tr><td>P value</td><td>42</td><td>16</td><td>15</td><td>16</td><td>19</td><td>27</td><td>66</td><td>18</td><td></td><td>45</td><td>27</td><td>7</td><td>11</td></tr><tr><td>Parameter</td><td>74</td><td>16</td><td>93</td><td>13</td><td>43</td><td>41</td><td>24</td><td>84</td><td>87</td><td>53</td><td>0</td><td>7</td><td>0</td></tr><tr><td></td><td></td><td>44</td><td>38</td><td>69</td><td>33</td><td>49</td><td>90</td><td>15</td><td>10</td><td>46</td><td>5</td><td>31</td><td>84</td></tr><tr><td>Reference</td><td>13</td><td>14</td><td>3</td><td>28</td><td>46</td><td>5</td><td>18</td><td>46</td><td>52</td><td></td><td></td><td>17</td><td>19</td></tr><tr><td>Study</td><td>83</td><td></td><td>20</td><td>7</td><td>39</td><td>59</td><td>65</td><td>56</td><td>39</td><td>45</td><td>32</td><td>95</td><td>70</td></tr></tbody> | 1 | ||
image_132522_1634657173.958153.png | fintabnet | <thead><tr><td>Second Quarter</td><td>Carrying Value</td><td>Sales</td><td>General and administrative expenses</td><td rowspan="2">Average</td><td>Operating revenues</td><td>Effect of dilutive securities:</td><td>Balance at December 31, 2014</td><td>Southwest</td></tr></thead><tbody><tr><td></td><td>Equipment</td><td>$</td><td>Projected benefit obligation</td><td>Interest rate swaps</td><td>Item 2.</td><td></td><td></td></tr><tr><td>101.PRE</td><td>Other intangible assets</td><td>Total comprehensive income</td><td>Income taxes</td><td>Item 3.</td><td></td><td></td><td></td><td></td></tr><tr><td>Loans held for sale</td><td>902522</td><td>739921</td><td>766796</td><td></td><td>317813</td><td>336378</td><td>660646</td><td></td></tr><tr><td>Balance at January 1</td><td>269288</td><td>218786</td><td></td><td>481332</td><td>646471</td><td>713686</td><td>91709</td><td>493850</td></tr><tr><td>Basic</td><td>255857</td><td>167598</td><td>66663</td><td>383750</td><td></td><td>651676</td><td>353998</td><td>251402</td></tr><tr><td></td><td>444823</td><td>331145</td><td>133838</td><td>197233</td><td>111719</td><td>940232</td><td>331004</td><td>649652</td></tr><tr><td>Equipment</td><td>862366</td><td>78865</td><td>953119</td><td></td><td>254739</td><td></td><td></td><td>647160</td></tr><tr><td>Expected volatility</td><td>110319</td><td>586434</td><td>659629</td><td>313162</td><td>741172</td><td>428747</td><td>887107</td><td>96358</td></tr><tr><td>Asia</td><td>912583</td><td>711679</td><td>507415</td><td>858096</td><td>434750</td><td>923662</td><td>512606</td><td>166066</td></tr><tr><td>Pinnacle West APS</td><td>353113</td><td>937835</td><td>366391</td><td>59724</td><td>656137</td><td>522912</td><td>114258</td><td>699437</td></tr><tr><td>Consent of Independent Registered Public Accounting Firm.</td><td>238479</td><td>126884</td><td>969853</td><td>895068</td><td>360314</td><td>113730</td><td>655488</td><td>92534</td></tr><tr><td>Total deferred tax liabilities</td><td></td><td>13369</td><td>511375</td><td>533288</td><td>417142</td><td>804079</td><td>34670</td><td>488395</td></tr><tr><td>Earnings from continuing operations</td><td>849934</td><td>751550</td><td>38952</td><td>571742</td><td>585807</td><td>970362</td><td></td><td>561401</td></tr><tr><td>Interest expense, net</td><td>107420</td><td>333063</td><td>116402</td><td>278122</td><td></td><td>398466</td><td>103413</td><td>159581</td></tr><tr><td>$ Change</td><td>395895</td><td>736645</td><td>668389</td><td>68848</td><td>308465</td><td>604703</td><td>298926</td><td>535785</td></tr><tr><td>Other, net</td><td>529556</td><td>96397</td><td>748581</td><td>170421</td><td>526880</td><td>687105</td><td>284562</td><td>343512</td></tr><tr><td>A3</td><td>13702</td><td>384960</td><td>99112</td><td>899660</td><td>539964</td><td>678979</td><td>300048</td><td>94801</td></tr></tbody> | <thead><tr><td> Second Quarter</td><td>Carrying Value</td><td>Sales</td><td>General and administrative expenses</td><td rowspan="2">Average</td><td>Operating revenues</td><td>Effect of dilutive securities:</td><td>Balance at December 31, 2014</td><td>Southwest</td></tr><tr><td></td><td>Equipment</td><td> $</td><td>Projected benefit obligation</td><td>Interest rate swaps</td><td>Item 2.</td><td colspan="2"></td></tr><tr><td>101.PRE</td><td>Other intangible assets</td><td>Total comprehensive income</td><td>Income taxes</td><td colspan="5">Item 3.</td></tr></thead><tbody><tr><td>Loans held for sale</td><td>902522</td><td>739921</td><td>766796</td><td></td><td>317813</td><td>336378</td><td>660646</td><td></td></tr><tr><td>Balance at January 1</td><td>269288</td><td>218786</td><td></td><td>481332</td><td>646471</td><td>713686</td><td>91709</td><td>493850</td></tr><tr><td>Basic</td><td>255857</td><td>167598</td><td>66663</td><td>383750</td><td></td><td>651676</td><td>353998</td><td>251402</td></tr><tr><td></td><td>444823</td><td>331145</td><td>133838</td><td>197233</td><td>111719</td><td>940232</td><td>331004</td><td>649652</td></tr><tr><td>Equipment</td><td>862366</td><td>78865</td><td>953119</td><td></td><td>254739</td><td></td><td></td><td>647160</td></tr><tr><td>Expected volatility</td><td>110319</td><td>586434</td><td>659629</td><td>313162</td><td>741172</td><td>428747</td><td>887107</td><td>96358</td></tr><tr><td>Asia</td><td>912583</td><td>711679</td><td>507415</td><td>858096</td><td>434750</td><td>923662</td><td>512606</td><td>166066</td></tr><tr><td>Pinnacle West APS</td><td>353113</td><td>937835</td><td>366391</td><td>59724</td><td>656137</td><td>522912</td><td>114258</td><td>699437</td></tr><tr><td>Consent of Independent Registered Public Accounting Firm.</td><td>238479</td><td>126884</td><td>969853</td><td>895068</td><td>360314</td><td>113730</td><td>655488</td><td>92534</td></tr><tr><td>Total deferred tax liabilities</td><td></td><td>13369</td><td>511375</td><td>533288</td><td>417142</td><td>804079</td><td>34670</td><td>488395</td></tr><tr><td>Earnings from continuing operations</td><td>849934</td><td>751550</td><td>38952</td><td>571742</td><td>585807</td><td>970362</td><td></td><td>561401</td></tr><tr><td>Interest expense, net</td><td>107420</td><td>333063</td><td>116402</td><td>278122</td><td></td><td>398466</td><td>103413</td><td>159581</td></tr><tr><td>$ Change</td><td>395895</td><td>736645</td><td>668389</td><td>68848</td><td>308465</td><td>604703</td><td>298926</td><td>535785</td></tr><tr><td>Other, net</td><td>529556</td><td>96397</td><td>748581</td><td>170421</td><td>526880</td><td>687105</td><td>284562</td><td>343512</td></tr><tr><td>A3</td><td>13702</td><td>384960</td><td>99112</td><td>899660</td><td>539964</td><td>678979</td><td>300048</td><td>94801</td></tr></tbody> | 0.936096 | ||
image_097598_1634641095.529679.png | sparse | <thead><tr><td>Number</td><td colspan="2">p Value</td><td></td></tr></thead><tbody><tr><td>Gene</td><td>Age years</td><td>P-value</td><td>Parameters</td></tr><tr><td>Total</td><td>Reference</td><td></td><td>Range</td></tr><tr><td>Sample</td><td></td><td></td><td></td></tr><tr><td>Author</td><td></td><td>44</td><td></td></tr><tr><td>Specificity</td><td></td><td></td><td>7</td></tr><tr><td>N %</td><td></td><td>78</td><td>76</td></tr><tr><td>95 % CI</td><td>67</td><td>86</td><td></td></tr><tr><td>Name</td><td>81</td><td></td><td>4</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td>Characteristic</td><td></td><td></td><td></td></tr><tr><td>Women</td><td>53</td><td></td><td></td></tr><tr><td>Sensitivity</td><td></td><td>83</td><td></td></tr><tr><td>Strain</td><td></td><td></td><td></td></tr><tr><td>Case</td><td>84</td><td></td><td></td></tr><tr><td>Sex</td><td></td><td></td><td></td></tr></tbody> | <thead><tr><td>Number</td><td>p Value</td><td rowspan="3">P-value</td><td rowspan="2">Parameters</td></tr><tr><td>Gene</td><td>Age years</td></tr><tr><td>Total</td><td>Reference</td><td>Range</td></tr></thead><tbody><tr><td>Sample</td><td></td><td></td><td></td></tr><tr><td>Author</td><td></td><td>44</td><td></td></tr><tr><td>Specificity</td><td></td><td></td><td>7</td></tr><tr><td>N %</td><td></td><td>78</td><td>76</td></tr><tr><td>95 % CI</td><td>67</td><td>86</td><td></td></tr><tr><td>Name</td><td>81</td><td></td><td>4</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td>Characteristic</td><td></td><td></td><td></td></tr><tr><td>Women</td><td>53</td><td></td><td></td></tr><tr><td>Sensitivity</td><td></td><td>83</td><td></td></tr><tr><td>Strain</td><td></td><td></td><td></td></tr><tr><td>Case</td><td>84</td><td></td><td></td></tr><tr><td>Sex</td><td></td><td></td><td></td></tr></tbody> | 0.876543 | ||
image_128671_1634647849.54945.png | pubtabnet | <thead><tr><td>Patient</td><td></td><td></td></tr></thead><tbody><tr><td>Author</td><td colspan="2">Year</td></tr><tr><td>Gene</td><td>68.54%</td><td>69.28%</td></tr><tr><td>Men</td><td>96.86%</td><td>86.83%</td></tr><tr><td>Genotype</td><td>0.44%</td><td>14.93%</td></tr><tr><td>Gene name</td><td></td><td>70.40%</td></tr><tr><td>Description</td><td>57.98%</td><td>99.77%</td></tr><tr><td></td><td>79.91%</td><td>36.47%</td></tr><tr><td>p-Value</td><td>39.90%</td><td>54.59%</td></tr><tr><td></td><td>71.22%</td><td>38.39%</td></tr><tr><td>P</td><td>36.1%</td><td>58.5%</td></tr><tr><td>Controls</td><td>86.61%</td><td>71.11%</td></tr><tr><td>p-Value</td><td>86.72%</td><td>69.39%</td></tr><tr><td>F</td><td>93.99%</td><td></td></tr><tr><td>Sex</td><td>73.95%</td><td>36.33%</td></tr><tr><td>Cases</td><td>1.95%</td><td>17.16%</td></tr><tr><td>Characteristics</td><td>5.35%</td><td>15.63%</td></tr><tr><td></td><td>81.1%</td><td>11.6%</td></tr><tr><td></td><td>29.72%</td><td></td></tr><tr><td>Group</td><td>21.56%</td><td>13.39%</td></tr></tbody> | <thead><tr><td>Patient</td><td rowspan="2" colspan="2">Year</td></tr><tr><td>Author</td></tr></thead><tbody><tr><td>Gene</td><td>68.54%</td><td>69.28%</td></tr><tr><td>Men</td><td>96.86%</td><td>86.83%</td></tr><tr><td>Genotype</td><td>0.44%</td><td>14.93%</td></tr><tr><td>Gene name</td><td></td><td>70.40%</td></tr><tr><td>Description</td><td>57.98%</td><td>99.77%</td></tr><tr><td></td><td>79.91%</td><td>36.47%</td></tr><tr><td>p-Value</td><td>39.90%</td><td>54.59%</td></tr><tr><td></td><td>71.22%</td><td>38.39%</td></tr><tr><td>P</td><td>36.1%</td><td>58.5%</td></tr><tr><td>Controls</td><td>86.61%</td><td>71.11%</td></tr><tr><td>p-Value</td><td>86.72%</td><td>69.39%</td></tr><tr><td>F</td><td>93.99%</td><td></td></tr><tr><td>Sex</td><td>73.95%</td><td>36.33%</td></tr><tr><td>Cases</td><td>1.95%</td><td>17.16%</td></tr><tr><td>Characteristics</td><td>5.35%</td><td>15.63%</td></tr><tr><td></td><td>81.1%</td><td>11.6%</td></tr><tr><td></td><td>29.72%</td><td></td></tr><tr><td>Group</td><td>21.56%</td><td>13.39%</td></tr></tbody> | 0.91358 | ||
image_033009_1634633355.315121.png | sparse | <thead><tr><td>Group</td><td>Treatment</td><td>SD</td><td>p Value</td><td rowspan="2">n %</td><td></td></tr></thead><tbody><tr><td>Item</td><td>t</td><td>Parameters</td><td>Controls</td><td></td></tr><tr><td>Name</td><td>44</td><td></td><td></td><td></td><td>34</td></tr><tr><td>Percent</td><td>76</td><td></td><td></td><td>26</td><td></td></tr></tbody> | <thead><tr><td>Group</td><td>Treatment</td><td>SD</td><td>p Value</td><td rowspan="2" colspan="2">n %</td></tr><tr><td>Item</td><td>t</td><td>Parameters</td><td>Controls</td></tr></thead><tbody><tr><td>Name</td><td>44</td><td></td><td></td><td></td><td>34</td></tr><tr><td>Percent</td><td>76</td><td></td><td></td><td>26</td><td></td></tr></tbody> | 0.758621 | ||
image_046348_1634639187.7573.png | fintabnet | <thead><tr><td rowspan="2">Fair Value</td><td>Benefits paid</td><td>Ameren Missouri</td></tr></thead><tbody><tr><td></td><td>Total</td></tr><tr><td>Distribution</td><td>581628</td><td>169512</td></tr><tr><td></td><td>87523</td><td></td></tr><tr><td>Variation</td><td>879668</td><td>565291</td></tr><tr><td>Yes</td><td>763754</td><td>670261</td></tr><tr><td>Treasury Stock</td><td>41563</td><td>794219</td></tr><tr><td></td><td>442418</td><td>89250</td></tr><tr><td>Amortized Cost</td><td>466900</td><td>465071</td></tr><tr><td>Net loss</td><td>572118</td><td>741570</td></tr><tr><td>Accumulated Amortization</td><td>452359</td><td>819619</td></tr><tr><td>Increase</td><td>991871</td><td>502839</td></tr></tbody> | <thead><tr><td rowspan="2"> Fair Value</td><td>Benefits paid</td><td>Ameren Missouri</td></tr><tr><td></td><td>Total</td></tr></thead><tbody><tr><td>Distribution</td><td>581628</td><td>169512</td></tr><tr><td></td><td>87523</td><td></td></tr><tr><td>Variation</td><td>879668</td><td>565291</td></tr><tr><td>Yes</td><td>763754</td><td>670261</td></tr><tr><td>Treasury Stock</td><td>41563</td><td>794219</td></tr><tr><td> </td><td>442418</td><td>89250</td></tr><tr><td> Amortized Cost</td><td>466900</td><td>465071</td></tr><tr><td>Net loss</td><td>572118</td><td>741570</td></tr><tr><td>Accumulated Amortization</td><td>452359</td><td>819619</td></tr><tr><td>Increase</td><td>991871</td><td>502839</td></tr></tbody> | 0.894898 | ||
image_125615_1634647424.748449.png | pubtabnet | <thead><tr><td>Groups</td><td>Treatment</td><td>HR</td></tr><tr><td>p Value</td><td>Patient</td><td>366073</td></tr><tr><td>Age</td><td>Baseline</td><td></td></tr></thead><tbody><tr><td></td><td>56.52%</td><td>24.63%</td></tr><tr><td>Percent</td><td></td><td>58.45%</td></tr><tr><td>Factor</td><td>84.52%</td><td>22.43%</td></tr><tr><td>Sample</td><td></td><td>81.52%</td></tr><tr><td>No</td><td>75.96%</td><td>45.60%</td></tr><tr><td></td><td>7.7%</td><td>77.72%</td></tr><tr><td>Frequency</td><td>38.93%</td><td>54.24%</td></tr><tr><td>t</td><td>85.90%</td><td>98.20%</td></tr><tr><td>P</td><td>90.13%</td><td>96.59%</td></tr><tr><td>Univariate analysis</td><td>6.59%</td><td>91.23%</td></tr><tr><td>Baseline</td><td>47.39%</td><td>23.97%</td></tr></tbody> | <thead><tr><td>Groups</td><td>Treatment</td><td>HR</td></tr><tr><td>p Value</td><td>Patient</td><td>366073</td></tr><tr><td>Age</td><td colspan="2">Baseline</td></tr></thead><tbody><tr><td></td><td>56.52%</td><td>24.63%</td></tr><tr><td>Percent</td><td></td><td>58.45%</td></tr><tr><td>Factor</td><td>84.52%</td><td>22.43%</td></tr><tr><td>Sample</td><td></td><td>81.52%</td></tr><tr><td>No</td><td>75.96%</td><td>45.60%</td></tr><tr><td></td><td>7.7%</td><td>77.72%</td></tr><tr><td>Frequency</td><td>38.93%</td><td>54.24%</td></tr><tr><td>t</td><td>85.90%</td><td>98.20%</td></tr><tr><td>P</td><td>90.13%</td><td>96.59%</td></tr><tr><td>Univariate analysis</td><td>6.59%</td><td>91.23%</td></tr><tr><td>Baseline</td><td>47.39%</td><td>23.97%</td></tr></tbody> | 0.965517 | ||
image_076138_1634640165.109514.png | pubtabnet | <thead><tr><td>Day</td><td>Function</td><td>Time</td><td>Data set</td><td>Heterogeneity</td><td rowspan="2">Total score</td><td></td><td>Disadvantages</td></tr><tr><td>Deaths</td><td>Event</td><td>Nutrient</td><td>Day 5</td><td>33.33</td><td>No. of patients</td><td>Antigen</td></tr><tr><td>Parameters</td><td>Subject</td><td>Outcomes</td><td colspan="2">Criteria</td><td></td><td>Mean square</td><td>Weight kg</td></tr></thead><tbody><tr><td>Number of genes</td><td>0/0</td><td>Physical activity</td><td>Employment status</td><td>β</td><td>β18</td><td>β’</td><td>1.0 reference</td></tr><tr><td></td><td>No</td><td>Z</td><td>[61]</td><td>Down</td><td>-0.05</td><td>Abdominal pain</td><td></td></tr><tr><td>W</td><td>Male sex</td><td>MF</td><td>IL-10</td><td>EGFR</td><td>1.00 Reference</td><td>NSCLC</td><td>β0.02</td></tr><tr><td>Cd</td><td><0.0001*</td><td>β</td><td>Demographics</td><td>Excellent</td><td>r</td><td></td><td>Fatigue</td></tr><tr><td>Female</td><td>Clinical stage</td><td>Cerebellum</td><td>Missing</td><td>+/-</td><td>Female</td><td></td><td>y</td></tr><tr><td>Exercise</td><td>β0.16</td><td>GA</td><td>Poor</td><td>unknown</td><td>Diabetes mellitus</td><td>Sex</td><td>Fever</td></tr><tr><td>Crude</td><td>-0.07</td><td>β24</td><td>Females</td><td>s</td><td></td><td></td><td>-0.09</td></tr><tr><td>Microorganism</td><td>Median range</td><td>Not reported</td><td>Unadjusted</td><td>β10</td><td>-0.01</td><td>β10</td><td></td></tr><tr><td></td><td>[45]</td><td></td><td>Others</td><td>Time</td><td>NAS</td><td></td><td>total</td></tr><tr><td>Etiology</td><td>β</td><td>C3</td><td>Alcohol consumption</td><td>Educational level</td><td>Model 3</td><td>Antisense</td><td>normal</td></tr><tr><td>Day 5</td><td>B2</td><td>III</td><td>Time</td><td></td><td>Absent</td><td>ns</td><td>Gender</td></tr><tr><td>AIC</td><td>Cohort</td><td>[8]</td><td>United States</td><td>Colon</td><td></td><td>Weight</td><td>β3</td></tr><tr><td>Instrument</td><td>F2</td><td>Total</td><td>40β49</td><td>Rural</td><td>P2</td><td>nd</td><td>-0.05</td></tr></tbody> | <thead><tr><td>Day</td><td>Function</td><td>Time</td><td>Data set</td><td>Heterogeneity</td><td rowspan="3">Total score</td><td></td><td>Disadvantages</td></tr><tr><td>Deaths</td><td>Event</td><td>Nutrient</td><td>Day 5</td><td>33.33</td><td>No. of patients</td><td>Antigen</td></tr><tr><td>Parameters</td><td>Subject</td><td>Outcomes</td><td colspan="2">Criteria</td><td>Mean square</td><td>Weight kg</td></tr></thead><tbody><tr><td>Number of genes</td><td>0/0</td><td>Physical activity</td><td>Employment status</td><td>β</td><td>β18</td><td>β’</td><td>1.0 reference</td></tr><tr><td></td><td>No</td><td>Z</td><td>[61]</td><td>Down</td><td>-0.05</td><td>Abdominal pain</td><td></td></tr><tr><td>W</td><td>Male sex</td><td>MF</td><td>IL-10</td><td>EGFR</td><td>1.00 Reference</td><td>NSCLC</td><td>β0.02</td></tr><tr><td>Cd</td><td><0.0001*</td><td>β</td><td>Demographics</td><td>Excellent</td><td>r</td><td></td><td>Fatigue</td></tr><tr><td>Female</td><td>Clinical stage</td><td>Cerebellum</td><td> Missing</td><td>+/-</td><td> Female</td><td></td><td>y</td></tr><tr><td>Exercise</td><td>β0.16</td><td>GA</td><td> Poor</td><td>unknown</td><td>Diabetes mellitus</td><td>Sex</td><td>Fever</td></tr><tr><td>Crude</td><td>-0.07</td><td>β24</td><td>Females</td><td>s</td><td></td><td>.</td><td>-0.09</td></tr><tr><td>Microorganism</td><td>Median range</td><td>Not reported</td><td>Unadjusted</td><td>β10</td><td>-0.01</td><td>β10</td><td></td></tr><tr><td></td><td>[45]</td><td></td><td>Others</td><td>Time</td><td>NAS</td><td></td><td>total</td></tr><tr><td>Etiology</td><td>β</td><td>C3</td><td>Alcohol consumption</td><td>Educational level</td><td>Model 3</td><td>Antisense</td><td>normal</td></tr><tr><td>Day 5</td><td>B2</td><td>III</td><td>Time</td><td></td><td>Absent</td><td>ns</td><td>Gender</td></tr><tr><td>AIC</td><td>Cohort</td><td>[8]</td><td>United States</td><td>Colon</td><td></td><td>Weight</td><td>β3</td></tr><tr><td>Instrument</td><td>F2</td><td>Total</td><td>40β49</td><td>Rural</td><td>P2</td><td>nd</td><td>-0.05</td></tr></tbody> | 0.975918 |
End of preview. Expand
in Dataset Viewer.
README.md exists but content is empty.
- Downloads last month
- 55